As filed with the Securities and Exchange Commission on December 22, 2006
Registration No. 333-137950
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
AMENDMENT NO.1
TO
FORM SB-2
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
SYSVIEW TECHNOLOGY, INC.
(Name of small business issuer in its charter)
Delaware 3679 59-3134518
----------------------------------------------------------------------------------------
(State or jurisdiction of (Primary Standard Industrial (I.R.S. Employer
incorporation or organization) Classification Code Number) Identification No.)
1772 Technology Drive
San Jose, California 95110
(408) 436-9888
--------------------------------------------------------------------------------
(Address and telephone number of principal executive offices)
Darwin Hu
1772 Technology Drive
San Jose, California 95110
(408) 436-9888
--------------------------------------------------------------------------------
(Name, address and telephone number of agent for service)
Copies to:
Jody R. Samuels, Esq.
Richardson & Patel LLP
The Chrysler Building
405 Lexington Avenue, 26th Floor
New York, New York 10174
(212) 907-6686
Approximate date of proposed sale to the public: As soon as practicable, after
this registration statement becomes effective.
If any of the securities being registered on this Form are to be offered on a
delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box. |X|
If this Form is filed to register additional securities for an offering pursuant
to Rule 462(b) under the Securities Act, please check the following box and list
the Securities Act registration statement number of the earlier effective
registration statement for the same offering. |_|
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under
the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. |_|
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under
the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. |_|
If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. |_|
CALCULATION OF REGISTRATION FEE
---------------------------------------------------------------------------------------------------------------------
PROPOSED PROPOSED MAXIMUM
TITLE OF EACH CLASS MAXIMUM AGGREGATE AMOUNT OF
OF SECURITIES AMOUNT TO BE OFFERING PRICE OFFERING REGISTRATION
TO BE REGISTERED REGISTERED PER UNIT PRICE FEE
---------------------------------------------------------------------------------------------------------------------
common stock, par value $0.01 per share, 1,150,000shares(1) $1.00 ((2)) $1,150,000 $35.31
underlying preferred stock
---------------------------------------------------------------------------------------------------------------------
common stock, par value $0.01 per share, 575,000 shares(1) $1.50 ((2)) $862,500 $26.48
underlying warrants
---------------------------------------------------------------------------------------------------------------------
common stock, par value $0.01 per share, 100,000 shares(1) $1.50((2)) $150,000 $4.61
underlying warrants
---------------------------------------------------------------------------------------------------------------------
TOTAL................................ 1,825,000 shares(1) $2,162,500 $66.40(3)
---------------------------------------------------------------------------------------------------------------------
----------
(1) The Registrant has completed a private placement to accredited investors
of units consisting of shares of the Registrant's Series B Convertible
Preferred Stock and Warrants to purchase shares of the Registrant's Common
Stock (the "Private Placement"). The Registrant is registering for resale
(i) 1,150,000 shares of Common Stock issuable upon conversion of shares of
the Series B Convertible Preferred Stock, (ii) 575,000 shares of Common
Stock issuable upon exercise of the Common Stock Purchase Warrants issued
to the purchasers in the Private Placement, and (iii) 100,000 shares of
Common Stock issuable upon the exercise of the Common Stock Purchase
Warrants issued to the placement agent in the Private Placement. Pursuant
to Rule 416 under the Securities Act, the shares being registered
hereunder include such indeterminate number of shares of Common Stock as
may be issuable with respect to the shares being registered hereunder as a
result of stock splits, stock dividends or similar transactions affecting
the shares to be offered by the selling shareholders.
(2) Represents the higher of: (i) the exercise prices of the convertible
security and (ii) the offering price of securities of the same class as
the common stock underlying the convertible security calculated in
accordance with Rule 457(c) under the Securities Act, for the purpose of
calculating the registration fee pursuant to Rule 457(g) under the
Securities Act.
(3) All of which has previously been paid.
The Registrant hereby amends this registration statement on such date or
dates as may be necessary to delay its effective date until the registrant shall
file a further amendment which specifically states that this registration
statement shall thereafter become effective in accordance with Section 8(a) of
the Securities Act or until the registration statement shall become effective on
such date as the Securities and Exchange Commission, acting pursuant to said
Section 8(a) may determine.
PRELIMINARY PROSPECTUS SUBJECT TO COMPLETION DATED DECEMBER 22, 2006
SYSVIEW TECHNOLOGY, INC.
1,825,000 SHARES OF COMMON STOCK
This prospectus relates to the public offering of up to 1,825,000 shares
of our common stock, par value $0.001 per share, for sale by the selling
stockholders for their own account. These shares include up to 1,150,000 shares
of common stock issuable upon conversion of the Series B Convertible Preferred
Stock and up to 675,000 shares of common stock issuable upon the exercise of
warrants. We will pay the expenses of registering these shares.
Our common stock is quoted on the NASD's Over the Counter Bulletin Board
(OTCBB) under the symbol "SYVT". On December 20, 2006, the closing sales price
for the common stock on the OTCBB was $0.60 per share.
To the extent they wish to sell their shares of our common stock as
provided for herein, the selling stockholders may offer and sell such shares on
a continuous or delayed basis in the future. These sales may be conducted in the
open market or in privately negotiated transactions and at market prices, fixed
prices or negotiated prices. We will not receive any of the proceeds from the
sale of the shares of common stock owned by the selling stockholders, but we
will receive funds from the exercise of their warrants upon exercise. Any such
proceeds will be used by us for working capital and general corporate purposes.
Prospective investors should read this prospectus and any amendment or
supplement hereto together with additional information described under the
heading "Available Information."
Our principal executive offices are located at 1772 Technology Drive, San
Jose, California 95110. Our telephone number is (408) 436-9888.
AN INVESTMENT IN THE SHARES OF OUR COMMON STOCK BEING OFFERED BY THIS
PROSPECTUS INVOLVES A HIGH DEGREE OF RISK. YOU SHOULD READ THE "RISK FACTORS"
SECTION BEGINNING ON PAGE 4 BEFORE YOU DECIDE TO PURCHASE ANY SHARES OF OUR
COMMON STOCK.
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES
COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE
ADEQUACY OR ACCURACY OF THE PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A
CRIMINAL OFFENSE.
The date of this prospectus is , 2006.
The information in this prospectus is not complete and may be changed. We may
not sell these securities until the registration statement filed with the
Securities and Exchange Commission is effective. This prospectus is not an offer
to sell these securities and it is not soliciting an offer to buy these
securities in any state where the offer or sale is not permitted.
TABLE OF CONTENTS
PAGE
Prospectus Summary.............................................................1
Risk Factors...................................................................4
Note on Forward Looking Statements............................................12
Business......................................................................13
Use of Proceeds...............................................................23
Selling Stockholders..........................................................23
Plan of Distribution..........................................................26
Directors, Executive Officers, Promoters and Control Persons;
Compliance with Section 16(a) of the Exchange Act.............................28
Security Ownership of Management..............................................31
Description of Securities.....................................................33
Management's Discussion and Analysis or Plan of Operation.....................40
Certain Relationships and Related Transactions................................55
Market for Comon Equity and Related Stockholder Matters.......................55
Executive Compensation........................................................55
Financial Statements..........................................................68
Legal Matters.................................................................68
Experts.......................................................................68
Available Information.........................................................68
You should rely only upon the information contained in this prospectus and
the registration statement of which this prospectus is a part. We have not
authorized any other person to provide you with different information. If anyone
provides you with different or inconsistent information, you should not rely on
it. We are not making an offer to sell these securities in any jurisdiction
where the offer or sale is not permitted. You should assume the information
appearing in this prospectus is accurate only as of the date on the front cover
of this prospectus. Our business, financial condition, results of operations and
prospects may have changed since that date. This prospectus is based on
information provided by us and other sources that we believe are reliable. We
have summarized certain documents and other information in a manner we believe
to be accurate, but we refer you to the actual documents for a more complete
understanding of what we discuss in this prospectus. In making an investment
decision, you must rely on your own examination of our business and the terms of
the offering, including the merits and risks involved.
PROSPECTUS SUMMARY
THE FOLLOWING SUMMARY HIGHLIGHTS SELECTED INFORMATION CONTAINED IN THIS
PROSPECTUS. THIS SUMMARY DOES NOT CONTAIN ALL OF THE INFORMATION YOU SHOULD
CONSIDER BEFORE INVESTING IN THE SECURITIES. BEFORE MAKING AN INVESTMENT
DECISION, YOU SHOULD READ THE ENTIRE PROSPECTUS CAREFULLY, INCLUDING THE RISK
FACTORS SECTION, THE FINANCIAL STATEMENTS AND THE NOTES TO THE FINANCIAL
STATEMENTS. IN THIS PROSPECTUS AND ANY AMENDMENT OR SUPPLEMENT HERETO, UNLESS
OTHERWISE INDICATED, THE TERMS "SYSVIEW TECHNOLOGY, INC.", "SYVT", "WE", "US",
AND "OUR" REFER AND RELATE TO SYSVIEW TECHNOLOGY, INC. AND ITS CONSOLIDATED
SUBSIDIARIES. ON JUNE 27, 2006, WE CHANGED OUR NAME FROM SYSCAN IMAGING, INC. TO
SYSVIEW TECHNOLOGY, INC.
OUR BUSINESS
We are in the business of developing, designing and delivering imaging
technology solutions. We currently have 14 issued patents held by us, all of
which are U.S. patents. Our technology is also covered by 5 issued patents in
Taiwan. We also have 5 patent applications currently pending with the US Patent
& Trademark Office, 3 of which relate to image display technology and 2 of which
relate to image scanning. Our approach to research and development (R&D) is
focused on creating new deliverable and marketable technologies. We sell our
products to clients throughout the world, including the United States, Canada,
Europe, South America, Australia and Asia. We intend to expand our business and
product offerings into the much larger image display market where we intend to
leverage our experience and expertise. We also believe that we may benefit from
a level of transfer of technologies from image capture to image display.
Our wholly-owned operating subsidiary, Syscan, Inc. ("SI"), was
incorporated on May 1, 1995, under the laws of the State of California and is
headquartered in San Jose with additional strategic offices in Arnhem (the
Netherlands) and Hong Kong. Our majority stockholder is Syscan Imaging Limited,
which is wholly-owned by Syscan Technology Holdings Limited. Syscan Technology
Holdings Limited is a publicly-held company incorporated in Bermuda whose shares
are listed on The Growth Enterprise Market of the Stock Exchange of Hong Kong
Limited.
Our strategy is to expand our image capture product line and technology
while leveraging our assets in other areas of the imaging industry. We are
actively shipping six categories of image capture products under several "house
brands" or their OEM counterparts versus five categories in 2004. The
introduction of the A4 duplex scanners (DocketPORT) in the third quarter created
a broader base of products. This new category quickly contributed over 7% of
unit sales in 2005, despite its mid-year introduction. The A4 simplex scanner
(TravelScan) category represented approximately 19% of our sales during the year
ended December 31, 2005, a decrease from 2004 (21%) of approximately 2%. The A6
simplex scanners that are widely used for capturing images of bank checks,
drivers licenses and various identification cards, represented the largest unit
sales in 2005 at 54%. This represented an increase of 8.1% over 2004 unit sales.
The A5 security document scanner experienced a 3% increase in unit sales in 2005
to 3% from less than 1% in 2004. Our fifth scanner product category,
representing approximately 15% of our sales ending the 12 months ended December
31, 2005, is the A8 business card reader scanner. In 2004 the A8 scanner
category represented approximately 21% of our sales, so we experienced a net
reduction in this category of 6%.
In addition to the finished scanner product line, we also design,
configure and sell the Contact Image Sensor (CIS) Modules that we use in our
products separately as an OEM component to manufacturers. This CIS business
represented approximately 5% of our overall sales during 2005, a decrease of 5%
from the previous year (2004 - 10%).
1
We intend to expand our image capture product line in 2007. These new
products are being introduced as both Syscan branded and OEM/ VAR branded
products launch. Many of these new scanners are being driven by increased market
demand for faster and easier-to-use products. They will also concentrate more on
the identity-security and financial transaction market needs.
Over the past twelve months we have begun focusing our sales and marketing
efforts substantially towards the vertical markets such as the Value Added
Reseller (VAR) and small-office-home-office (SOHO) markets. We believe focusing
on these markets is the most effective way to showcase our technological
capabilities and manufacturing efficiencies, while enabling us to maintain
higher margins, and require fewer resources than working directly with the mass
retailers.
While we continue to grow our presence in image capture technology, we
have begun creating, through acquisition and research and development, new
technology solutions for the substantially larger, image display market. More
specifically we are creating products and technologies to accent and enhance the
HDTV television market. Our first image display product is expected to be
available for delivery in 2007. We believe that these HDTV products will provide
advanced image quality at a highly competitive price point, creating a value
point product.
In addition to future products and technologies in various stages of
research and development, one of our objectives is to acquire companies in the
image capture and display industry that could compliment our business model,
improve our competitive positioning and expand our offerings to the marketplace,
all of which there can be no assurance. In identifying potential acquisition
candidates we will seek to acquire companies with varied distribution channels,
rich intellectual property (IP) and high caliber engineering personnel.
We intend to finance our research and development, commercialization and
distribution efforts and our working capital needs primarily through cash flow
generated from operations, our line of credit and through funding from other
sources, including debt financing and equity financing. While there can be no
assurance that such sources will provide adequate funding for our operations,
management believes such sources will be available to us.
Our principal executive offices are located at 1772 Technology Drive, San
Jose, California 95110 and our phone number (408) 436-9888.
SERIES B PREFERRED STOCK FINANCING
On August 8, 2006, we sold $1.150 million of our Series B Preferred Stock
to accredited investors. Net proceeds from the financing will be used for
marketing and sales, research and development opportunities and for general
working capital purposes.
The Series B Preferred Stock is convertible into shares of our common
stock at a conversion price of $1.00 per share. In connection with the
financing, we also issued to the selling stockholders common stock purchase
warrants to purchase up to 575,000 shares of our common stock at a price equal
to $1.50 per share. Starboard Capital Markets, LLC, an NASD member firm, acted
as placement agent in the sale of our Series B Preferred Stock and received a
cash commission of $80,000 and warrants to purchase up to 100,000 shares of our
common stock at an exercise price of $1.50 per share.
We have agreed, pursuant to a registration rights agreement, to register
the shares of common stock underlying the Series B Preferred Stock and warrants,
and are fulfilling our agreement by filing the registration statement of which
this prospectus is a part with the Securities and Exchange Commission.
2
THE OFFERING
Outstanding Common Stock 24,092,092 shares as of August 16, 2006.
Common Stock Offered Up to 1,825,000 shares of
common stock, including up to 1,150,000
shares of common stock issuable upon
conversion of the Series B Preferred
Stock and up to 675,000 shares of common
stock issuable upon the exercise of
warrants, which warrants have an
exercise price of $1.50 per share.
Proceeds We will not receive any proceeds from
the sale of the common stock issuable
upon conversion of the Series B
Preferred Stock that may be sold
pursuant to this prospectus. We will,
however, receive proceeds upon the
exercise of the warrants which, if all
such warrants are exercised in full,
would be $1,012,500. The selling
stockholders are under no obligation to
exercise their warrants. Proceeds, if
any, received from the exercise of
warrants will be used for general
corporate purposes.
Risk Factors The securities offered hereby involve a
high degree of risk. See "Risk Factors."
OTC Bulletin Board Symbol SYVT
[remainder of page intentionally left blank]
3
RISK FACTORS
AN INVESTMENT IN OUR SECURITIES IS EXTREMELY RISKY. YOU SHOULD CAREFULLY
CONSIDER THE FOLLOWING RISKS, IN ADDITION TO THE OTHER INFORMATION PRESENTED IN
THIS PROSPECTUS BEFORE DECIDING TO PURCHASE OUR SECURITIES. IF ANY OF THE
FOLLOWING RISKS ACTUALLY MATERIALIZE, OUR BUSINESS AND PROSPECTS COULD BE
SERIOUSLY HARMED, THE PRICE AND VALUE OF OUR SECURITIES COULD DECLINE AND YOU
COULD LOSE ALL OR PART OF YOUR INVESTMENT.
RISKS RELATING TO OUR BUSINESS
BECAUSE WE DEPEND ON A SMALL NUMBER OF KEY CUSTOMERS, OUR BUSINESS COULD BE
ADVERSELY AFFECTED IF WE FAIL TO RETAIN THESE CLIENTS AND/OR OBTAIN NEW CLIENTS
AT A LEVEL SUFFICIENT TO SUPPORT OUR OPERATIONS AND/OR BROADEN OUR CLIENT BASE.
During the year ended December 31, 2005 four of our customers accounted
for approximately 79% of total revenues and during the nine months ended
September 30, 2006 three of our customers accounted for approximately 82% of
total revenues. During the year ended December 31, 2004, four of our customers
accounted collectively for approximately 78% of total revenues. The loss of any
of our largest clients could have a material adverse effect on our business.
FOR EACH OF THE YEAR ENDED DECEMBER 31, 2005 AND THE NINE MONTHS ENDED SEPTEMBER
30, 2006 WE SUFFERED A NET LOSS AND WE MAY CONTINUE TO INCUR LOSSES FOR THE
FORESEEABLE FUTURE.
During the fiscal year ended December 31, 2005 and the nine months ended
September 30, 2006, we had an increase in revenues but we sustained an operating
loss and cannot be sure that we will again operate profitably in the future.
During the fiscal year ended December 31, 2005, our revenues increased by $1.79
million (29.5%) from $6.06 million for the year ended December 31, 2004 to $7.85
million for the year ended December 31, 2005. In addition, we had a net loss of
$1,493,238 for the year ended December 31, 2005, as compared to net loss of
$179,866 for the year ended December 31, 2004. During the nine months ended
September 30, 2006, our revenues increased by $3.673 million (68%) from $5.402
million for the nine months ended September 30, 2005 to $9.075 million for the
nine months ended September 30, 2006. In addition, we had a net loss of $1.370
million for the nine months ended September 30, 2006, as compared to net loss of
$1.644 million for the nine months ended September 30, 2005.
WE OUTSOURCE THE MANUFACTURING OF OUR IMAGE SCANNING PRODUCTS TO SYSCAN
TECHNOLOGY HOLDINGS LIMITED (STH), THE PARENT COMPANY OF OUR MAJORITY
SHAREHOLDER, AND IF THE OPERATIONS OF STH ARE INTERRUPTED OR IF OUR ORDERS
EXCEED THE MANUFACTURING CAPABILITIES OF STH, WE MAY NOT BE ABLE TO DELIVER OUR
PRODUCTS TO CUSTOMERS ON TIME.
We currently utilize the manufacturing services of STH the parent company
of our majority stockholder to manufacture all of our current products. STH
serves as the exclusive manufacturer of all current and future image capture
products to be produced by us, although there is no written agreement between us
and STH. STH operates a single facility and if our customers place orders for
large quantities of our products, or if STH's other customers place large orders
of products, may not be able to produce our products in sufficient quantities.
In addition, if the operations of STH were halted or restricted, even
temporarily, or they are unable to fulfill large orders, we could experience
business interruption, increased costs, damage to our reputation and loss of our
customers. Although we have the right to utilize other manufacturers at any
time, identifying and qualifying a new manufacturer to replace STH as the
manufacturer of our products could take several months during which time, we
would likely lose customers and our revenues could be materially delayed and/or
reduced.
FORMER RELATIONSHIP WITH STH.
Our majority stockholder is a wholly-owned subsidiary of STH and our
Chairman of the Board and Chief Executive Officer was formerly an officer of STH
4
WE DEPEND ON A LIMITED NUMBER OF SUPPLIERS FOR OUR COMPONENTS AND RAW MATERIALS
AND ANY INTERRUPTION IN THE AVAILABILITY OF THESE COMPONENTS AND RAW MATERIALS
USED IN OUR PRODUCT COULD REDUCE OUR REVENUES.
We rely on a limited number of suppliers for the components and raw
materials used in our image scanning products. Although there are many suppliers
for each of our component parts and raw materials, we are dependent on a single
or limited number of suppliers for many of the significant components and raw
materials. This reliance involves a number of significant risks, including:
- unavailability of materials and interruptions in delivery of
components and raw materials from our suppliers;
- manufacturing delays caused by such unavailability or interruptions
in delivery; and
- fluctuations in the quality and the price of components and raw
materials.
We do not have any long-term or exclusive purchase commitments with any of
our suppliers. Our failure to maintain existing relationships with our suppliers
or to establish new relationships in the future could also negatively affect our
ability to obtain our components and raw materials used in our products in a
timely manner. If we are unable to obtain ample supply of product from our
existing suppliers or alternative sources of supply, we may be unable to satisfy
our customers' orders which could reduce our revenues and adversely affect our
relationships with our customers
OUR BUSINESS COULD BE ADVERSELY AFFECTED IF WE FAIL TO ADAPT TO EMERGING AND
EVOLVING MARKETS.
The markets for our products are changing rapidly and evolving and,
therefore, the ultimate level of demand for our products is subject to
substantial uncertainty. Most of our historic revenue was generated from selling
image scanning products only. We expect that our future revenues will be
generated by the sale of image scanning and image display products. We intend to
expend significant resources towards developing our image display products. Any
significant decline in demand for image scanning and/or image display products
could materially and adversely affect our business and prospects.
IF WE SHOULD EXPERIENCE RAPID GROWTH, SUCH GROWTH COULD STRAIN OUR MANAGERIAL
AND OPERATIONAL RESOURCES, WHICH COULD ADVERSELY AFFECT OUR BUSINESS.
Any rapid growth that we may experience would most likely place a
significant strain on our managerial and operational resources. If we continue
to acquire other companies, we will be required to manage multiple relationships
with various clients, strategic partners and other third parties. Further growth
(organic or by acquisition) or an increase in the number of strategic
relationships may increase this strain on existing managerial and operational
resources, inhibiting our ability to achieve the rapid execution necessary to
implement our growth strategy without incurring additional corporate expenses.
WE DEPEND ON OUR MANAGEMENT. IF WE FAIL TO RETAIN KEY PERSONNEL, OUR BUSINESS
COULD BE ADVERSELY AFFECTED.
There is intense competition for qualified personnel in the areas in which
we operate. The loss of existing personnel or the failure to recruit additional
qualified managerial, technical and sales personnel, as well as expenses in
connection with hiring and retaining personnel could adversely affect our
business. We also depend upon the performance of our executive officers and key
employees in particular, Messrs. Darwin Hu and William Hawkins. Although we
intend to enter into employment agreements with each of Messrs. Hu and Hawkins,
the loss of either of these individuals could have a material adverse effect
upon us. In addition, we have not obtained "key man" life insurance on the lives
of either Messrs. Hu or Hawkins.
We will need to attract, train and retain more employees for management,
engineering, research and development, sales and marketing and support
positions. As noted above, competition for qualified employees, particularly
engineers and research and development personnel, continues to be intense.
Consequently, we may not be able to attract, train and retain the personnel we
need to continue to offer our products to current and future customers in a cost
effective manner, if at all.
5
IF WE FAIL TO RAISE CAPITAL THAT WE MAY NEED TO SUPPORT AND INCREASE OUR
OPERATIONS, OUR BUSINESS COULD BE ADVERSELY AFFECTED.
Our future capital uses and requirements will depend on numerous factors,
including:
- the extent to which our products gain market acceptance;
- the level of revenues from current and future products;
- the expansion of operations;
- the costs and timing of product developments and sales and marketing
activities;
- the costs related to acquisitions of technology or businesses; and
- competitive developments.
We may require additional capital in order to continue to support and
increase our sales and marketing efforts, continue to expand and enhance the
products we offer to current and future customers and fund potential
acquisitions. This capital may not be available on terms acceptable to us, if at
all. In addition, we may be required to spend greater-than-anticipated funds if
unforeseen difficulties arise in the course of these or other aspects of our
business. As a consequence, we will be required to raise additional capital
through public or private equity or debt financings, collaborative
relationships, bank facilities or other arrangements. We cannot assure you that
such additional capital will be available on terms acceptable to us, if at all.
Any additional equity financing is expected to be dilutive to our stockholders,
and debt financing, if available, may involve restrictive covenants and
increased interest costs. Our inability to obtain sufficient financing may
require us to delay, scale back or eliminate some or all of our expansion
programs or to limit the marketing of our products. This could have a material
and adverse effect on our business.
WE HAVE NOT PAID DIVIDENDS IN THE PAST AND DO NOT EXPECT TO PAY DIVIDENDS IN THE
FUTURE, AND ANY RETURN ON INVESTMENT MAY BE LIMITED TO THE VALUE OF YOUR STOCK.
We have never paid any cash dividends on our common stock and do not
anticipate paying any cash dividends on our common stock in the foreseeable
future and any return on investment may be limited to the value of your stock.
We plan to retain any future earnings to finance growth.
OUR MAJORITY STOCKHOLDER, SYSCAN IMAGING LIMITED, AND ITS PARENT COMPANY STH OWN
AND CONTROL A SIGNIFICANT NUMBER OF THE OUTSTANDING SHARES OF OUR COMMON STOCK
AND WILL CONTINUE TO HAVE SIGNIFICANT OWNERSHIP OF OUR VOTING SECURITIES FOR THE
FORESEEABLE FUTURE.
Syscan Imaging Limited, our majority stockholder, and STH its parent
company, beneficially own approximately 77.9% of our outstanding common stock.
As a result, these entities will have the ability to control our affairs and
business, including the election of directors and subject to certain
limitations, approval or preclusion of fundamental corporate transactions. This
concentration of ownership of our common stock may:
- delay or prevent a change in the control;
- impede a merger, consolidation, takeover or other transaction
involving us; or
- discourage a potential acquirer from making a tender offer or
otherwise attempting to obtain control of us.
THE AUTHORIZATION AND ISSUANCE OF "BLANK CHECK" PREFERRED STOCK COULD HAVE AN
ANTI-TAKEOVER EFFECT DETRIMENTAL TO THE INTERESTS OF OUR STOCKHOLDERS.
Our certificate of incorporation allows the Board of Directors to issue
preferred stock with rights and preferences set by our board without further
stockholder approval. The issuance of shares of this "blank check preferred"
under particular circumstances could have an anti-takeover effect. For example,
in the event of a hostile takeover attempt, it may be possible for management
and the board to endeavor to impede the attempt by issuing shares of blank check
preferred, thereby diluting or impairing the voting power of the other
outstanding shares of common stock and increasing the potential costs to acquire
control of us. Our Board of Directors has the right to issue blank check
preferred without first offering them to holders of our common stock, as the
holders of our common stock have no preemptive rights.
6
WE MAY NOT BE ABLE TO COMPLY WITH THE SARBANES-OXLEY ACT.
The enactment of the Sarbanes-Oxley Act in July 2002 created a significant
number of new corporate governance requirements and additional requirements may
be enacted in the future. Although we expect to implement the requisite changes
to become compliant with existing and new requirements when they do apply to us,
we may not be able to do so, or to do so in a timely manner.
RISKS RELATED TO OUR INTELLECTUAL PROPERTY AND TECHNOLOGY
UNAUTHORIZED USE OF OUR PROPRIETARY TECHNOLOGY AND INTELLECTUAL PROPERTY WILL
ADVERSELY AFFECT OUR BUSINESS AND RESULTS OF OPERATIONS.
Our success and competitive position depend in large part on our ability
to obtain and maintain intellectual property rights protecting our products. We
currently and may in the future rely on a combination of patents, copyrights,
trademarks, service marks, trade secrets, confidentiality provisions and
licensing arrangements to establish and protect our intellectual property and
proprietary rights. Unauthorized parties may attempt to copy aspects of our
products or to obtain, license, sell or otherwise use information that we regard
as proprietary. Policing unauthorized use of our products is difficult and we
may not be able to protect our technology from unauthorized use. Additionally,
our competitors may independently develop technologies that are substantially
the same or superior to ours and that do not infringe our rights. In these
cases, we would be unable to prevent our competitors from selling or licensing
these similar or superior technologies. In addition, the laws of some foreign
countries do not protect our proprietary rights to the same extent as the laws
of the United States.
Third parties have claimed and may claim in the future that we are
infringing their intellectual property, and we could be exposed to significant
litigation or licensing expenses or be prevented from selling our products if
such claims are successful. From time to time, we are subject to claims that we
or our customers may be infringing or contributing to the infringement of the
intellectual property rights of others. We may be unaware of intellectual
property rights of others that may cover some of our technologies and products.
If it appears necessary or desirable, we may seek licenses for these
intellectual property rights. However, we may not be able to obtain licenses
from some or all claimants, the terms of any offered licenses may not be
acceptable to us, and we may not be able to resolve disputes without litigation.
Any litigation regarding intellectual property could be costly and
time-consuming and could divert the attention of our management and key
personnel from our business operations. In the event of a claim of intellectual
property infringement, we may be required to enter into costly royalty or
license agreements. Third parties claiming intellectual property infringement
may be able to obtain injunctive or other equitable relief that could
effectively block our ability to develop and sell our products.
THE MARKETS IN WHICH WE OPERATE ARE HIGHLY COMPETITIVE AND RAPIDLY CHANGING, AND
WE MAY BE UNABLE TO COMPETE SUCCESSFULLY.
There are a number of companies that develop or may develop products that
compete in our targeted markets; however, currently there is no single company
that competes with us in all of our product areas. The individual markets in
which we compete are highly competitive, and are subject to rapid technological
change. Within image capture, we compete directly with Plustek and Portable
Peripheral Limited. Within Image Display, we will compete with Spatialight,
Sony, JVC and Syntax-Brillian. In image scanning, we compete with numerous
companies, some of which are our private label partners. In addition, a number
of smaller companies in both image scanning and image display technologies are
in some markets competitive with our solutions. Current and potential
competitors have established, or may establish, cooperative relationships among
themselves or with third parties to increase the ability of their technologies
to address the needs of our prospective customers. Most of our competitors in
each of the markets in which we compete have significantly greater financial,
technical and marketing resources than us. These competitors may be able to
respond more rapidly than we can to new or emerging technologies or changes in
customer requirements. They may also devote greater resources to the
development, promotion and sale of products than we do.
7
The market for image scanning and image display products is rapidly
evolving. Significant technological changes could render our products obsolete.
We must adapt to this rapidly changing market by continually improving the
functionality and features of our products to meet clients' needs. If we are
unable to develop new products and enhance functionalities or technologies to
adapt to these changes in a cost-effective and timely manner, our business could
be materially and adversely affected.
RISKS RELATING TO ACQUISITIONS
ANY ACQUISITIONS WE MAKE COULD RESULT IN DILUTION TO OUR EXISTING SHAREHOLDERS
AND COULD BE DIFFICULT TO INTEGRATE WHICH COULD CAUSE DIFFICULTIES IN MANAGING
OUR BUSINESS, RESULTING IN A DECREASE THE VALUE OF YOUR INVESTMENT.
We believe that we will need to make strategic acquisitions of other
businesses in order to achieve growth and profitability. Evaluating acquisition
targets is difficult and acquiring other businesses involves risk. Our
consummation of the acquisition of other businesses would subject us to a number
of risks, including the following:
- difficulty in integrating the acquired operations and retaining
acquired personnel;
- limitations on our ability to retain acquired sales and distribution
channels and customers;
- diversion of management's attention and disruption of our ongoing
business; and
- limitations on our ability to incorporate acquired technology and
rights into our product offerings and maintain uniform standards,
controls, procedures and policies.
Furthermore, we may incur indebtedness or issue equity securities to pay
for future acquisitions. The issuance of equity or convertible debt securities
would be dilutive to our then existing shareholders.
RISKS RELATING TO OUR COMMON STOCK
THE LIMITED PRIOR PUBLIC MARKET AND TRADING MARKET MAY CAUSE POSSIBLE VOLATILITY
IN OUR STOCK PRICE.
There has only been a limited public market for our securities and there
can be no assurance that an active trading market in our securities will be
maintained. The Over The Counter Bulletin Board (OTCBB) is an unorganized,
inter-dealer, over-the-counter market which provides significantly less
liquidity than NASDAQ and the national securities exchange, and quotes for
securities quoted on the OTCBB are not listed in the financial sections of
newspapers as are those for NASDAQ and the national securities exchange. In
addition, the overall market for securities in recent years has experienced
extreme price and volume fluctuations that have particularly affected the market
prices of many smaller companies. The trading price of our common stock is
expected to be subject to significant fluctuations including, but not limited
to, the following:
- quarterly variations in operating results and achievement of key
business metrics;
- changes in earnings estimates by securities analysts, if any;
- any differences between reported results and securities analysts'
published or unpublished expectations;
- announcements of new products by us or our competitors;
- market reaction to any acquisitions, joint ventures or strategic
investments announced by us or our competitors;
- demand for our products;
- shares being sold pursuant to Rule 144 or upon exercise of warrants
and options or conversion of Series A Preferred Stock or Series B
Preferred Stock; and
- general economic or stock market conditions unrelated to our
operating performance.
These fluctuations, as well as general economic and market conditions, may
have a material or adverse effect on the market price of our common stock.
THERE ARE LIMITATIONS IN CONNECTION WITH THE AVAILABILITY OF QUOTES AND ORDER
INFORMATION ON THE OTCBB.
8
Trades and quotations on the OTCBB involve a manual process and the market
information for such securities cannot be guaranteed. In addition, quote
information, or even firm quotes, may not be available. The manual execution
process may delay order processing and intervening price fluctuations may result
in the failure of a limit order to execute or the execution of a market order at
a significantly different price. Execution of trades, execution reporting and
the delivery of legal trade confirmation may be delayed significantly.
Consequently, one may not able to sell shares of our common stock at the optimum
trading prices.
THERE ARE DELAYS IN ORDER COMMUNICATION ON THE OTCBB.
Electronic processing of orders is not available for securities traded on
the OTCBB and high order volume and communication risks may prevent or delay the
execution of one's OTCBB trading orders. This lack of automated order processing
may affect the timeliness of order execution reporting and the availability of
firm quotes for shares of our common stock. Heavy market volume may lead to a
delay in the processing of OTCBB security orders for shares of our common stock,
due to the manual nature of the market. Consequently, one may not able to sell
shares of our common stock at the optimum trading prices.
PENNY STOCK REGULATIONS MAY IMPOSE CERTAIN RESTRICTIONS ON MARKETABILITY OF OUR
SECURITIES.
The SEC has adopted regulations which generally define a "penny stock" to
be any equity security that has a market price (as defined) of less than $5.00
per share or an exercise price of less than $5.00 per share, subject to certain
exceptions. As a result, our shares of common stock are subject to rules that
impose additional sales practice requirements on broker-dealers who sell such
securities to persons other than established clients and "accredited investors".
For transactions covered by these rules, the broker-dealer must make a special
suitability determination for the purchase of such securities and have received
the purchaser's written consent to the transaction prior to the purchase.
Additionally, for any transaction involving a penny stock, unless exempt, the
rules require the delivery, prior to the transaction, of a risk disclosure
document mandated by the SEC relating to the penny stock market. The
broker-dealer must also disclose the commission payable to both the
broker-dealer and the registered representative, current quotations for the
securities and, if the broker-dealer is the sole market maker, the broker-dealer
must disclose this fact and the broker-dealer's presumed control over the
market. Finally, monthly statements must be sent disclosing recent price
information for the penny stock held in the account and information on the
limited market in penny stocks. Consequently, the "penny stock" rules may
restrict the ability of broker-dealers to sell our shares of common stock and
may affect the ability of investors to sell such shares of common stock in the
secondary market and the price at which such investors can sell any of such
shares.
Investors should be aware that, according to the SEC, the market for penny
stocks has suffered in recent years from patterns of fraud and abuse. Such
patterns include:
- control of the market for the security by one or a few
broker-dealers that are often related to the promoter or issuer;
- manipulation of prices through prearranged matching of purchases and
sales and false and misleading press releases;
- "boiler room" practices involving high pressure sales tactics and
unrealistic price projections by inexperienced sales persons;
- excessive and undisclosed bid-ask differentials and markups by
selling broker-dealers; and
- the wholesale dumping of the same securities by promoters and
broker-dealers after prices have been manipulated to a desired
level, along with the inevitable collapse of those prices with
consequent investor losses.
Our management is aware of the abuses that have occurred historically in
the penny stock market.
THERE IS A RISK OF MARKET FRAUD.
OTCBB securities are frequent targets of fraud or market manipulation. Not
only because of their generally low price, but also because the OTCBB reporting
requirements for these securities are less stringent than for listed or NASDAQ
traded securities, and no exchange requirements are imposed. Dealers may
dominate the market and set prices that are not based on competitive forces.
Individuals or groups may create fraudulent markets and control the sudden,
sharp increase of price and trading volume and the equally sudden collapse of
the market price for shares of our common stock.
9
THERE IS LIMITED LIQUIDITY ON THE OTCBB.
When fewer shares of a security are being traded on the OTCBB, volatility
of prices may increase and price movement may outpace the ability to deliver
accurate quote information. Due to lower trading volumes in shares of our common
stock, there may be a lower likelihood of one's orders for shares of our common
stock being executed, and current prices may differ significantly from the price
one was quoted by the OTCBB at the time of one's order entry.
THERE IS A LIMITATION IN CONNECTION WITH THE EDITING AND CANCELING OF ORDERS ON
THE OTCBB.
Orders for OTCBB securities may be canceled or edited like orders for
other securities. All requests to change or cancel an order must be submitted
to, received and processed by the OTCBB. Due to the manual order processing
involved in handling OTCBB trades, order processing and reporting may be
delayed, and one may not be able to cancel or edit one's order. Consequently,
one may not able to sell shares of our common stock at the optimum trading
prices.
INCREASED DEALER COMPENSATION COULD ADVERSELY AFFECT THE STOCK PRICE.
The dealer's spread (the difference between the bid and ask prices) may be
large and may result in substantial losses to the seller of shares of our common
stock on the OTCBB if the stock must be sold immediately. Further, purchasers of
shares of our common stock may incur an immediate "paper" loss due to the price
spread. Moreover, dealers trading on the OTCBB may not have a bid price for
shares of our common stock on the OTCBB. Due to the foregoing, demand for shares
of our common stock on the OTCBB may be decreased or eliminated.
ADDITIONAL AUTHORIZED SHARES OF OUR COMMON STOCK AND PREFERRED STOCK AVAILABLE
FOR ISSUANCE MAY ADVERSELY AFFECT THE MARKET.
We are authorized to issue 50,000,000 shares of our common stock. As of
September 30, 2006, there were 24,092,092 shares of common stock issued and
outstanding. However, the total number of shares of our common stock issued and
outstanding does not include shares reserved in anticipation of the exercise of
options or warrants or the conversion of our Series A Preferred Stock or our
Series B Preferred Stock. As of September 30, 2006, we had outstanding 16,150
shares of Series A Preferred Stock, 11,500 shares of Series B Preferred Stock,
stock options and warrants to purchase approximately 8,584,000 shares of our
common stock, the exercise or conversion prices of which range between $0.01 and
$2.00 per share, and we have reserved shares of our common stock for issuance in
connection with the potential exercise thereof. Of the reserved shares, a total
of 2,790,000 shares are currently reserved for issuance in connection with our
2002 Stock Option Plan, of which options to purchase an aggregate of 2,790,000
shares have been granted under the plan. Reserved shares does not include
1,500,000 shares that are reserved pursuant to the 2006 Stock Option Plan,
pursuant to which no options have been granted as of the date hereof. A
significant number of such options and warrants contain provisions for cashless
exercise. To the extent such options or warrants are exercised, the holders of
our common stock will experience further dilution. In addition, in the event
that any future financing should be in the form of, be convertible into or
exchangeable for, equity securities, and upon the exercise of options and
warrants, investors may experience additional dilution.
The exercise of the outstanding derivative securities will reduce the
percentage of common stock held by our stockholders. Further, the terms on which
we could obtain additional capital during the life of the derivative securities
may be adversely affected, and it should be expected that the holders of the
derivative securities would exercise them at a time when we would be able to
obtain equity capital on terms more favorable than those provided for by such
derivative securities. As a result, any issuance of additional shares of common
stock may cause our current stockholders to suffer significant dilution which
may adversely affect the market.
10
In addition to the above-referenced shares of common stock which may be
issued without stockholder approval, we have 2,000,000 shares of authorized
preferred stock, the terms of which may be fixed by our Board of Directors. We
currently have 60,000 shares of Series A Preferred Stock authorized, 16,150 of
which are issued and outstanding and 30,000 shares of Series B Preferred Stock
authorized, 11,500 of which are issued and outstanding. While we have no present
plans to issue any shares of preferred stock other than the Series A Preferred
Stock and the Series B Preferred Stock, our Board of Directors has the
authority, without stockholder approval, to create and issue one or more series
of such preferred stock and to determine the voting, dividend and other rights
of holders of such preferred stock. Our outstanding Series A Preferred Stock is
convertible into approximately 1,615,000 shares of our common stock and our
Series B Preferred Stock is convertible into 1,150,000 shares of our common
stock. The issuance of any of such series of preferred stock may have an adverse
effect on the holders of common stock.
SHARES ELIGIBLE FOR FUTURE SALE MAY ADVERSELY AFFECT THE MARKET.
From time to time, certain of our stockholders may be eligible to sell all
or some of their shares of common stock by means of ordinary brokerage
transactions in the open market pursuant to Rule 144, promulgated under the
Securities Act of 1933 (Securities Act), subject to certain limitations. In
general, pursuant to Rule 144, a stockholder (or stockholders whose shares are
aggregated) who has satisfied a one-year holding period may, under certain
circumstances, sell within any three-month period a number of securities which
does not exceed the greater of 1% of the then outstanding shares of common stock
or the average weekly trading volume of the class during the four calendar weeks
prior to such sale. Rule 144 also permits, under certain circumstances, the sale
of securities, without any limitation, by our stockholders that are
non-affiliates that have satisfied a two-year holding period. Any substantial
sale of our common stock pursuant to Rule 144 or pursuant to any resale
prospectus may have material adverse effect on the market price of our
securities.
DIRECTOR AND OFFICER LIABILITY IS LIMITED.
As permitted by Delaware law, our certificate of incorporation limits the
liability of our directors for monetary damages for breach of a director's
fiduciary duty except for liability in certain instances. As a result of our
charter provision and Delaware law, stockholders may have limited rights to
recover against directors for breach of fiduciary duty. In addition, our
certificate of incorporation provides that we shall indemnify our directors and
officers to the fullest extent permitted by law.
11
NOTE ON FORWARD LOOKING STATEMENTS
Certain statements contained in this prospectus constitute
"forward-looking statements" as that term is defined under the Private
Securities Litigation Reform Act of 1995 and releases issued by the Securities
and Exchange Commission and within the meaning of Section 27A of the Securities
Act and Section 21E of the Securities Exchange Act of 1934, as amended, or the
Exchange Act. The words "believe," "expect," "anticipate," "intend," "estimate,"
"plan" and other expressions which are predictions of or indicate future events
and trends and which do not relate to historical matters identify
forward-looking statements. Reliance should not be placed on forward-looking
statements because they involve known and unknown risks, uncertainties and other
factors, which may cause our actual results, performance or achievements to
differ materially from anticipated future results, performance or achievements
expressed or implied by such forward-looking statements. Factors that could
cause actual results to differ materially from those expressed or implied by
such forward-looking statements include, among other things, those listed under
"Risk Factors" and elsewhere in this prospectus.
We operate in a very competitive and rapidly changing environment. New
risks emerge from time to time and it is not possible for our management to
predict all risks, nor can we assess the impact of all risks on our business or
the extent to which any risk, or combination of risks, may cause actual results
to differ from those contained in any forward-looking statements. All
forward-looking statements included in this prospectus are based on information
available to us on the date of this prospectus. Except to the extent required by
applicable laws or rules, we undertake no obligation to publicly update or
revise any forward-looking statement, whether as a result of new information,
future events or otherwise. All subsequent written and oral forward-looking
statements attributable to us or persons acting on our behalf are expressly
qualified in their entirety by the cautionary statements contained throughout
this prospectus.
12
BUSINESS
GENERAL
Sysview Technology, Inc. (referred to herein as "we", "us", "our",
"Sysview" or "Company") through our wholly-owned operating subsidiaries
develops, designs and delivers various imaging technology solutions to the
corporate/enterprise, small office-home office (SOHO), professional practice and
consumer markets. We are a provider of USB powered, scanning solutions to a wide
variety of industries and market applications. Our proprietary page-imaging
devices facilitate the way information is stored, shared and managed in both
business and personal use. We market and distribute our products indirectly
through a global network of Original Equipment Manufacturers (OEM), private
label business channels, system integrators, value-added resellers (VAR's), and
distributors. Our products may be viewed on our website at www.syscaninc.com. We
believe that the value of our mobile image scanning solutions is best realized
in vertical markets that are information and process intensive, such as
healthcare, document security, financial services, legal and government.
We have always developed our business model around intellectual property
(IP) driven products sold primarily to OEM's, Private Label brands and VAR's. In
keeping with this business model, our wholly owned subsidiary Sysview
Technologies, Inc. is currently in the process of developing multiple new
technologies related to the High Definition TV (HDTV) market, including an
innovative line of large format (42-60 inches) high definition television
products that incorporate liquid crystal on silicon (LCoS) rear projection
display technology (RPDT). Our core engineering-to-manufacturing experience and
resources lend themselves to developing this new technology. Going forward we
plan on leveraging certain patents and inventions related to RPDT to forge
industry relationships and market channels.
Our world-wide corporate headquarters and logistics center is currently
located at 1772 Technology Drive, San Jose, California 95110. We have additional
offices and warehousing facilities in The Netherlands and Southern China. Our
Annual Reports on Form 10-KSB, Quarterly Reports on Form 10-QSB, Proxy
Statements relating to our annual meetings of stockholders, Current Reports on
Form 8-K and amendments to these reports are available free of charge on our
website at www.syscaninc.com, as well as from the SEC's website at www.sec.gov.
BACKGROUND
Our wholly-owned subsidiary, Syscan, Inc., was founded in Silicon Valley
in 1995 to develop and manufacture a new generation of CIS (Contact Image
Sensors) that are CMOS-Complimentary Metal Oxide Silicon imaging sensor devices.
During the late 1990's, we established many technical milestones and were
granted numerous patents based on our linear imaging technology (Contact Image
Sensors). Our patented CIS and mobile imaging scanner technology provides very
high quality images but at extremely low power consumption, allowing us to
deliver very compact scanners in a form ideally suited for the laptop computer
users or desktop computer users who need a small "footprint", light weight
device to scan and/or fax documents.
This "enabling" technology is found in a variety of applications such as
document management, ID card and passport security scanners, bank note/check
verification, business card readers, scanning bar codes and optical mark readers
used in lottery terminals. In the past ten years we have grown to be one of the
largest OEM - VAR - private label manufacturers of page-fed scanning systems and
contact image sensor modules for several hundred companies including major
brands such as VISIONEER, PENTAX, CARDSCAN, DATACOLOR, DIGIMARC, SCANSOFT,
NORTEK and OMRON. Our vertically integrated design and manufacturing model
allows rapid time-to-market for these leading companies. Our manufacturing is
completed in China by a wholly-owned subsidiary of the parent company of our
majority stockholder, which provides a low-cost manufacturing base for these
industrial and consumer products.
13
MARKET OPPORTUNITIES
IMAGE CAPTURE TECHNOLOGY
In the past decade, information has become an increasingly important
source of capital for businesses and enterprises, and the speed and
sophistication of information exchange is often a defining characteristic of the
most successful entities worldwide. Many organizations define their strategy,
assess their ability to compete and manage their customer relationships based on
the quality, diversity and availability of their information products, services
and resources. The medium and optimal format for vital business information is
wide and varied, and includes paper, electronic files and Web content.
Confronted by exponentially increasing information through more and more
channels, consumers and business personnel employ a variety of resources for
retrieving information, conducting transactions and performing their jobs. The
Internet and related corporate infrastructure have emerged as a powerful global
communications network and channel for business. These electronic systems have
fundamentally changed the way organizations and consumers obtain information,
communicate, purchase goods and conduct business.
Businesses around the world share a common motivation to improve operating
efficiency and enhance customer service. Customer satisfaction, employee
productivity and company operating results can often be linked to an
organization's ability to effectively manage, utilize and communicate
information.
We believe there is a significant opportunity for our solutions to help
simplify the way people access, share, manage and use information in business
and in daily life. Our strategy is to deliver premier, comprehensive imaging
technologies. Our imaging solutions eliminate the need to manually reproduce
documents, automate the integration of documents into business systems, and
enable the use of electronic documents and forms over the Internet, through
mobile faxing and other business applications. Our products and technologies
deliver a measurable return on investment to our customers.
OUR IMAGE CAPTURE MARKET SOLUTION
As a manufacturer of USB powered imaging devices, we set out in late 2004
to create a new opportunity within our own market. We found through our existing
sales channels that there was a growing demand for duplex page imaging products
that allowed the end-user to scan both sides of a document simultaneously. The
overall growth of this market is being propelled by paper conservation cycles
that require two-sided printing of official documents and forms. The added
availability of duplex printers in the office and home has accelerated the
demand for duplex imaging devices. Our introduction in June of 2005, of the
world's first duplex image capture device under 2 pounds in weight, allow users
to incorporate two-sided images and documents into digital applications, systems
and devices. Our new duplex products highly automate the document capture
process and help enterprises, professionals and consumers increase productivity,
reduce costs and save time. We plan to substantially expand our product
offerings in the duplex imaging scanning market and plan to further expand our
business to include a wider base of software development tools for our existing
patented products used throughout the image capture market.
14
IMAGE DISPLAY TECHNOLOGY
Until the year 2001, home televisions have changed very little relying
(almost) exclusively on the Cathode Ray Tube (CRT). This technology provided a
good quality picture, based on the broadcasting (and cable operators) signal
limitations, but weight and size limited the screen size to around forty (40)
inches. With the relatively new introduction of high definition television
(HDTV) the consumer (and commercial) markets are dramatically increasing the
demand for larger screen sizes in order to bring the movie theater experience
into the home. In response to this demand various types of liquid crystal
display (LCD) and plasma display panel (PDP) models have been introduced to the
marketplace. These LCD and PDP models solved the screen size issue, but the
picture quality could not achieve the HDTV standard of 1080 active lines (1080p)
and the comparatively high pricing versus CRT models allowed them limited
consumer market penetration.
To date PDP technology has been the leader in delivering a price
performance value in the larger format screen sizes typically 42" and up. In the
past year, Digital Light Processing(TM) (DLP) by Texas Instruments has emerged
as the strongest challenger to PDP products, typically offering 720p picture
resolution, acceptable brightness characteristics and generally a price tag 20%
- 30% below comparable PDP products. Plasma technology continues to be
vulnerable to both the LCD and DLP formats as the size and performance to price
ratios converge. We recognize that the television display market is in the
process of a major transition, as several technologies challenge plasma
technology as the dominant force in large format displays. We believe the
transition will happen over the next 12-24 months as the major (tier 1)
competitors "hedge" with product lines that include the top 2 or 3 technologies.
The current top eight leaders (Samsung, Sony, Sanyo, Toshiba, LG, SAMPO,
Panasonic and Hitachi) compete under the different brand names but are
frequently in collaboration with each other as well as regional brands in the
international markets. The local brand - private label (tier 2) competitors add
another 15-20 competitors to the marketplace. In short, there are roughly 30
different competitors worldwide in the large format TV market worldwide. Several
of the major suppliers have already announced introduction of "true" 1080p HDTV
technology, but they struggle with the reality that plasma, LCD and DLP
technology still have difficulty achieving the price performance ratio being
demanded by the consumer market.
OUR DISPLAY MARKET SOLUTION
While continuing R&D on multiple HDTV technology solutions, in October of
2005, Syscan expanded its Sysview HDTV display technology group through the
purchase of Nanodisplay Inc., the holder of key intellectual property related to
LCoS (liquid crystal on silicon) HDTV technology. Nanodisplay has multiple
patents pending surrounding its proprietary methods and technologies that
utilize CNT (Carbon Nanotube) technology and advanced assemblage and integration
processes. Nanodisplay is in late stage research and development for the
production of an advanced high yield LCoS chip with true 1080P resolution. Upon
completion of this innovative LCoS technology, of which there can be no
assurance, it is expected that technology upgrades to even greater resolutions
are likely possible at an accelerated pace. Our ultimate goal is to achieve
superior visual performance and resolution at a significant value in large
screen format HDTV's.
Nanodisplay co-founder Dr. Gihong Kim brings a tremendous amount of
experience to Syscan and Sysview alike. Dr. Kim has been a research and
development engineer in the field of semiconductor materials, process
integration and devices, for the majority of his career. He attributes the
genesis of his solutions to solving key LCoS challenges and limitations to his
involvement with LCoS since the technologies initial R&D stages. To his credit
Dr. Kim has over 20 patents issued and has had 13 papers published in the field
of semiconductor technology.
15
Since the strategic acquisition of Nanodisplay, we have carefully
established market entry points that will allow this emerging (LCoS) technology
to achieve the anticipated price performance ratio within 12 months, potentially
eclipsing market share held by the current leading technologies in the large
format HDTV arena, of which there can be no assurance. It is also expected that
relationships resulting from our LCoS technology initiative will benefit our
pending LED backlighting solution for LCD panels as well as our ITV (Intelligent
TV) technology still in the R&D phase.
OUR COMPETITIVE STRENGTHS
CORE TECHNOLOGY ASSETS. In recent years, we have developed and acquired
technology assets, intellectual property and industry expertise in both the
image capture and image display markets. We believe a significant investment in
capital and time would be necessary for competitors to replicate our current
capabilities. We continue to invest in the advancement of our technologies to
maintain our market position as well as to develop new markets/products. As of
September 30, 2006, we had 17 (63%) full-time employees involved in the research
and development of our products and our technologies that continue to add to the
existing issued patents that we hold in the U.S. and Foreign territories.
BROAD DISTRIBUTION CHANNELS. We maintain an extensive network of distribution
channels to address the needs of specific markets such as financial, legal,
healthcare and government. We believe that our extensive channel relationships
increase the difficulty for competitors to develop a similar channel network and
make it difficult for our products to be displaced. In addition, our
far-reaching channel network enables us to introduce new products quickly and
effectively throughout the global marketplace.
CAPTURING MARKET SHARE. Our customers tend to look to established, experienced
vendors when making product selections and as an established manufacturer in our
markets, we believe we can target and win more partnership arrangements and new
customers than our competition.
INTERNATIONAL FOCUS. Our international experience and diverse heritage allow us
to efficiently compete on a global basis. We have established effective bases of
operations in the USA, European Union and Asia Pacific. We recognize cultural
and language benefits in both manufacturing, warehousing and time-to-market
sales.
OUR STRATEGY
PURSUE HIGH GROWTH MARKETS IN IMAGE SCANNING. We intend to leverage our
technologies and market leadership to expand our opportunities in mobile and
other markets. We also intend to pursue emerging opportunities to use our
technology within consumer devices, and other wide spread devices. To expand our
position in mobile image capture, we intend to continue to introduce new
versions of our products and applications; complete new license agreements with
customers and partners that will resell our technologies; and make strategic
acquisitions that we believe complement our existing solutions and resources in
various evolving markets.
EXPAND IMAGE SCANNING SOLUTIONS. We intend to enhance the value of our imaging
scanning solutions for enterprises to address the proliferation of security
related applications, the expanded use of content management systems, and the
widespread adoption of networked multifunction and digital image scanning
devices. We intend to introduce new products or new versions of existing
products to take advantage of these growth opportunities. We also plan to
enhance our software development toolkits so our technologies can be integrated
with more third-party solutions.
16
FOCUS ON SPECIFIC VERTICAL MARKETS. We intend to focus our marketing and sales
resources to generate demand and deliver solutions in specific vertical markets.
The value of our solutions is best realized in vertical markets that are
information and process intensive, such as healthcare, telecommunications,
financial services, legal and government. In addition, we intend to offer custom
versions of certain applications and products for specific vertical markets such
as medical, legal and utilities.
EXPAND WORLDWIDE CHANNELS. We intend to expand our global channel network and
build upon our existing distribution channels, especially in Europe, Asia and
Latin America. In particular, we intend to replicate our successful North
American value-added reseller channel in Europe. Along these lines, we intend to
add sales employees in different geographic regions and launch programs and
events to help recruit new partners for our channel network.
PURSUE STRATEGIC ACQUISITIONS. We will selectively pursue strategic acquisitions
of companies in the image capture and display industry that could compliment our
business model, improve our competitive positioning and expand our offerings to
the marketplace, of which there can be no assurance. In identifying potential
acquisition candidates we will seek to acquire companies with varied
distribution channels, rich intellectual property (IP) and high caliber
engineering personnel.
Over the past twelve months we have begun focusing our sales and marketing
efforts substantially towards the vertical markets such as the Value Added
Reseller (VAR) and small-office-home-office (SOHO) markets. We believe focusing
on these markets is the most effective way to showcase our technological
capabilities and manufacturing efficiencies, while enabling us to maintain
higher margins, and require fewer resources than working directly with the mass
retailers.
For the HDTV market, we are currently concentrating our efforts and
investment towards the completion and mass market delivery of the Nanodisplay
LCoS HDTV solution. Although there can be no assurances, we intend to initiate a
relationship in the near future with a partner that may allow us to provide a
proprietary low cost light engine component which would be used to drive the
Nanodisplay imager/chip. We believe that by co-designing and combining these two
critical components we will be able to deliver a complete, low cost high
performance, LCoS solution to the market. Separately, we also recognize that
there are other viable non-TV applications for the Nanodisplay LCoS imager and
expect to explore those possibilities.
Beyond our LCoS initiative we continue development of an LCD product that
uses RGB (red, green, and blue) LED's controlled sequentially as an alternative
longer life backlight source with visual performance benefits. Most of our LCD
HDTV strategy is leveraged on core technologies and market synergy that we
established in the image capture (scanning) market since our scanner devices
utilize LED's as a light source, and the precise control of this light source is
a critical capability in the performance and ultimate market success of this new
technology. It is not expected that there will be mass acceptance of variations
of this technology until late 2007. In order to meet the competitive
requirements, we believe that we will need a collaborator (or partner) that has
significant experience in the FPD panel design and tooling. A partner will also
reduce the time-to-market and overall risk associated with entry into the
marketplace.
17
PRODUCTS
IMAGE SCANNING PRODUCTS
TRAVELSCAN, DOCKETPORT & OEM BRANDS
In 2005 we shipped six categories of image capture products under several
"house brands" or their OEM counterparts versus five categories in 2004. The
introduction of the A4 duplex scanners (DocketPORT) in the third quarter created
a broader base of products. This new category quickly contributed over 7% of
unit sales in 2005, despite its mid-year introduction. The A4 simplex scanner
(TravelScan) category represented approximately 19% of our sales during the year
ended December 31, 2005, a decrease from 2004 (21%) of approximately 2%. The A6
simplex scanners that are widely used for capturing images of bank checks,
drivers licenses and various identification cards, represented the largest unit
sales in 2005 at 54%. This represented an increase of 8.1% over 2004 unit sales.
The A5 security document scanner experienced a 3% increase in unit sales in 2005
to 3% from less than 1% in 2004. Our fifth scanner product category,
representing approximately 15% of our sales ending the 12 months ended December
31, 2005, is the A8 business card reader scanner. In 2004 the A8 scanner
category represented approximately 21% of our sales, so we experienced a net
reduction in this category of 6%.
CONTACT IMAGE SENSOR (CIS) MODULES
In addition to the finished scanner product line, we also design,
configure and sell the Contact Image Sensor (CIS) Modules that we use in our
products and separately as an OEM component to other manufacturers. This CIS
business represented approximately 5% of our overall sales during 2005, a
decrease of 5% from the previous year (2004 - 10%).
PRODUCTS IN DEVELOPMENT
We have a product development program currently in place to add new
products in 2007. These new products are being introduced as both Syscan branded
and OEM/ VAR branded products. Many of these new scanners are being driven by
increased market demand for duplex, faster and easier-to-use products. They will
also concentrate more on the identity-security and financial transaction market
needs.
IMAGE DISPLAY PRODUCTS
SYSVIEW TECHNOLOGY
During 2005 we saw the establishment of SysView Technology Inc., a wholly
owned subsidiary of ours that is focused on introducing breakthrough
price-performance technology in the HDTV display market. As part of this
objective, we acquired Nanodisplay Inc. in October 2005. Nanodisplay is a
designer of LCoS HDTV technology and we believe that the acquired technology and
personnel will contribute significantly to our efforts in the display market. We
also intend to enter into a relationship that will provide us with a proprietary
light engine technology focused on performance value. The light engine is the
optics component that actually projects the image that the chip (Nanodisplay)
creates. We believe that it is important that both of these technologies be
vertically integrated and co-designed in order to offer the best and most
cost-effective complete solution.
18
In addition we are in various stages of development on two other HDTV
initiatives. The first is the design and implementation of a unique backlighting
system for large format LCD screens. Through the use of RGB (red, green and
blue) LED's we will attempt to replace the current industry standard CCFL (cold
cathode florescent light). The expected end result is both extended product life
and enhanced visual performance. The ultimate success of this technology is
based on the ability to sequentially manage the timing of the independent
colored LED's appropriately. We believe that we have a unique understanding of
this process as it is used in our patented mobile image scanning devices.
We are also currently investing in the R&D of what we call ITV or intelligent
TV. We believe that the step will ultimately become less passive and more
interactive. To that end we are working on a host of hardware and software
applications that would allow for that interactivity. Our goal is to deliver the
hardware component of this technology at a price that would allow for it to be
transparently included in new TV's. We also recognize the importance of making
the technology seamless and simple to use. Tivo is an example of how the
consumer is beginning to accept the idea of greater functionality in their TV.
SALES, DISTRIBUTION AND FULFILLMENT
We market and distribute our products indirectly through a global network
of OEM's, system integrators, value-added resellers and regional distributors.
We have established relationships with more than 32 channel partners,
including leading system vendors, value-added resellers and regional
distributors. In addition our products are sold through a variety of retail and
web-based channels.
MANUFACTURING
All of our products are currently manufactured by a subsidiary of Syscan
Technology Holdings (STH), the parent company of our majority stockholder. We
and STH have established an internal-pricing agreement that is updated on a
semi-annual basis. STH serves as the exclusive manufacturer of all current and
future image capture products to be produced by us. We believe, for quality
control and pricing reasons that this type of relationship is more favorable
than could be attained from unaffiliated third-parties. We purchase and provide
STH with critical parts and components necessary to manufacture our products.
STH warrants the products it manufactures for us against defects in
material and workmanship for a period of 18 months after the completion of
manufacture. After such 18 month period, STH has agreed to provide repair
services for the products to us at its customary hourly repair rate plus the
cost of any parts, components or items necessary to repair the products.
Since STH is the primary manufacturer of all of our current products, if
the operations of STH are interrupted or if our orders or orders of other STH
clients exceed the manufacturing capabilities of STH, STH may not be able to
deliver our products to us on time and we may not be able to deliver our
products to our customers on time, which could adversely affect our business,
reduce our revenues and significantly harm our relationship with our customers.
We have the right at anytime to engage third parties to manufacture some or all
of our products.
We believe that it could take approximately three to six months to secure
a third-party manufacturer to supplement STH's manufacturing capabilities and
approximately six to twelve months to replace STH as our sole manufacturer.
Although we believe that there are a number of third-party manufacturers (other
than STH) available to us, there can be no assurances that we would be able to
secure another manufacturer on terms favorable to us, or at all, or how long it
would take us to secure such manufacturing.
19
SUPPLIERS
All of the raw materials, parts, components and other items that are
required to manufacture our products are purchased by us. We rely on a single or
limited number of suppliers for such raw materials, parts, components and other
items. Although there are many suppliers for each of these raw materials, parts,
components and other items, we are dependent on a limited number of suppliers
for many of the significant raw materials and components. We do not have any
long-term or exclusive purchase commitments with any of such suppliers. Our
failure to maintain existing relationships with our suppliers or to establish
new relationships in the future could also negatively affect our ability to
obtain the raw materials and components used in the manufacture of our products
in a timely manner. If we are unable to obtain ample supply of product from our
existing suppliers or alternative sources of supply, we may be unable to satisfy
our customers' orders which could reduce our revenues and adversely affect our
relationship with our customers.
PROPRIETARY TECHNOLOGY
We exploit our proprietary technology, trade secrets, know-how, continuing
technological innovations and licensing opportunities to maintain our
competitive position. We rely on patent law, copyright law, trade secret laws,
secrecy, technical measures, licensee agreements and non-disclosure agreements
to protect our technology, trade secrets and other proprietary rights. Our
policy is to file patent applications to protect technology, inventions and
improvements that are important to the development of our business, to maintain
a technological advantage over our competitors and to in some cases generate
licensing revenue. In this regard, we have obtained patents that directly relate
to our products. Our mobile imaging scanning technologies are covered by
numerous patents and patent applications owned by us. We currently have 25
issued (granted) patents, 16 of which are U.S. patents and 9 issued in foreign
jurisdictions. We currently have 5 pending patents, of which 4 are related to
image display technologies and 1 related to image scanning. These patents expire
on various dates between 2017 and 2022.
We require our employees to execute confidentiality and invention
assignment agreements in order to protect our proprietary technology and other
proprietary rights. We also rely on trade secrets and proprietary know-how to
protect our proprietary rights.
RESEARCH AND DEVELOPMENT
The market for our products and services is characterized by rapid
technological change, frequent new product introductions and enhancements,
evolving industry standards, and rapidly changing client requirements. As a
result, we believe that our future growth is highly dependent on the timely and
efficient introduction of new and updated products and technology. As of
December 31, 2005, we employed or directly contracted 14 people in research and
development, 4 of whom are located in international locations. Our employees
based in overseas facilities extend our global focus while often lowering our
overall cost of research and development. To promote efficiency in our research
and development efforts, we have organized the effective use of global
development teams and a comprehensively integrated development process. In
addition, we have developed and refined our time-to-market process, which
contributes to cost-effective resource management while promoting technology
sharing across programs.
20
Our future success will depend in part on our ability to anticipate
changes, enhance our current products, develop and introduce new products that
keep pace with technological advancements and address the increasingly
sophisticated needs of our clients. Our research and development expenses for
the twelve months ending December 31, 2005 and the twelve months ended December
31, 2004 were $951,333 and $528,417, respectively. We expect that we will
continue to commit significant resources to research and development in the
future, specifically with respect to the HDTV market. To date we have not
capitalized any research and development expenses and all costs have been
expensed as incurred.
INTERNATIONAL OPERATIONS
Our international operations include research and development, customer
support and sales and marketing. Our international research and development is
conducted in the US and China. Additionally sales and support offices are
located in the US, the Netherlands, Korea and China to support our current
international customers and to expand our international revenue opportunities.
Geographic revenue classification is based on the country in which the
sale is invoiced. Revenue for the twelve months ended December 31, 2005 was 87%
in North America, 9% in Asia and 4% in the European market. This is compared to
the 2004 geographic sales of 96% in North America, 2% in Asia and 2% in Europe.
Additional financial information relating to foreign and domestic sales
and operations for each of the twelve months ended December 31, 2005 and the
year ended in the period ended December 31, 2004 is set forth in Note 1, "
Geographic Sales and Significant Customers," of the Notes to Consolidated
Financial Statements.
COMPETITION
There are very few companies that have products that directly compete in
America, against our page-fed scanner markets. There are however, several
companies that sell competitive products in the European market where the
enforcement of our patents is considerably more difficult. There is currently no
single company that competes with us in all of our product areas. Within Image
Display, we will compete with Sony, Samsung, Sharp, Sanyo and LG. Our HDTV
products could compete with some of these companies' products, however, we
intend to enter into OEM and private label relationships with some of those
competitors. In addition, there are several smaller vertically positioned
companies in the image display technologies that may be competitive with our
solutions. Current and potential competitors have established, or may establish,
cooperative relationships among themselves or with third parties to increase the
ability of their technologies to address the needs of our prospective customers.
Most of our competitors in each of the markets in which we compete have
significantly greater financial, technical and marketing resources than us.
These competitors may be able to respond more rapidly than we can to new or
emerging technologies or changes in customer requirements. They may also devote
greater resources to the development, promotion and sale of products than we do.
EMPLOYEES
As of September 30, 2006, we employed 30 people on a full-time basis, 21
in the United States and 9 internationally. Of the total, 18 were in product
research and development, 4 in sales and marketing, 2 in operations and support,
and 6 in finance and administration. None of our employees located in the United
States or internationally are represented by unions or collective bargaining
agreements. We have experienced no work stoppages and believe that our employee
relations are good. We have utilized the services of consultants, third-party
developers, and other vendors in our sales, development, manufacturing
activities and finance and administration functions.
21
AVAILABLE INFORMATION
We file annual, quarterly and current reports, proxy statements and other
information with the Securities and Exchange Commission. You may read and copy
any document we file with the Commission at the Commission's public reference
rooms at 100 F Street, N.E., Washington, D.C. 20549, 233 Broadway, New York, New
York 10279, and Citicorp Center, 500 West Madison Street, Suite 1400, Chicago,
Illinois 60661-2511. Please call the Commission at 1-800-SEC-0330 for further
information on the public reference rooms. Our Commission filings are also
available to the public from the Commission's Website at "http://www.sec.gov."
We make available free of charge our annual, quarterly and current reports,
proxy statements and other information upon request. To request such materials,
please contact our Corporate Secretary at our address as set forth above.
We maintain a Website at "http://www.syscaninc.com" (this is not a
hyperlink, you must visit this website through an internet browser). Our Website
and the information contained therein or connected thereto are not incorporated
into this Prospectus.
DESCRIPTION OF PROPERTY
Our corporate headquarters are located at 1772 Technology Drive, San Jose,
CA 95110. Our offices contain 6,800 square feet of office space and our monthly
rental expense is approximately $12,000. In August 2006, we entered into an
agreement with the landlord at 1772 Technology Drive, whereby effective December
1, 2006 our total office space will increase to 8,759 square feet and our
monthly rental expense will be $21,364 for the first 12 months thereafter,
increasing to $21,898 for the second twelve months thereafter, expiring in
November 2008. We also maintain a sales office in the Netherlands at
IJsselburcht 3, Lorentz Building, Suite 201, 6825 BS Arnhem, Netherlands. The
lease is on a month-to-month basis at a monthly rate of $480.
We believe that our current facilities are adequate for our current
operations.
LEGAL PROCEEDINGS
Syscan, Inc., our wholly-owned subsidiary, filed a lawsuit captioned
Syscan v. PPL (Case No. C03-02367 VRW) in United States District Court, Northern
District of California in San Francisco. Syscan alleges claims against Portable
Peripheral Co., Ltd., Image Recognition Integrated Systems, Inc., Cardreader
Inc., and Targus, Inc. for patent infringement. On November 21, 2006, Syscan,
Inc. formally withdrew this lawsuit and reserved its right to refile at a later
date an updated lawsuit against PPL.
Other than as disclosed above, we are not a party to any material legal
proceedings. We from time to time experience routine litigation in the normal
course of our business. We do not believe that any pending litigation will have
a material adverse effect on our financial condition, results of operations or
cash flows.
22
USE OF PROCEEDS
We will not receive any of the proceeds from the sale of the shares of
common stock issuable upon conversion of the Series B Preferred Stock by the
selling stockholders. If and when all of the warrants held by the selling
stockholders are exercised, we will receive the proceeds from the exercise of
those warrants. If these warrants are exercised in full, we may receive up to
$1,012,500, which we intend to use for working capital and other general
corporate purposes.
SELLING STOCKHOLDERS
Up to an aggregate of 1,825,000 shares of common stock may be offered
under this prospectus consisting of up to (i) 1,150,000 shares of common stock
issuable upon conversion of Series B Preferred Stock, and (ii) up to 675,000
shares of common stock issuable upon the exercise of warrants.
All proceeds of this offering will be received by the selling stockholders
for their own account. We may receive proceeds in connection with the exercise
of the warrants, the underlying shares associated with which may, in turn, be
sold by the selling stockholders. As used in this prospectus, the term "selling
stockholder" includes the selling stockholders listed below and their
transferees, assignees, pledgees, donees or other successors.
On August 8, 2006, we consummated the sale of 11,500 shares of our Series
B Preferred Stock for gross proceeds of $1,150,000. The Series B Preferred Stock
is convertible, under certain conditions, into shares of our common stock at a
price equal to $1.00 per share. In connection with the financing, we also issued
to the purchasers of the Series B Preferred Stock common stock purchase warrants
to purchase up to 575,000 shares of our common stock at a price equal to $1.50
per share. We also issued an aggregate of 100,000 warrants to Starboard Capital
Markets, LLC and its affiliates, to purchase common stock at a price equal to
$1.50 per share, as compensation for its services as placement agent in our
Series B Preferred Stock offering. For its services as placement agent in our
Series B Preferred Stock offering, Starboard Capital Markets, LLC received an
eight percent (8%) cash commission (only with respect to investors introduced by
Starboard) and warrants to purchase up to ten percent (10%) of the number of
shares of common stock into which the Series B Preferred Stock sold in the
offering (only with respect to investors introduced by Starboard) was initially
convertible, at an exercise price equal to $1.50 per share. Starboard Capital
Markets, LLC acquired the warrants in the ordinary course of business and at the
time of its acquisition of the warrants it did not have any agreements,
understandings or arrangements with any other persons, either directly or
indirectly, to dispose of the warrants or the shares of common stock issuable
upon exercise of the warrants.
The following table sets forth, to our knowledge, certain information
about the selling stockholders as of the date of this prospectus. None of the
selling stockholders, other than Starboard Capital Markets, LLC, is a registered
broker-dealer.
Beneficial ownership is determined in accordance with Rule 13d-3
promulgated by the Securities and Exchange Commission, and generally includes
voting or investment power with respect to securities. In computing the number
of shares beneficially owned by the holder and the percentage ownership of the
holder, shares of common stock issuable upon conversion of the note and upon
exercise of the warrant held by the holder that are currently convertible or are
exercisable within 60 days after the date of the table are deemed outstanding.
The percent of beneficial ownership for the selling stockholder is based
on 24,092,092 shares of common stock outstanding as of the date hereof. Shares
of common stock subject to warrants, options and other convertible securities
that are currently exercisable or exercisable within 60 days of the date hereof,
are considered outstanding and beneficially owned by a selling stockholder who
holds those warrants, options or other convertible securities for the purpose of
computing the percentage ownership of that selling stockholder but are not
treated as outstanding for the purpose of computing the percentage ownership of
any other stockholder.
23
The following table sets forth information as of that date regarding
beneficial ownership of our common stock by each of the selling stockholders
before and immediately after the offering. Actual ownership of the shares is
subject to conversion of the Series B Preferred Stock and exercise of the
warrants.
The shares of common stock being offered under this prospectus may be
offered for sale from time to time during the period the registration statement
of which this prospectus is a part remains effective, by or for the account of
the selling stockholders.
After the date of effectiveness of the registration statement of which
this prospectus is a part, the selling stockholders may have sold or
transferred, in transactions covered by this prospectus or in transactions
exempt from the registration requirements of the Securities Act, some or all of
its common stock. Information about the selling stockholders may change over
time.
Any changed information will be set forth in an amendment to the
registration statement or supplement to this prospectus, to the extent required
by law.
NUMBER OF SHARES NUMBER OF
POSITION, OF COMMON STOCK, SHARES TOTAL NUMBER OF NUMBER OF
OFFICE OR NOT INCLUDING REPRESENTED BY NUMBER OF SHARES TO BE SHARES TO PERCENTAGE
OTHER MATERIAL SHARES ISSUABLE ON PREFERRED SHARES OF OFFERED FOR BE OWNED TO BE
RELATIONSHIP CONVERSION OF STOCK AND COMMON THE ACCOUNT AFTER BENEFICIALLY
WITH US PREFERRED STOCK WARRANTS, STOCK OF THE THIS OWNED AFTER
DURING PAST OR WARRANTS, BENEFICIALLY BENEFICIALLY SELLING OFFERING THIS
NAME THREE YEARS BENEFICIALLY OWNED OWNED OWNED STOCKHOLDER (1) OFFERING (1)
Whalehaven
Capital Fund (2) None -0- 2,100,000 2,100,000 1,500,000 600,000 2.4%
Gregory Wong (3) None -0- 75,000 75,000 75,000 -0- -0-
Wesley Wong (4) None -0- 150,000 150,000 150,000 -0- -0-
Starboard Capital
Markets, LLC (5) (6) -0- 146,625 146,625 100,000 46,625 -0-
* Less than one percent.
(1) Assumes that all shares of common stock offered in this prospectus
and otherwise beneficially owned will be sold.
(2) The address for Whalehaven Capital Fund Limited is 3rd Floor, 14
Par-La-Ville Road, P.O. Box HM 1027, Hamilton HMDX Bermuda. Evan
Schemenauer, Arthur Jones and Jennifer Kelly share voting and
investment power over the shares held by Whalehaven Capital Fund
Limited. The number of shares being registered for Whalehaven
Capital Fund Limited includes 1,000,000 shares issuable upon the
conversion of Series B preferred stock and 500,000 shares issuable
upon the exercise of warrants. The number of shares beneficially
owned also includes 400,000 shares of common stock issuable upon the
conversion of Series A Preferred Stock and 200,000 shares issuable
upon the exercise of warrants that are currently exercisable and
were issued in connection with the purchase of the Series A
Preferred Stock.
24
(3) The number of shares being registered for Mr. Wong includes 50,000
shares issuable upon the conversion of Series B preferred stock and
25,000 shares issuable upon the exercise of warrants.
(4) The number of shares being registered for Mr. Wong includes 100,000
shares issuable upon the conversion of preferred stock and 50,000
shares issuable upon the exercise of warrants.
(5) Starboard Capital Markets, LLC acted as our placement agent in
connection with the sale of the Series B Preferred Stock and
Warrants sold by us in the Series B Preferred Stock offering.
Starboard Capital Markets, LLC received the shares of our common
stock in the ordinary course of their business and at the time that
they received the shares of our common stock had no agreements,
understandings, directly or indirectly, with any person to
distribute the securities. Starboard Capital Markets, LLC's address
is One Logan Square, Suite 2650, Philadelphia, PA 19103. James
Dotzman, a managing director of Starboard Capital Markets, LLC, has
voting and investment control over the shares held by Starboard
Capital Markets, LLC. The number of shares being registered for
Starboard Capital Markets, LLC includes 100,000 shares issuable upon
the exercise of warrants.
(6) In March 2005, Starboard Capital Markets, LLC acted as placement
agent in connection with our Series A Preferred Stock and Warrant
offering.
The selling stockholders and we are not making any representation that any
shares covered by the prospectus will or will not be offered for sale or resale.
The selling stockholders reserve the right to accept or reject, in whole or in
part, any proposed sale of shares. The shares offered by this prospectus may be
offered from time to time by the selling stockholder named above.
25
PLAN OF DISTRIBUTION
Selling stockholders may offer and sell, from time to time, the shares of
our common stock covered by this prospectus. The term selling stockholders
includes donees, pledgees, transferees or other successors-in-interest selling
securities received after the date of this prospectus from a selling stockholder
as a gift, pledge, partnership distribution or other non-sale related transfer.
The selling stockholders will act independently of us in making decisions with
respect to the timing, manner and size of each sale. Sales may be made on one or
more exchanges or in the over-the-counter market or otherwise, at prices and
under terms then prevailing or at prices related to the then current market
price or in negotiated transactions. The selling stockholders may sell their
securities by one or more of, or a combination of, the following methods:
o purchases by a broker-dealer as principal and resale by the
broker-dealer for its own account pursuant to this prospectus;
o ordinary brokerage transactions and transactions in which the broker
solicits purchasers;
o block trades in which the broker-dealer so engaged will attempt to
sell the securities as agent but may position and resell a portion
of the block as principal to facilitate the transaction;
o an over-the-counter distribution in accordance with the rules of the
NASDAQ National Market;
o in making short sales or in transactions to cover short sales;
o in put or call option transactions relating to the shares;
o in privately negotiated transactions; and
o in options, swaps or derivatives transactions.
The selling stockholders may effect these transactions by selling shares
directly to purchasers or to or through broker-dealers, which may act as agents
or principals. These broker-dealers may receive compensation in the form of
discounts, concessions or commissions from the selling stockholders and/or the
purchasers of shares for whom such broker-dealers may act as agents or to whom
they sell as principals, or both (which compensation as to a particular
broker-dealer might be in excess of customary commissions). The selling
stockholders have advised us that they have not entered into any agreements,
understandings or arrangements with any underwriters or broker-dealers regarding
the sale of their securities.
To the extent required, we may amend or supplement this prospectus to
describe a specific plan of distribution. In connection with distributions of
the securities or otherwise, the selling stockholders may enter into hedging
transactions with broker-dealers or other financial institutions. In connection
with those transactions, broker-dealers or other financial institutions may
engage in short sales of shares of our common stock in the course of hedging the
positions they assume with selling stockholders. The selling stockholders may
also sell shares of our common stock short and redeliver the securities to close
out their short positions. The selling stockholders may also enter into option
or other transactions with broker-dealers or other financial institutions that
require the delivery to the broker-dealer or other financial institution of
securities offered by this prospectus, which securities the broker-dealer or
other financial institution may resell pursuant to this prospectus, as
supplemented or amended to reflect the transaction. The selling stockholders may
also loan or pledge securities to a broker-dealer or other financial
institution, and, upon a default, the broker-dealer or other financial
institution, may affect sales of the loaned or pledged securities pursuant to
this prospectus, as supplemented or amended to reflect the transaction.
26
The selling stockholders may also sell shares under Rule 144 under the
Securities Act, if available, rather than under this prospectus. In effecting
sales, broker-dealers or agents engaged by the selling stockholders may arrange
for other broker-dealers to participate. Broker-dealers or agents may receive
commissions, discounts or concessions from the selling stockholders in amounts
to be negotiated immediately prior to the sale.
In offering the securities covered by this prospectus, the selling
stockholders and any broker-dealers who execute sales for the selling
stockholders may be treated as "underwriters" within the meaning of the
Securities Act in connection with sales. Any profits realized by the selling
stockholders and the compensation of any broker-dealer may be treated as
underwriting discounts and commissions.
The selling stockholders and any other person participating in a
distribution will be subject to the Securities Exchange Act of 1934 (Exchange
Act). The Exchange Act rules include, without limitation, Regulation M, which
may limit the timing of purchases and sales of any of the securities by the
selling stockholders and other participating persons. In addition, Regulation M
may restrict the ability of any person engaged in the distribution of the
securities to engage in market-making activities with respect to the particular
security being distributed for a period of up to five business days prior to the
commencement of the distribution. This may affect the marketability of the
securities and the ability of any person or entity to engage in market-making
activities with respect to the securities. We have informed the selling
stockholders that the anti-manipulation rules of the SEC, including Regulation M
promulgated under the Exchange Act, may apply to their sales in the market.
We will make copies of this prospectus available to the selling
stockholders for the purpose of satisfying the prospectus delivery requirements
of the Securities Act. The selling stockholders may indemnify any broker-dealer
that participates in transactions involving the sale of the securities against
certain liabilities, including liabilities arising under the Securities Act. We
have agreed to indemnify the selling stockholders and the selling stockholders
have agreed to indemnify us against certain liabilities in connection with the
offering of the shares, including liabilities arising under the Securities Act.
At the time a particular offer of securities is made, if required, a
prospectus supplement will be distributed that will set forth the number of
securities being offered and the terms of the offering, including the name of
any underwriter, dealer or agent, the purchase price paid by any underwriter,
any discount, commission and other item constituting compensation, any discount,
commission or concession allowed or re-allowed or paid to any dealer, and the
proposed selling price to the public.
We are paying all expenses and fees in connection with the registration of
the shares. The selling stockholders will bear all brokerage or underwriting
discounts or commissions paid to broker-dealers in connection with the sale of
their shares.
27
DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS;
COMPLIANCE WITH SECTION 16(A) OF THE EXCHANGE ACT
The following table sets forth the names and ages our current directors
and executive officers, the principal offices and positions with us held by each
person and the date such person became a director or executive officer. Each
year the stockholders elect the members of our Board of Directors.
Our directors and executive officers are as follows:
--------------------------------------------------------------------------------
YEAR FIRST ELECTED AS
NAME AN OFFICER OR DIRECTOR AGE POSITION(S) HELD
--------------------------------------------------------------------------------
Darwin Hu 2004 53 President, Chief Executive
Officer and Chairman
--------------------------------------------------------------------------------
William Hawkins 2004 50 Chief Operating Officer,
Acting Chief Financial Officer
and Secretary
--------------------------------------------------------------------------------
David Clark 2004 38 Senior Vice President of
Business Development and
Director
--------------------------------------------------------------------------------
Lawrence Liang 2004 70 Director
--------------------------------------------------------------------------------
Lai Ming Lau 2006 43 Director
--------------------------------------------------------------------------------
There are no family relationships between any director, executive officer, or
person nominated or chosen to become a director or executive officer. DARWIN HU
became our Chairman, President and Chief Executive Officer on April 2, 2004, in
connection with our acquisition of Syscan, Inc. Prior thereto, Mr. Hu was the
President and Chief Executive Officer of Syscan, Inc., our wholly-owned
subsidiary. Mr. Hu has over 21 years of experience in the high-tech industry and
has held various management related positions within organizations related to
color graphic imaging input scanning, display output and imaging communication
product development, manufacturing and sales and marketing. Before joining
Syscan, Inc. in April 1998, Mr. Hu held senior management positions at Microtek,
Xerox, OKI, AVR, DEST, Olivetti and Grundig. Mr. Hu holds a bachelor's degree in
Engineering Science from National Cheng-Kung University, Taiwan, and a master's
degree in Computer Science and Engineering from California State University,
Chico, USA.
WILLIAM HAWKINS became our Chief Operating Officer and Secretary on April 2,
2004, in connection with our acquisition of Syscan, Inc. On April 1, 2005 he
became our interim Chief Financial Officer, after the departure of our former
CFO. Mr. Hawkins has held various management positions at Syscan, Inc., the
Company's wholly-owned subsidiary, since 1999, including V.P. of Sales and
Marketing, President and General Manager Syscan Imaging Group. Prior thereto,
Mr. Hawkins' product focus has been primarily in the imaging systems and
computer peripheral markets, including senior positions with General Electric
(UK), Kaman Aerospace, British Aerospace Engineering, Gartner Research and Per
Scholas. Mr. Hawkins received a bachelor's degree in physics from the University
of Maryland in 1978 and an MBA from Johns Hopkins University in Management of
Technology Concentration (MOT).
28
DAVID CLARK has been our Senior Vice President of Business Development and a
director since July 15, 2004. In July 2005, Mr. Clark was appointed President of
Sysview Technology Inc., our wholly owned subsidiary. From October, 2003 to
July, 2004 Mr. Clark was President of Nautical Vision, Inc. a market specific
image display company where he created and implemented the company's business
plan which involved product sourcing, sales and marketing and general
management. From June, 2001 to October, 2003, Mr. Clark actively invested in and
consulted to a diverse group of companies in addition to being involved in
residential development. Mr. Clark was President and CEO of Homebytes.com from
November, 1998 to May of 2001, where he was primarily responsible for raising in
excess of twenty five million dollars in funding from investors including
America Online, FBR Technology Venture Partners, PNC Bank, and Bank of America,
as well as being instrumental in the acquisition of a key competitor of
Homebytes.com. Prior thereto Mr. Clark was the head of distribution and a
director of Take Two Interactive (NASDAQ:TTWO) which was a result of TTWO's
acquisition of Inventory Management Systems, Inc. (I.M.S.I.), of which Mr. Clark
was a co-founder and President. Prior to founding I.M.S.I., Mr. Clark held
various management positions with Acclaim Entertainment (NASDAQ:AKLM), and the
Imagesoft division of SONY Music (NYSE:SNE). Mr. Clark received a B.S. in
Business from the State University of New York at Binghamton in 1990.
LAWRENCE LIANG has been a director since April 2, 2004. Since 1984 Mr. Liang has
been the President and Vice President of Genoa Systems Corporation, a graphics
company that developed the flicker free and true color technologies in the late
1980's, the President of Telecom Marketing, a marketing consultant for
telecommunications infrastructure, and the President of Cwaves Technology, a
wireless LAN/WAN company. Mr. Liang has also worked for IBM's Technology
Component Division to help develop semiconductor products and RISC CPU
Instruction sets. Mr. Liang also spent five years in IBM's Disk Drive division
in Silicon Valley where he held various management positions. Mr. Liang holds a
master's degree in Applied Mathematics from the City University of New York.
LAI MING LAU has been a director since July 14, 2006. Ms. Lau has been the
director and chief executive officer of RC Capital Limited since July 1992. RC
Capital Limited is a privately-held company located in Hong Kong which advises
public and private companies with respect to initial public offerings, U.S.
listings and capital raising transactions. RC Capital Limited's parent company,
Score One, Inc., is a publicly-held Nevada corporation. Ms. Lau has been the
chief financial officer and a director of Score One, Inc. since November 2005
and was appointed as the secretary of Score One, Inc. in March 2006. Ms. Lau has
over 15 years experience in working with trading businesses in Asia, in
countries such as China, Indonesia and Taiwan, in activities specifically
related to commodities trading and production in Asia. Ms. Lau earned an Hons.
Diploma in Law and Business from Hong Kong Shue Yan College in 1986.
BOARD COMMITTEES
Our board of directors does not currently have any committees. We intend
to establish an audit committee which we expect will be comprised of a majority
of our independent directors.
SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a) of the Securities Exchange Act of 1934, as amended, requires
that our directors and executive officers and persons who beneficially own more
than 10% of our common stock (referred to herein as the "reporting persons")
file with the SEC various reports as to their ownership of and activities
relating to our common stock. Such reporting persons are required by the SEC
regulations to furnish us with copies of all Section 16(a) reports they file.
Based solely upon a review of copies of Section 16(a) reports and
representations received by us from reporting persons, and without conducting
any independent investigation of our own, in 2005, we believe all Forms 3, 4 and
5 were timely filed with the SEC by such reporting persons.
29
CODE OF ETHICS
Our Board of Directors has adopted a Code of Ethics which is applicable to
all of our chief executive officers, senior financial officers and members of
our board of directors, including our principal executive officer and principal
financial officer, principal accounting officer or controller, or other persons
performing similar functions.
Any amendment of our Code of Ethics or waiver thereof applicable to any of
our principal executive officer, principal financial officer and controller,
principal accounting officer, directors or persons performing similar functions
will be disclosed on our website within 5 days of the date of such amendment or
waiver. In the case of a waiver, the nature of the waiver, the name of the
person to whom the waiver was granted and the date of the waiver will also be
disclosed.
SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS
For information regarding securities authorized for issuance under Equity
Compensation Plans, and the equity compensation plan information table see
"Market for Common Equity and Related Stockholder Matters."
30
SECURITY OWNERSHIP OF MANAGEMENT
AND CERTAIN BENEFICIAL OWNERS
The following table sets forth, as of August 16, 2006, information regarding the
beneficial ownership of our common stock based upon the most recent information
available to us for: (i) each person known by us to own beneficially more than
five (5%) percent of our outstanding common stock, (ii) each of our officers and
directors, and (iii) all of our officers and directors as a group. Unless
otherwise indicated, each of the persons listed below has sole voting and
investment power with respect to the shares beneficially owned by them. As of
August 16, 2006 there were 24,092,092 shares of our common stock outstanding.
NUMBER OF COMMON SHARES PERCENTAGE OF COMMON SHARES
NAME AND ADDRESS OF BENEFICIAL OWNER(1) BENEFICIALLY OWNED(2) BENEFICIALLY OWNED
Darwin Hu (3) 1,280,000 5.0%
William Hawkins (4) 846,667 3.4%
David Clark (5) 783,333 3.1%
Lawrence Liang (6) 40,000 *
Lai Ming Lau -0- --
Syscan Imaging Limited (7) 18,773,514 77.9%
All Directors and Officers as a group
(5 persons) (3)-(6) 2,950,000 10.9%
* less than one percent
(1) Unless otherwise indicated, the address of each person listed below is c/o
Sysview Technology, Inc., 1772 Technology Drive, San Jose, California 95110.
(2) Pursuant to the rules and regulations of the Securities and Exchange
Commission, shares of common stock that an individual or group has a right to
acquire within 60 days pursuant to the exercise of options or warrants are
deemed to be outstanding for the purposes of computing the percentage ownership
of such individual or group, but are not deemed to be outstanding for the
purposes of computing the percentage ownership of any other person shown in the
table.
(3) Includes 1,000,000 shares of common stock issuable upon the exercise of
options issued to Mr. Hu in connection with his employment agreement with us.
Also includes 280,000 shares issuable upon the exercise of options granted
pursuant to our Amended and Restated 2002 Stock Option Plan which we expect to
formally issue during the fourth quarter of 2006. Does not include 280,000
shares issuable upon the exercise of options granted pursuant to our Amended and
Restated 2002 Stock Option Plan, all of which are not exercisable within 60 days
of the date hereof. Also does not include 500,000 shares underlying options
issued to Mr. Hu in connection with the execution of his employment agreement
with us, which are not exercisable within 60 days of the date hereof.
(4) Includes 666,667 shares of common stock issuable upon the exercise of
options issued to Mr. Hawkins in connection with his employment agreement with
us. Also includes 180,000 shares issuable upon the exercise of options granted
pursuant to our Amended and Restated 2002 Stock Option Plan which we expect to
formally issue during the fourth quarter of 2006. Does not include 180,000
shares issuable upon the exercise of options granted pursuant to our Amended and
Restated 2002 Stock Option Plan, all of which are not exercisable within 60 days
of the date hereof. Also does not include 333,333 shares underlying options
issued to Mr. Hawkins in connection with the execution of his employment
agreement with us, which are not exercisable within 60 days of the date hereof.
(5) Includes 50,000 shares of common stock and 533,333 shares of common stock
issuable upon the exercise of options issued to Mr. Clark in connection with his
employment agreement with us. Also includes 200,000 shares issuable upon the
exercise of options granted pursuant to our Amended and Restated 2002 Stock
Option Plan which we expect to formally issue during the fourth quarter of 2006.
Does not include 200,000 shares issuable upon the exercise of options granted
pursuant to our Amended and Restated 2002 Stock Option Plan, all of which are
not exercisable within 60 days of the date hereof. Also does not include 266,667
shares underlying options issued to Mr. Clark in connection with the execution
of his employment agreement with us, which are not exercisable within 60 days of
the date hereof.
31
(6) Includes 40,000 shares issuable upon the exercise of options granted
pursuant to our Amended and Restated 2002 Stock Option Plan which we expect to
formally issue during the fourth quarter of 2006. Does not include 40,000 shares
issuable upon the exercise of options granted pursuant to our Amended and
Restated 2002 Stock Option Plan, all of which are not exercisable within 60 days
of the date hereof.
(7) The sole shareholder of Syscan Imaging Limited is is Syscan Technology
Holdings Limited, a publicly-held company whose shares are listed on The Growth
Enterprise Market of The Stock Exchange of Hong Kong Limited. The address for
Syscan Imaging Limited is Unit 808, 8th floor, K. Wah Centre, 191 Java Road,
North Point Hong Kong.
32
DESCRIPTION OF SECURITIES
GENERAL
The following description of our capital stock does not purport to be
complete and is subject to and qualified in its entirety by our certificate of
incorporation and bylaws, which are included as exhibits to the registration
statement of which this prospectus forms a part, and by the applicable
provisions of Delaware law.
Our authorized capital stock consists of 50,000,000 shares of common
stock, and 2,000,000 shares of blank-check preferred stock, 60,000 of which have
been designated Series A Preferred Stock and 30,000 of which have been
designated Series B Preferred Stock. As of the date of this prospectus, our
outstanding capital stock consists of 24,092,092 shares of common stock, $.001
par value, 16,150 shares of Series A Preferred Stock, $.001 par value and 11,500
shares of Series B Preferred Stock. These figures do not include securities to
be issued pursuant to our Amended and Restated 2002 Stock Option Plan.
COMMON STOCK
As of the date of this prospectus, we have 24,092,092 shares of common
stock outstanding, held of record by approximately 365 stockholders. The holders
of common stock are entitled to one vote for each share held of record on all
matters submitted to a vote of the stockholders. Subject to preferential rights
with respect to any outstanding preferred stock, holders of common stock are
entitled to receive ratably such dividends as may be declared by the board of
directors out of funds legally available therefor. In the event of our
liquidation, dissolution or winding up, the holders of common stock are entitled
to share ratably in all assets remaining after payment of liabilities and
satisfaction of preferential rights of any outstanding preferred stock.
Our common stock has no preemptive or conversion rights or other
subscription rights. There are no sinking fund provisions applicable to the
common stock. The outstanding shares of common stock are fully paid and
non-assessable.
PREFERRED STOCK
We have authorized 2,000,000 shares of preferred stock, of which an
aggregate of 60,000 have been designated Series A Preferred Stock, of which
16,150 are outstanding as of the date of this prospectus, and 30,000 have been
designated Series B Preferred Stock, of which 11,500 are outstanding as of the
date of this prospectus. During the year ended December 31, 2005, 250 shares of
Series A Preferred Stock were converted into shares of our common stock. The
issuance of preferred stock with voting and conversion rights may adversely
affect the voting power of the holders of common stock, including voting rights,
of the holders of common stock. In certain circumstances, such issuance could
have the effect of decreasing the market price of the common stock.
Notwithstanding the broad discretion granted to our Board of Directors with
respect to designating the terms and conditions of any series of preferred
stock, our Board of Directors has agreed to refrain from issuing shares of
preferred stock, unless such designation and issuance are approved by a majority
of our independent directors who do not have an interest in the transactions and
who have access to and consulted with (at our expense) our counsel or counsel of
their choosing.
33
SERIES A PREFERRED STOCK
In March 2005, we sold an aggregate of 18,650 shares of our Series A
Preferred Stock, 2,500 of which were converted into shares of our common stock
during the year ended December 31, 2005, the material terms of which are
described below:
Preferred Stock Conversion Rights. All or any portion of the stated value
of Preferred Stock outstanding may be converted into common stock at anytime by
the purchasers. The initial fixed conversion price of the preferred stock is
$1.00 per share ("CONVERSION PRICE"). The Conversion Price is subject to
anti-dilution protection adjustments for stock splits, stock dividends and other
similar transactions at anytime that the preferred stock is outstanding.
Dividends. The Preferred Stock accrues dividends at a rate of 5% per
annum, payable semiannually on July 1 and January 1 in cash, by accretion of the
stated value or in shares of common stock. Subject to certain terms and
conditions, the decision whether to accrete dividends to the stated value of the
Preferred Stock or to pay for dividends in cash or in shares of common stock,
shall be at our discretion.
Redemption. On March 15, 2008 (the "REDEMPTION DATE"), all of the
outstanding Preferred Stock shall be redeemed for a per share redemption price
equal to the stated value on the Redemption Date (the "REDEMPTION PRICE"). The
Redemption Price is payable by us in cash or in shares of common stock at our
discretion and shall be paid within five trading days after the Redemption Date.
In the event we elect to pay all or some of the Redemption Price in shares of
common stock, the shares of common stock to be delivered to the purchasers shall
be valued at 85% of the fifteen-day volume weighted average price of the common
stock on the Redemption Date.
Right to Compel Conversion. If, on any date after March 15, 2006, (A) the
closing market price per share of our common stock for ten (10) consecutive
trading days equals at least $4.00 (subject to adjustment for certain events),
and (B) the average reported daily trading volume during such ten-day period
equals or exceeds 100,000 shares, then we shall have the right, at our option,
to convert, all, but not less than all, of the outstanding shares of Preferred
Stock at the Conversion Price; provided that there shall be an effective
registration statement covering the resale of the shares of common stock
underlying the preferred stock at all times during such 10-day period and during
the 30-day notice period to the holders thereof.
Restrictions on Conversion of Preferred Stock. No holder of our Preferred
Stock is entitled to receive shares upon payment of dividends on the Preferred
Stock, or upon conversion of the Preferred Stock held by such holder if such
receipt would cause such holder to be deemed to beneficially own in excess of
4.999% of the outstanding shares of our common stock on the date of issuance of
such shares (such provision may be waived by such holder upon 61 days prior
written notice to us). In addition, no individual holder is entitled to receive
shares upon payment of dividends on the Preferred Stock, or upon conversion of
the Preferred Stock held by such holder if such receipt would cause such holder
to be deemed to beneficially own in excess of 9.999% of the outstanding shares
of our common stock on the date of issuance of such shares (such provision may
be waived by such holder upon 61 days prior written notice to us).
Registration Rights. Pursuant to the terms of a Registration Rights
Agreement between us and the holders of the preferred stock, we are obligated to
file a registration statement on Form SB-2 registering the resale of shares of
our common stock issuable upon conversion of the preferred stock and exercise of
the warrants. We are required to file the registration statement on or before
April 24, 2005 and have the registration statement declared effective on or
before July 13, 2005. If the registration statement is not declared effective
within the timeframe described, or if the registration is suspended other than
as permitted in the Registration Rights Agreement, we will be obligated to pay
each holder a fee equal to 1.0% of such holders purchase price of the Preferred
Stock during the first 90 days, and 2.0% for each 30 day period thereafter (pro
rated for partial periods), that such registration conditions are not satisfied.
34
Right of First Refusal. Subject to certain conditions, we have granted the
holders a right of first refusal, for a period until one (1) year from the
effective date of the registration statement required to be filed in connection
with the purchase of the Preferred Stock, to participate in any subsequent
financing that we conduct.
Voting Rights. Holders of the Preferred Stock shall have no voting rights.
However, so long as any shares of Preferred Stock are outstanding, we shall not,
without the affirmative vote of the holders of a majority of the shares of the
Preferred Stock then outstanding, (a) alter or change adversely the powers,
preferences or rights given to the Preferred Stock or alter or amend the Series
A Certificate of Designation, (b) authorize or create any class of stock ranking
as to dividends or distribution of assets upon a liquidation senior to or
otherwise PARI PASSU with the Preferred Stock, (c) amend our certificate or
articles of incorporation or other charter documents so as to affect adversely
any rights of the holders of the Preferred Stock, (d) increase the authorized
number of shares of Preferred Stock, or (e) enter into any agreement with
respect to the foregoing.
Liquidation Preference. Upon our liquidation, dissolution or winding up,
whether voluntary or involuntary (a "LIQUIDATION"), the holders of the Preferred
Stock shall be entitled to receive out of our assets, whether such assets are
capital or surplus, for each share of Preferred Stock an amount equal to the
stated value per share before any distribution or payment shall be made to the
holders of any of our securities with rights junior to the Preferred Stock, and
if our assets shall be insufficient to pay in full such amounts, then the entire
assets to be distributed to the holders of the Preferred Stock shall be
distributed among such holders ratably in accordance with the respective amounts
that would be payable on such shares if all amounts payable thereon were paid in
full.
Anti-dilution. The Conversion Price of the Preferred Stock has standard
anti-dilution protection for splits, dividends, subdivisions, distributions,
reclassifications and combinations of our common stock.
SERIES B PREFERRED STOCK
On August 8, 2006, we sold an aggregate of 11,500 shares of our Series B
Preferred Stock, the material terms of which are described below:
Preferred Stock Conversion Rights. All or any portion of the stated value
of Preferred Stock outstanding may be converted into Common Stock at anytime by
the Investors. The initial fixed conversion price of the Preferred Stock is
$1.00 per share ("CONVERSION PRICE"), which is subject to adjustment as
described below.
Redemption. On August 7, 2009 (the "REDEMPTION DATE"), all of the
outstanding Preferred Stock shall be redeemed for a per share redemption price
equal to the stated value on the Redemption Date (the "REDEMPTION PRICE"). The
Redemption Price is payable by the Company in cash or in shares of Common Stock
at the Company's discretion and shall be paid within five trading days after the
Redemption Date. In the event the Company elects to pay all or some of the
Redemption Price in shares of Common Stock, the shares of Common Stock to be
delivered to the Investors shall be valued at 85% of the fifteen-day volume
weighted average price of the Common Stock on the Redemption Date.
35
Right to Compel Conversion. If, on any date after August 7, 2007, (A) the
closing market price for a share of Common Stock for ten (10) consecutive
trading days equals at least $4.00 (subject to adjustment for certain events),
and (B) the average reported daily trading volume during such ten-day period
equals or exceeds 100,000 shares, then the Company shall have the right, at its
option, to convert, all, but not less than all, of the outstanding shares of
Preferred Stock at the Conversion Price; provided that the Registration
Statement shall be effective at all times during such 10-day period and during
the 30-day notice period to the Investors.
Warrant Terms. The Warrants grant Investors the right to purchase up to an
aggregate of 575,000 shares of common stock of the Company at an exercise price
of $1.50 per share. The Warrants expire on August 7, 2009 and must be exercised
by the payment of cash, except if there is no effective registration statement
covering the resale of the shares of Common Stock underlying the Warrants, at
which time an investor may exercise their Warrants on a cashless basis.
Restrictions on Conversion of Preferred Stock and Exercise of Warrant. No
individual Investor is entitled to receive shares upon conversion of the
Preferred Stock held by such Investor if such receipt would cause such Investor
to be deemed to beneficially own in excess of 4.999% of the outstanding shares
of our Common Stock on the date of issuance of such shares (such provision may
be waived by such Investor upon 61 days prior written notice to the Company). In
addition, no individual Investor is entitled to receive shares upon conversion
of the Preferred Stock held by such Investor if such receipt would cause such
Investor to be deemed to beneficially own in excess of 9.999% of the outstanding
shares of our Common Stock on the date of issuance of such shares (such
provision may be waived by such Investor upon 61 days prior written notice to
the Company).
None of the individual holders of the Warrants are entitled to exercise
any such Warrant held by them, if such exercise would cause such Investor to be
deemed to beneficially own in excess of 4.999% of the outstanding shares of our
Common Stock on the date of issuance of such shares Registration Rights.
Pursuant to the terms of a Registration Rights Agreement between the Investors
and the Company, the Company is obligated to file a registration statement on
Form SB-2 (or if Form SB-2 is not available another appropriate form)
registering the resale of shares of the Company's Common Stock issuable upon
conversion of the Preferred Stock and exercise of the Warrants. The Company is
required to file the registration statement within 60 days of August 8, 2006 and
have the registration statement declared effective within 120 days of August 8,
2006. If the registration statement is not timely filed, or declared effective
within the timeframe described, or if the registration is suspended other than
as permitted, in the Registration Rights Agreement, the Company will be
obligated to pay each Investor a fee equal to 1.0% of such Investor's purchase
price of the Preferred Stock for each 30 day period thereafter (pro rated for
partial periods), that such registration conditions are not satisfied, up to a
maximum of 12 months.
Right of First Refusal. Subject to certain conditions, the Company has
granted the Investors a right of first refusal, for a period of one (1) year
from the effective date of the registration statement required to be filed in
connection with this transaction, to participate in any subsequent financing
that the Company conducts.
36
Voting Rights. Holders of the Preferred Stock shall have no voting rights.
However, so long as any shares of Preferred Stock are outstanding, the Company
shall not, without the affirmative vote of the holders of a majority of the
shares of the Preferred Stock then outstanding, (a) alter or change adversely
the powers, preferences or rights given to the Preferred Stock or alter or amend
the Series B Certificate of Designation, (b) authorize or create any class of
stock ranking as to dividends or distribution of assets upon a liquidation
senior to or otherwise PARI PASSU with the Preferred Stock, (c) amend its
certificate or articles of incorporation or other charter documents so as to
affect adversely any rights of the holders of the Preferred Stock, (d) increase
the authorized number of shares of Preferred Stock, or (e) enter into any
agreement with respect to the foregoing.
Liquidation Preference. Upon any liquidation, dissolution or winding up of
the Company, whether voluntary or involuntary (a "LIQUIDATION"), the holders of
the Preferred Stock shall be entitled to receive out of the assets of the
Company, whether such assets are capital or surplus, for each share of Preferred
Stock an amount equal to the stated value per share before any distribution or
payment shall be made to the holders of any securities of the Company with
rights junior to the Preferred Stock, and if the assets of the Company shall be
insufficient to pay in full such amounts, then the entire assets to be
distributed to the holders of the Preferred Stock shall be distributed among
such holders ratably in accordance with the respective amounts that would be
payable on such shares if all amounts payable thereon were paid in full.
Anti-dilution. The Conversion Price of the Preferred Stock has standard
anti-dilution protection for stock splits, dividends, subdivisions,
distributions, reclassifications and combinations of our common stock.
Additionally, if we issue or sell any common stock or securities convertible
into common stock, at anytime prior to the twelve month period following the
effective date of the registration statement required to be filed pursuant to
the registration rights agreement entered into between the Preferred Stock
holders and us, at below the Conversion Price, the Conversion price shall be
automatically adjusted to equal such lower price.
WARRANTS
We have outstanding warrants to purchase an aggregate of up to 1,794,000
shares of our Common stock. 932,500 of such warrants are exercisable at $2.00
per share, 675,000 of such warrants are exercisable at $1.50 per share and
186,500 of such warrants are exercisable at $1.00 per share, 1,119,000 of which
were issued in connection with our Series A Preferred Stock financing and
675,000 of which were issued in connection with our Series B Preferred Stock
financing. 1,119,000 of the warrants are exercisable through March 15, 2010 and
675,000 of the warrants are exercisable through August 7, 2009 and must be
exercised by the payment of cash, except if there is no effective registration
statement covering the resale of the shares of Common stock underlying the
warrants, a holder may exercise their warrants on a cashless basis.
Holders of the 675,000 warrants are entitled to price protection for
issuances of common stock or common stock equivalents, prior to the effective
date of the registration statement covering the resale of the shares of common
stock underlying the Preferred Stock, at less than the exercise price of such
warrants, so the exercise price would be adjusted to equal the lower price.
Holders of all warrants also have standard anti-dilution protection for splits,
dividends, subdivisions, distributions, reclassifications and combinations of
our common stock.
37
None of the individual holders of the Warrants are entitled to exercise
any such Warrant held by them, if such exercise would cause such holder to be
deemed to beneficially own in excess of 4.999% of the outstanding shares of our
Common stock on the date of issuance of such shares.
ANTI-TAKEOVER LAW
We are subject to Section 203 of the Delaware General Corporation Law,
which restricts certain transactions and business combinations between a
corporation and an "interested stockholder" (as defined in Section 203) owning
15% or more of the corporation's outstanding voting stock, for a period of three
years from the date the stockholder becomes an interested stockholder. Subject
to certain exceptions, unless the transaction is approved by the board of
directors and the holders of at least two-thirds of our outstanding voting stock
(excluding shares held by the interested stockholder), Section 203 prohibits
significant business transactions such as a merger with, disposition of assets
to, or receipt of disproportionate financial benefits by the interested
stockholder, or any other transaction that would increase the interested
stockholder's proportionate ownership of any class or series of the
corporation's stock. The statutory ban does not apply if, upon consummation of
the transaction in which any person becomes an interested stockholder, the
interested stockholder owns at least 85% of the outstanding voting stock of the
corporation (excluding shares held by persons who are both directors and
officers or by certain employee stock plans).
TRANSFER AGENT AND REGISTRAR
Interwest Transfer Company is the transfer agent for our common stock. The
address for Interwest Trust Company is 1981 East Murray Holladay Road, Salt Lake
City, Utah 84117.
38
DISCLOSURE OF COMMISSION POSITION OF INDEMNIFICATION FOR
SECURITIES ACT LIABILITIES
Our certificate of incorporation provides that all our directors,
officers, employees and agents shall be entitled to be indemnified by us to the
fullest extent permitted under the Delaware General Corporation Law, provided
that they acted in good faith and that they reasoned their conduct or action was
in, or not opposed to, the best interest of our company.
Our Bylaws provide for indemnification of our officers, directors and
others who become a party to an action on our behalf by us to the fullest extent
not prohibited under the Delaware General Corporation Law. Further, we maintain
officer and director liability insurance.
Insofar as indemnification for liabilities arising under the Securities
Act may be permitted to our directors, officers, and controlling persons
pursuant to the foregoing provisions, or otherwise, we have been advised that in
the opinion of the SEC such indemnification is against public policy as
expressed in the Securities Act and is, therefore, unenforceable. In the event
that a claim for indemnification against such liabilities (other than the
payment of expenses incurred or paid by a director, officer or controlling
person in a successful defense of any action, suit or proceeding) is asserted by
such director, officer or controlling person in connection with the securities
being registered, we will, unless in the opinion of our counsel the matter has
been settled by controlling precedent, submit to the court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.
[remainder of page intentionally left blank]
39
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
THE FOLLOWING DISCUSSION AND ANALYSIS OF OUR FINANCIAL CONDITION AND RESULTS OF
OPERATIONS SHOULD BE READ IN CONJUNCTION WITH OUR CONSOLIDATED FINANCIAL
STATEMENTS AND RELATED NOTES APPEARING ELSEWHERE IN THIS PROSPECTUS. THIS
DISCUSSION AND ANALYSIS CONTAINS FORWARD-LOOKING STATEMENTS THAT INVOLVE RISKS,
UNCERTAINTIES AND ASSUMPTIONS. THE ACTUAL RESULTS MAY DIFFER MATERIALLY FROM
THOSE ANTICIPATED IN THESE FORWARD-LOOKING STATEMENTS AS A RESULT OF CERTAIN
FACTORS, INCLUDING, BUT NOT LIMITED TO, THOSE WHICH ARE NOT WITHIN OUR CONTROL.
Management's discussion and analysis of financial condition and results of
operations (MD&A) is provided as a supplement to the accompanying consolidated
financial statements and footnotes to help provide an understanding of our
financial condition, changes in financial condition and results of operations.
The MD&A is organized as follows:
o OVERVIEW. This section provides a general description of our
business, as well as recent developments that we believe are
important in understanding the results of operations and to
anticipate future trends in those operations.
o CRITICAL ACCOUNTING POLICIES. This section provides an analysis of
the significant estimates and judgments that affect the reported
amounts of assets, liabilities, revenues and expenses, and related
disclosure of contingent assets and liabilities.
o RESULTS OF OPERATIONS. This section provides an analysis of our
results of operations for the three and nine months ended September
30, 2006 compared to the same period in 2005 and the year ended
December 31, 2005 compared to the same period in 2004. A brief
description is provided of transactions and events, including
related party transactions that impact the comparability of the
results being analyzed.
o LIQUIDITY AND CAPITAL RESOURCES. This section provides an analysis
of our financial condition and cash flows as of and for the quarter
ended September 30, 2006 and for the year ended December 31, 2005.
The following management's discussion and analysis should be read in
conjunction with our consolidated unaudited financial statements for the three
and nine months ended September 30, 2006 and 2005, the consolidated audited
financial statements for the fiscal years ended December 31, 2005 and 2004 and
related notes to those financial statements.
OVERVIEW
Management's Discussion and Analysis (MD&A) contains statements that are
forward-looking. These statements are based on current expectations and
assumptions that are subject to risks and uncertainties. Actual results could
differ materially because of factors discussed in this prospectus, as well as
factors not within our control. We undertake no duty to update any
forward-looking statement to conform the statement to actual results or changes
in our expectations.
We are in the business of developing, designing and delivering imaging
technology solutions. We currently have 14 patents issued in the United States
and five patents issued in Taiwan. Additionally, we have five patents currently
pending with the United States Patent and Trademark Office, three relate to
image display technology and two relate to image scanning. We focus our research
and development toward new deliverable and marketable technologies. We sell our
products to clients throughout the world, including the United States, Canada,
Europe, South America, Australia and Asia. We intend to leverage our experience,
expertise and current technology in the image capture market by expanding our
business to the image display market, which is deemed to be a much larger
market.
40
Our strategy is to expand our image capture product line and technology
while leveraging our assets in other areas of the imaging industry. We are
actively shipping six categories of image capture products and have expanded our
product offerings to include six new products during fiscal 2006. During the
first three months of fiscal 2006, we introduced two new products under our
Original Equipment Manufacturers' ("OEM") brand names. During the third quarter
of fiscal 2006 we introduced one additional product through one of our OEMs. Our
expanded product line is in response to the increased market demand for faster
and easier-to-use products as well as increased security to meet the growing
need for information protection, including identity and financial transaction
protection. In addition to expanding our image capture product line, we actively
pursue the acquisition of technology and or companies in the image capture and
display industry to complement our business model, improve our competitive
positioning and further expand our product offerings.
While we continue to grow our presence in image capture technology, we
have begun creating, through acquisition and research and development, new
technology solutions for the substantially larger, image display market. More
specifically we are creating products and technologies to accent and enhance the
HDTV television market. Our first image display product is expected to be
available for delivery in 2007. We believe that these HDTV products will provide
advanced image quality at a highly competitive price point, creating a value
point product.
CRITICAL ACCOUNTING POLICIES
Our discussion and analysis is based upon our consolidated financial
statements, which have been prepared in accordance with accounting principles
generally accepted in the United States. The preparation of these financial
statements requires us to make estimates and judgments that affect the reported
amounts of assets, liabilities, revenues and expenses, and related disclosure of
contingent assets and liabilities. On an on-going basis, we evaluate our
estimates, including those related to revenue recognition, accounts receivable
and allowance for doubtful accounts, inventories, intangible and long-lived
assets, and income taxes. We base our estimates on historical experience and on
various other assumptions that are believed to be reasonable under the
circumstances, the results of which form the basis for making judgments about
the carrying values of assets and liabilities that are not readily apparent from
other sources. Actual results may differ from these estimates under different
assumptions or conditions.
An accounting policy is deemed to be critical if it requires an accounting
estimate to be made based on assumptions about matters that are highly uncertain
at the time the estimate is made, and if different estimates that reasonably
could have been used or changes in the accounting estimate that are reasonably
likely to occur could materially change the financial statements. We believe the
following critical accounting policies reflect our more significant estimates
and assumptions used in the preparation of our consolidated financial
statements:
REVENUE RECOGNITION
Revenues consist of sales of merchandise, including optical image
capturing devices, modules of optical image capturing devices, and chips and
other optoelectronic products. Revenue is recognized when the product is shipped
and the risks and rewards of ownership have transferred to the customer. We
recognize shipping and handling fees as revenue, and the related expenses as a
component of cost of sales. All internal handling charges are charged to
selling, general and administrative expenses.
41
ACCOUNTS RECEIVABLE AND ALLOWANCE FOR DOUBTFUL ACCOUNTS
We present accounts receivable, net of allowances for doubtful accounts,
to ensure accounts receivable are not overstated due to uncollectibility. The
allowances are calculated based on detailed review of certain individual
customer accounts, historical rates and an estimation of the overall economic
conditions affecting our customer base. We review a customer's credit history
before extending credit. If the financial condition of our customers were to
deteriorate, resulting in an impairment of their ability to make payments,
additional allowances may be required. In the event that our trade receivables
became uncollectible after exhausting all available means of collection, we
would be forced to record additional adjustments to receivables to reflect the
amounts at net realizable value. The effect of this entry would be a charge to
income, thereby reducing our net profit. Although we consider the likelihood of
this occurrence to be remote based on past history and the current status of our
accounts, there is a possibility of this occurrence.
INVENTORIES
Inventories consist of finished goods, which are stated at the lower of
cost or net realizable value, with cost computed on a first in, first-out basis.
Provision is made for obsolete, slow-moving or defective items where
appropriate. The amount of any provision of inventories is recognized as an
expense in the period the provision occurs. The amount of any reversal of any
provision is recognized as other income in the period the reversal occurs. Our
inventory purchases and commitments are made in order to build inventory to meet
future shipment schedules based on forecasted demand for our products. We
perform a detailed assessment of inventory for each period, which includes a
review of, among other factors, demand requirements, product life cycle and
development plans, component cost trends, product pricing and quality issues.
Based on this analysis, we record adjustments to inventory for excess,
obsolescence or impairment, when appropriate, to reflect inventory at net
realizable value. Revisions to our inventory adjustments may be required if
actual demand, component costs or product life cycles differ from our estimates.
In the event we were unable to sell our products, the demand for our products
diminished, other competitors offered similar or better technology, and/or the
product life cycles deteriorated causing quality issues, we would be forced to
record an adjustment to inventory for impairment or obsolescence to reflect
inventory at net realizable value. The effect of this entry would be a charge to
income, thereby reducing our net profit. Although we consider the likelihood of
this occurrence to be remote based on our forecasted demand for our products,
there is a possibility of this occurrence.
INTANGIBLE AND LONG-LIVED ASSETS
We evaluate our intangible assets and long-lived assets, which represent
goodwill, long-term investments, and fixed assets, for impairment annually and
when circumstances indicate the carrying value of an asset may not be
recoverable. If impairment exists, an adjustment is made to write the asset down
to its fair value, and a loss is recorded as the difference between the carrying
value and fair value would be charged to operations. We do not believe any
impairment exists for any of these types of assets as of December 31, 2005.
INCOME TAXES
The Company accounts for income taxes under the provisions of Statement of
Financial Accounting Standards ("SFAS" No. 109), "Accounting for Income Taxes,"
whereby deferred income tax assets and liabilities are computed for differences
between the financial statements and tax bases of assets and liabilities that
will result in taxable or deductible amounts in the future, based on enacted tax
laws and rates applicable to the periods in which the differences are expected
to affect taxable income. Valuation allowances are established when necessary to
reduce deferred income tax assets to the amount expected to be realized.
42
CONTINGENCIES
Currently, there are no outstanding legal proceedings or claims, other
than that disclosed in Note 7 of the Consolidated Financial Statements. The
outcomes of potential legal proceedings and claims brought against us are
subject to significant uncertainty. SFAS 5, ACCOUNTING FOR CONTINGENCIES,
requires that an estimated loss from a loss contingency such as a legal
proceeding or claim should be accrued by a charge to income if it is probable
that an asset has been impaired or a liability has been incurred and the amount
of the loss can be reasonably estimated. Disclosure of a contingency is required
if there is at least a reasonable possibility that a loss has been incurred. In
determining whether a loss should be accrued we evaluate, among other factors,
the degree of probability of an unfavorable outcome and the ability to make a
reasonable estimate of the amount of loss. Changes in these factors could
materially impact our financial position or results of operations.
ACCOUNTING FOR CERTAIN FINANCIAL INSTRUMENTS WITH CHARACTERISTICS OF BOTH
LIABILITIES AND EQUITY
We account for our Series A 5% cumulative convertible preferred stock
("Series A Stock") and our Series B convertible preferred stock ("Series B
Stock") pursuant to Statement of Financial Accounting Standards ("SFAS")
"ACCOUNTING FOR DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES" ("SFAS 133") and
the Emerging Issues Task Force ("EITF") Abstract 00-19, "ACCOUNTING FOR
DERIVATIVE FINANCIAL INSTRUMENTS" ("EITF 00-19"). Accordingly, the embedded
conversion feature associated with our Series A Stock and related warrants and
our Series B Stock and related warrants have been determined to be derivative
instruments. The fair value of these derivative instruments, as determined by
applying the Black-Scholes valuation model, is adjusted quarterly. The
Black-Scholes valuation model requires the input of highly subjective
assumptions, including the expected stock price volatility. Additionally,
although the Black-Scholes model meets the requirements of SFAS 133, the fair
values generated by the model may not be indicative of the actual fair values of
our Series A Stock and Series B Stock as our derivative instruments have
characteristics significantly different from traded options.
RESULTS OF OPERATIONS
The following table summarizes certain aspects of our results of
operations for the three and nine months ended September 30, 2006 compared to
the three and nine months ended September 30, 2005 (IN THOUSANDS):
43
THREE MONTHS ENDED NINE MONTHS ENDED
SEPTEMBER 30, SEPTEMBER 30,
2006 2005 $ % 2006 2005 $ %
---- ---- - - ---- ---- - -
Net sales $4,098 $2,207 $1,891 86% $9,075 $5,402 $3,673 68%
Cost of sales 2,700 1,417 1,283 91 5,976 3,404 2,572 76
As a percentage of sales 65% 64% 66% 63%
Selling and marketing expense 307 332 (25) (8) 900 742 158 21
General and administrative expense 676 698 (22) (3) 1,963 2,329 (366) (16)
Research and development expense 584 242 342 141 1,449 640 809 126
Total other income (expense) 687 (680) NM NM 347 464 NM NM
Dividend on 5% convertible )
preferred stock and accretion of (209) (184 NM NM (504) (394) NM NM
preferred stock redemption value
NM = Not Meaningful
NET SALES
The significant increase in net sales was attributable to our increased
product offerings. We introduced our duplex scanners (DocketPORT) near the end
of the third quarter of fiscal 2005, which created a broader base of products.
Sales of our duplex scanners were approximately $538,000 and $1,143,000 during
the three and nine months ended September 30, 2006, respectively, as compared to
$235,000 for both the three and nine months ended September 30, 2005. Our
largest customer has significantly expanded its distribution channels in 2006,
which resulted in a substantial revenue increase during the three months ended
September 30, 2006 as compared to the three months ended September 30, 2005. To
a lesser extent, our net sales were positively impacted by our gradual trending
towards our Value Added Reseller ("VAR") channel distribution and the growth in
the small office home office ("SOHO") markets, which is a result of our efforts
to appeal to customers in these sales channels.
Sales to our three largest customers represented 84% and 82% for the three
and nine months ended September 30, 2006, respectively, and 68% and 64% for the
three and nine months ended September 30, 2005, respectively. We expect that our
largest customers will continue to account for a substantial portion of our net
sales in the remainder of fiscal 2006 and for the foreseeable future. The
identities of our largest customer and their respective contributions to our net
sales have varied and will likely continue to vary from period to period.
Although we expect net sales to increase as we continue to offer
additional products in the image display market and expand to the image display
market, there can be no assurance that our net sales will increase.
COST OF SALES, INCLUDING GROSS PROFIT
Cost of sales includes all direct costs related to the transfer of
scanners, imaging modules and services related to the delivery of those items
manufactured in China, and to a lesser extent engineering services and software
royalties. Cost of sales increased in absolute dollars as a result of the
increased net sales during both the three and nine months ended September 30,
2006 as compared to the three and nine months ended September 30, 2005. Cost of
sales as a percentage of net sales remained fairly constant as a result of the
stability of our average selling price and related material cost used to
manufacture our products. We expect this trend to continue for the foreseeable
future.
44
We purchase the majority of our finished scanner imaging products from a
wholly-owned subsidiary of our majority stockholder, Syscan Technology Holdings
Limited ("STH"). Our Chairman and CEO, Darwin Hu, was formerly the CEO of STH.
Related party purchases from entities that are wholly-owned subsidiaries
of STH were $3,254,000 for the nine months ended September 30, 2006, and
$1,542,000 and $3,521,000 for the three and nine months ended September 30,
2005. The purchases were carried out in the normal course of business.
SELLING AND MARKETING EXPENSE
Selling and marketing expenses consist primarily of salaries and related
costs of employees, including stock-based compensation costs, engaged in the
sales, marketing and customer account management functions and to a lesser
extent market development and promotional funds for our retail distributions
channels, tradeshows, website support, warehousing, logistics and certain sales
representative fees. The increase during the nine months ended September 30,
2006 as compared to the nine months ended September 30, 2005 is primarily
attributable to the increased staff and related marketing activities to support
our expanding products offerings and the addition of direct sales personnel in
Europe and Asia. The slight decrease in selling and marketing expense during the
three months ended September 30, 2006 as compared to the three months ended
September 30, 2005 is a result of the timing of advertising and promotions of
our various new products. Overall, we expect selling and marketing expenses to
increase as we continue to expand our marketing efforts and the number of
products we offer.
GENERAL AND ADMINISTRATIVE EXPENSE
General and administrative expense consists primarily of costs associated
with our executive, financial, human resources and information services
functions, including stock-based compensation costs, facilities-related expenses
and outside professional services such as legal and accounting. The slight
decrease in general and administrative expenses during the three months ended
September 30, 2006 as compared to the three months ended September 30, 2005 was
a result of decreased costs associated with our investor relations function. We
believe the decrease is temporary and is a result of the timing of certain
investor relations events. The decrease in the nine months ended September 30,
2006 as compared to the same period in 2005 is mainly attributable to
stock-based compensation cost (a non-cash charge) as a result of granting stock
options to certain executives and key employees at less than fair market value
on the grant date during 2005 and adopting SFAS 123(R). See "Notes to Financial
Statements Note 2." Stock-based compensation cost was $227,000 and $788,000 for
the three and nine months ended September 30, 2006, respectively, and $211,000
and $1,195,000 for the three and nine months ended September 30, 2005,
respectively. The increase was a result of increased personnel costs to support
our expanding business and related infrastructure and the increased expenses
associated with maintaining our public company status. We anticipate that
general and administrative expenses will continue to increase over the long term
as our business continues to grow and the costs associated with being a public
company continue to increase as a result of our required reporting requirements,
including but not limited to expenses incurred to comply with the Sarbanes-Oxley
Act of 2002.
45
RESEARCH AND DEVELOPMENT EXPENSE
Research and development expense consists primarily of salaries and
related costs, including stock-based compensation costs, of employees engaged in
product research, design and development activities, compliance testing,
documentation, prototypes and expenses associated with transitioning the product
to production. Research and development expense significantly increased during
both the three and nine months ended September 30, 2006 as compared to the three
and nine months ended September 30, 2005 as a result of an increase in the
number of employees engaged in research and development activities, resulting
from both direct hiring and acquisitions. We anticipate that research and
development expense will continue to increase over the long term as a result of
the growth and diversification of the products we offer, new product
opportunities and our continued efforts to invest in the future and strengthen
our intellectual property position within our highly competitive market.
TOTAL OTHER INCOME (EXPENSE)
Other income (expense) for the three and nine months ended September 30,
2006 was mainly attributable to the $955,000 and $645,000, respectively,
decrease in the fair value of the liability for derivative contracts (associated
with our Series A Stock and related warrants and Series B Stock and related
warrants). During the three and nine months ended September 30, 2005, the fair
value of the liability for derivative contracts increased $686,000 and decreased
$975,000, respectively. Pursuant to SFAS 133, ACCOUNTING FOR DERIVATIVE
INSTRUMENTS AND HEDGING ACTIVITIES, ("SFAS 133") and EITF Abstract 00-19,
ACCOUNTING FOR DERIVATIVE FINANCIAL INSTRUMENTS ("EITF 00-19"), the increase in
the fair value of the liability for derivative contracts is included as other
expense in our consolidated statements of operations and the decrease in the
fair value of the liability for derivative contracts is included as other income
in our consolidated statements of operations.
The remaining other income (expense) during the nine months ended September 30,
2006 was a result of issuing our Series B Stock as follows:
o Cash paid for issuance costs of $80,000 in connection with our
offering; and
o A non-cash charge of $173,000 representing the fair value of 100,000
warrants issued to the placement agent for the sale of the stock.
The remaining other income (expense) during the nine months ended September 30,
2005 was a result of issuing our Series A Stock as follows:
o Cash paid for issuance costs of $237,000 in connection with our
offering; and
o A non-cash charge of $290,000 representing the fair value of 186,500
warrants issued to the placement agent for the sale of the stock.
DIVIDEND ON SERIES A STOCK AND ACCRETION OF PREFERRED STOCK REDEMPTION VALUE
During the three and nine months ended September 30, 2006 accretion on our
preferred stock, both Series A and Series B, totaled approximately $187,000 and
$445,000, respectively. During the three and nine months ended September 30,
2005 accretion on our Series A Stock was approximately $155,000 and $337,000,
respectively. The increase during the three and nine months ended September 30,
2006 as compared to the three and nine months ended September 30, 2005 was
attributable to the sale of our Series B Stock during the three months ended
September 30, 2006. Series A Stock dividends were $22,000 and $59,000 during the
three and nine months ended September 30, 2006, respectively, and $29,000 and
$57,000 for the three and nine months ended September 30, 2005, respectively We
do not pay dividends on our Series B Stock.
46
TWELVE MONTHS ENDED DECEMBER 31, 2005 COMPARED TO DECEMBER 31, 2004
REVENUE
During the fiscal year ended December 31, 2005, our revenues increased by
$1.79 million (29.5%) from $6.06 million for the year ended December 31, 2004 to
$7.85 million for the year ended December 31, 2005.
Scanner products and imaging modules comprised approximately 99% of our
revenues during each of these periods. Our revenue mix has been gradually
trending towards the Value Added Reseller (VAR) and small office home office
(SOHO) markets, which is a result of our efforts to appeal to customers in these
sales channels. During the year ended December 31, 2005 four of our customers
accounted for approximately 79% of total revenues. During the year ended
December 31, 2004, these same four customers accounted collectively for
approximately 78% of total revenues. The loss of any of our largest clients
could have a material adverse effect on our business.
COST OF SALES
Cost of goods sold (COGS) includes all direct costs related to the
transfer of scanners, imaging modules and services related to the delivery of
those items manufactured in China. A relatively small percentage (< 2%) of COGS
is due to engineering services and (< 6%) of COGS is due to software royalties
paid by us. COGS was approximately 63.6% for the year ended December 31, 2005
compared to 68.1% for the same period in 2004. COGS decreased as a percentage of
revenues for the year ended December 31, 2005 as compared to the same period in
2004 primarily as a result of greater gross margins and better pricing
elasticity than projected. We anticipate that our COGS may remain at the current
level during 2006 as a result of "flat" unit sales prices and stable material
costs.
GROSS PROFIT
Gross profit increased to $2,859,389 or 36.4% of net revenues for the year
ended December 31, 2005 from $1,931,859 or 31.9% of net revenues for the same
period in 2004. This increase in gross profit is primarily a result of increased
revenue and increased margins realized with our new products. We anticipate that
our gross profit margins may continue to increase during 2006, as we discontinue
older and less-profitable products.
SELLING AND MARKETING
Selling and marketing expenses include payroll, employee benefits,
stock-based compensation cost and other costs associated with sales, marketing
and account management personnel. Other direct selling and marketing costs
include market development funds and promotions (retail channels only),
tradeshows, website support costs, warehousing, logistics and certain sales
representative fees. Selling and marketing expenses increased to $1,037,221 for
the year ended December 31, 2005 from $745,557 for the same period in 2004, an
increase of $291,664 or approximately 39.1%. The increase during the year ended
December 31, 2005 is primarily attributable to changes in staffing and marketing
activities related to the display imaging group and the addition of direct sales
personnel in Europe and Asia. Additionally, during the year ended December 31,
2005, we booked $85,231 of stock-based compensation cost (a non-cash charge) as
a result of granting stock options to certain executives and key employees at
less than fair market value on the grant date. We had no stock-based
compensation cost during the corresponding periods in 2004.
47
GENERAL AND ADMINISTRATIVE
General and administrative costs include accounting, legal, administrative
personnel, stock-based compensation cost and other headcount-related costs
associated with the facilities and certain human resources, as well as other
professional and administrative fees. General and administrative expenses
increased to $2,917,564 for the year ended December 31, 2005 from $783,108 for
the same period in fiscal 2004, an increase of $2,134,456 or approximately 273%.
The increase for the year ended December 31, 2005 is primarily attributable
$1,406,312 of stock-based compensation cost (a non-cash charge) as a result of
granting stock options to certain executives and key employees at less than fair
market value on the grant date. We had no stock-based compensation cost during
the corresponding periods in 2004. The increase is also attributable to the
additional cost of outside fees incurred in connection with our public listing
compliance expenses costs incurred related to our image display subsidiary.
RESEARCH AND DEVELOPMENT
Research and Development (R&D) costs include payroll, employee benefits,
stock-based compensation and other headcount-related costs associated with the
product design, development, compliance testing, documentation and transition to
production. R&D expenses increased to $951,333 for the year ended December 31,
2005 from $528,417 for the same period in fiscal 2004, an increase of $422,916
or approximately 80%. This significant increase for the year ended December 31,
2005 is primarily attributable to engineering staff and expenditures for the
image display products. We believe that this investment is necessary to
establish a strong intellectual property (IP) position within this highly
competitive market. Additionally, during the year ended December 31, 2005, we
booked $85,231 of stock-based compensation cost (a non-cash charge) as a result
of granting stock options to certain executives and key employees at less than
fair market value on the grant date. We had no stock-based compensation cost
during the corresponding periods in 2004.
OTHER INCOME (EXPENSE)
Our other income (expense) for the year ended December 31, 2005 was
$556,723 compared to $2,958 during the same period of 2004.
Other income (expense) for 2005 consisted mainly of the following items:
(i) The $1,112,005 decrease in the fair value of the liability for derivative
contracts (associated with our 5% Convertible Series A Preferred Stock) from the
date of issuance, March 15, 2005 through June 30, 2005. Pursuant to SFAS 133,
"Accounting for Derivative Instruments and Hedging Activities" ("SFAS 133") and
EITF Abstract No. 00-19, "Accounting for Derivative Financial Instruments"
("EITF 00-19"), the decrease in the fair value of the liability for derivative
contracts is included as other income in our consolidated statements of
operations.
(ii) In connection with the sale of the Company's 5% Series A Convertible
Preferred Stock, the paid issuance costs of $236,500 and recorded a non-cash
charge for the fair value of 186,500 warrants issued to the placement agent for
the sale of the preferred stock. The fair value of these warrants totaled
$290,000. Total issuance costs of $526,500 were charged to other expense during
2005.
48
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS
Net loss available to common stockholders for the year ended December 31,
2005 was $2,038,673 versus net loss of $179,866 during the same period in 2004.
The increase in net loss was primarily the result of (i) costs incurred and
non-cash accounting entries in connection with the sale of our 5% Series A
Preferred Stock and. (ii) stock-based compensation cost for the grant of stock
options at less than fair market value.
RELATED PARTY TRANSACTIONS
We purchase significantly all of our finished scanner imaging products
from the parent company of our majority stockholder, Syscan Technology Holdings
Limited ("STH"). Our Chairman and CEO, Darwin Hu, was formerly the CEO of STH.
The following is a summary of significant related party transactions, which were
carried out in the normal course of the Company's business, during the years
ended December 31, 2005 and 2004:
The following is a summary of significant related party purchases from
entities that are wholly-owned subsidiaries of STH. The transactions were
carried out in the normal course of our business.
2005 2004
------- -------
SYSCAN Intervision Limited, a wholly-owned subsidiary of $4.915M $3.825M
======= =======
STH (purchases)
SYSCAN Optoelectronics Technology (Shenzhen) Company - $0.520M
Limited, a wholly-owned subsidiary of STH (purchases)
======= =======
Amounts due to/from related parties are unsecured, interest-free and repayable
on demand and consisted of the following:
Due from STH $345,998
Due from Majority Stockholder $100,000
Due from various subsidiaries wholly-owned by STH $1,956,522
----------
$2,402,520
==========
LIQUIDITY AND CAPITAL RESOURCES
SEPTEMBER 30, 2006
At September 30, 2006, our principal sources of liquidity included cash
and cash equivalents of $1,419,000 and unused borrowing capacity of $1,487,000
under our bank line of credit. We had no significant cash outlays during the
nine months ended September 30, 2006.
49
Operating activities: Cash used by operating activities during the nine months
ended September 30, 2006 was primarily to fund our net loss, as adjusted for
non-cash items such as stock-based compensation associated with issuing options
and changes in our derivative instruments and convertible preferred stock.
Additional uses of cash included an increase in trade receivables resulting from
the significant increase in sales of our products during the three months ended
September 30, 2006 and an increase in inventory as we anticipate this growth in
revenues to continue. Sources of operating cash include an increase in accounts
payable as a result of managing our working capital and the normal fluctuation
and timing of purchases. As we have had to ramp up inventory purchases to meet
the increased demand for our products, our cash was somewhat constrained during
the nine months ended September 30, 2006. During the nine months ended September
30, 2005, cash used by operations resulted from funding our net loss, adjusted
for non-cash items such as stock-based compensation associated with issuing
options and changes in our derivative instruments and convertible preferred
stock and changes to trade receivables and inventories. We expect future cash
provided (used) by operating activities to fluctuate, primarily as a result of
fluctuations in our operating results, timing of product shipments, trade
receivables collections, inventory management and timing of vendor payments.
Investing activities: For both the nine months ended September 30, 2006 and
2005, cash used in investing activities was solely attributable to the purchase
of capital equipment and licensed technology.
Financing activities: On August 8, 2006, we sold $1,150,000 of our Series B
Stock. Net proceeds of this offering after payment of related commissions, fees
and other expenses were approximately $1,070,000. We intend to use the proceeds
for sales, marketing, research and development and for working capital and
general corporate purposes. Other cash provided by financing activities for the
nine months ended September 30, 2006, was a result of payments from related
party receivables. For the nine months ended September 30, 2005, cash provided
by financing activities was a result of issuing our Series A Stock, somewhat
offset by advances to related parties. All advances to and repayments from
related parties during the nine months ended September 30, 2006 and 2005 were
made in the ordinary course of business.
CASH AND WORKING CAPITAL REQUIREMENTS
As previously discussed, we plan to continue increasing our presence in
the image capture market and expand our operations into the image display area,
which may require additional capital. Additionally, we may seek to expand our
operations through acquisitions of companies in the image capture and display
industry that we believe could complement our business model, improve our
competitive positioning and expand our product offerings.
Considering current cash reserves and other sources of liquidity,
including our bank line of credit, borrowing from related parties and the
aforementioned funds raised through the sale of our Series B Stock, management
believes that the Company will have sufficient sources of financing to continue
its normal operations through at least the next twelve months. However, our
business expansion plans may require additional capital through either the
incurrence of debt or the issuance of equity securities, or a combination
thereof, depending on the prevailing market and other conditions. There is no
assurance that such additional funds will be available for us to finance our
expansion plans. Furthermore, there is no assurance the net proceeds from any
successful financing arrangement will be sufficient to cover cash requirements
as we expand our business operations.
50
CONTRACTUAL OBLIGATIONS
The following table summarizes our contractual obligations at September 30,
2006, and the effect such obligations are expected to have on our liquidity and
cash flows in future periods (IN THOUSANDS):
LESS THAN ONE - THREE THREE - FIVE
TOTAL ONE YEAR YEARS YEARS
------- --------- ----------- ------------
Line of credit (1) $ 1,013 $ 1,013 $ -- $ --
Operating lease obligations 568 251 315 2
------- --------- ----------- ------------
Total contractual cash obligations $ 1,581 $ 1,264 $ 315 $ 2
======= ========= =========== ============
(1) We have a line of credit up to $2,500,000, bearing interest at the rate of
prime (8.25% at September 30, 2006) plus 0.5% and secured by all our assets.
Interest payments are due monthly and all unpaid interest and principal was due
in full on October 30, 2006. Although we are currently negotiating a new line of
credit with the same bank, the new terms have not been finalized. The bank
agreed to extend our current line of credit for two months with the existing
terms while the new agreement is finalized.
OFF-BALANCE SHEET ARRANGEMENTS
At September 30, 2006, we did not have any relationship with
unconsolidated entities or financial partnerships, which other companies have
established for the purpose of facilitating off-balance sheet arrangements or
other contractually narrow or limited purposes as defined in Item 303(a)(4)(ii)
of SEC Regulation S-K. Therefore, we are not materially exposed to any
financing, liquidity, market or credit risk that could arise if we had engaged
in such relationships.
TRENDS
As of September 30, 2006, to the best of our knowledge, no known trends or
demands, commitments, events or uncertainties, except as described in "NOTES TO
FINANCIAL STATEMENTS NOTE 9 - COMMITMENTS AND CONTINGENCIES" existed, which are
likely to have a material effect on our liquidity.
DECEMBER 31, 2005
Cash and cash equivalents were approximately $1.4M as of December 31, 2005
compared to approximately $686K as of December 31, 2004, an increase of
approximately 104%. Working capital at December 31, 2005 was approximately $4.6M
as compared to approximately $3.7M at December 31, 2004, an increase of
approximately 24%. The increase in cash and working capital is primarily
attributable cash received in connection with the sale of our 5% Series A
Preferred stock, better cash-flow management and inventory "turn" time.
OPERATING ACTIVITIES. Net cash flows used in operating activities totaled
$801,248 and $26,009 for the years ended December 31, 2005 and 2004,
respectively. Net cash used in operating activities for 2005 primarily reflects
net loss adjusted by (i) non-cash accounting entries in connection with the sale
of our 5% Series A Preferred Stock, (ii) non-cash entries in connection with
issuing stock options below fair market value, (iii) increases in inventory
levels as we built up inventories to respond to forecasted demand for our
products from the prior year's fourth quarter, and (iv) increase in sales over
the prior year.
51
Net cash used in operating activities for 2004 primarily reflects net loss
adjusted for a reversal of provision for slow-moving inventories by a decrease
in trade receivables resulting from cash collections and increases in inventory
levels as we built up inventories to respond to forecasted demand for our
products from the prior year's fourth quarter.
INVESTING ACTIVITIES. Net cash flows used in investing activities for 2005
primarily consisted of cash paid for capital expenditures and the acquisition of
a subsidiary. Cash flows from investing activities in 2004 were minimal.
FINANCING ACTIVITIES. Net cash flows provided by financing activities for 2005
primarily consisted of $1,865,000 cash received from the sale of our 5% Series A
Convertible Preferred Stock. Other cash flows from financing activities for 2005
and 200 consisted of advances / repayments under our line of credit totaling to
fund working capital and funds advanced under a letter(s) of credit for goods
shipped on account. For both periods presented, advances to and/or repayments
from related party receivables and payables were made in the ordinary course of
business.
We have financed our activities primarily with cash flows from operations,
borrowings under our credit facilities, and the sale of our 5% Series A
Convertible Preferred Stock. We have a $2,500,000 bank line of credit, which
bears interest at prime plus .5%, which is secured by all of our general
business assets. The subject bank line of credit had $1,486,964 available for
use as of December 31, 2005. In order to implement our growth strategy and
expansion into the image display area, additional funds will be required.
Our plans for the next twelve months include continuing to increase our
presence in the image capture market, heavily investing our resources into the
image display market and adding future products and technologies to our current
product offerings. Additionally, we intend to seek to identify acquisition
candidates in the image capture and display industry that we believe could
compliment our business model, improve our competitive positioning and expand
our offerings to the marketplace, of which there can be no assurance. In
identifying potential acquisition candidates, we will seek to acquire companies
with varied distribution channels, rich intellectual property (IP) and high
caliber engineering personnel.
To finance our business expansion plans, we plan to aggressively pursue
additional sources of funds, the form of which will vary depending on the
prevailing market and other conditions, and may include the issuance and sale of
debt or equity securities. However, there is no assurance that such additional
funds will be available for us to finance our expansion plans. Furthermore,
there is no assurance the net proceeds from any successful financing arrangement
will be sufficient to cover cash requirements as we expand our business
operations.
CONCENTRATION OF CREDIT RISK
CONCENTRATION OF CREDIT RISK FOR CASH HELD AT BANKS. We maintain cash balances
at several banks. Accounts at each institution are insured by the Federal
Deposit Insurance Corporation up to $100,000. As of December 31, 2005, the
Company had consolidated balances of approximately $1,030,000, which were not
guaranteed by FDIC. The Company has not experienced any losses in such accounts
and believes the exposure is minimal.
52
CONCENTRATION OF CREDIT RISK DUE TO GEOGRAPHIC SALES AND SIGNIFICANT CUSTOMERS.
We operate in a single industry segment - scanner and fax modules. We market our
products in the United States, Europe and the Asia Pacific region through our
sales personnel and independent sales representatives.
Our geographic sales as a percent of total revenue were as follows for the years
ended December 31:
2005 2004
---- ----
United States 87% 96%
Asia Pacific 9% 2%
Europe and others 4% 2%
Sales to major customers as a percentage of total revenues were as follows for
the years ended December 31:
2005 2004
---- ----
Customer A 33% 38%
Customer B 18% 16%
Customer C 16% 15%
Customer D 12% 9%
CONCENTRATION OF CREDIT RISK DUE TO ACCOUNTS RECEIVABLE. Financial instruments
that potentially subject us to a concentration of credit risk consist primarily
of trade receivables. Our customers are concentrated in the industrial/consumer
electronics channels and with major original equipment manufacturers. As of
December 31, 2005 the concentration was approximately 92.5% (3 customers). The
loss of any of these customers could have a material adverse effect on our
results of operations, financial position and cash flows.
CONCENTRATION OF CREDIT RISK DUE TO SIGNIFICANT VENDORS. For each of the years
ended December 31, 2005 and 2004, our purchases have primarily been concentrated
with the wholly-owned subsidiary of our majority stockholder. If this vendor was
unable to provide materials in a timely manner and we were unable to find
alternative vendors, our business, operating results and financial condition
would be materially adversely affected.
CONCENTRATION OF CREDIT RISK DUE TO PRODUCT SALES. We had 3 different product
categories in 2005 and 4 different products in 2004 that each accounted for more
than 10% of sales. If any of these products were to become obsolete or
unmarketable and we were unable to successfully develop and market alternative
products, our business, operating results and financial condition could be
adversely affected
OFF-BALANCE SHEET ARRANGEMENTS
We do not have any transactions, agreements or other contractual
arrangements that constitute off-balance sheet arrangements.
CONTRACTUAL OBLIGATIONS
Our Contractual Obligations and Commercial Commitments are detailed below:
53
Payments Due by Period
Contractual
Obligations
-------------------------------------------------------------------------------------------
Less
Than 1 1-3 4 - 5 After 5
Total Year Years Years Years
-------------------------------------------------------------------------------------------
Line / letter of credit (1) $1,013,000 $1,013,000 -- -- --
-------------------------------------------------------------------------------------------
Operating Leases (2) $274,000 $139,000 $135,000 -- --
-------------------------------------------------------------------------------------------
Total Cash Contractual
Obligations $1,287,000 $1,152,000 $135,000 -- --
-------------------------------------------------------------------------------------------
(1) LINE OF CREDIT / letter of credit - We have a line of credit to borrow up to
$2,500,000, bearing interest at the rate of prime (7.25% at December 31, 2005)
plus 0.5%, and secured by all of our assets. Interest payments are due monthly
and all unpaid interest and principal is due in full on October 30, 2006. Upon
certain events of defaults as more fully described in the agreement, the default
variable interest rate increases to prime plus 5.5%. We had $1,486,964 available
for use at December 31, 2005. We issue letters of credit in the normal course of
business. The total amount available can never be more than the face amount of
all advances under bank line of credit or letters of credit outstanding.
(2) OPERATING LEASES - We are committed under various non-cancelable operating
leases which expire through November 2007. Future minimum rental commitments are
as follows: 2006-$139,000 and 2007-$135,000. Rent expense charged to operations
was approximately $131,000 for 2005 (2004: $99,000).
54
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
MANUFACTURING
All of our products are manufactured by Syscan Technology Holdings (STH),
the parent company of our majority stockholder. We and STH have established an
internal-pricing agreement that is updated on a semi-annual basis. STH currently
serves as the manufacturer of all current image capture products produced by us.
We believe, for quality control and pricing reasons, that this type of
relationship is more favorable then could be attained from unaffiliated
third-parties. We purchase and provide STH with critical parts and components
necessary to manufacture our products.
We purchase significantly all of our finished scanner imaging products
from the parent company of our majority stockholder, Syscan Technology Holdings
Limited ("STH"). Our Chairman and CEO, Darwin Hu, was formerly the CEO of STH.
The following is a summary of significant related party transactions, which were
carried out in the normal course of the Company's business, during the years
ended December 31, 2005 and 2004:
The following is a summary of significant related party purchase transactions,
which were carried out in the normal course of the Company's business:
2005 2004
------- --------
SYSCAN Intervision Limited, a wholly-owned subsidiary of $4.915M $3.825M
STH (purchases)
======= ========
SYSCAN Optoelectronics Technology (Shenzhen) Company - $0.520M
Limited, a wholly-owned subsidiary of STH (purchases)
======= ========
Amounts due to/from related parties are unsecured, interest-free and repayable
on demand and consisted of the following:
Due from STH $345,998
Due from Majority Stockholder $100,000
Due from various subsidiaries wholly-owned by STH $1,956,522
----------
$2,402,520
==========
In April 2005 we entered into employment agreements with each of Darwin
Hu, our Chief Executive Officer, William Hawkins, our Chief Operating Officer
and Acting Chief Financial Officer, and David Clark, our Senior Vice President
of Business Development. In connection therewith we granted options to each of
Messrs. Hu, Hawkins and Clark to purchase 1,500,000, 1,000,000 and 800,000
shares of our common stock, respectively, at an exercise price of $0.01 per
share. Such options shall vest one-third on the execution date of the employment
agreement, one-third on April 3, 2006 and one-third on April 2, 2007. Pursuant
to such employment agreements, each of Messrs. Hu, Hawkins and Clark shall be
entitled to receive annual salaries of $200,000, $160,000 and $150,000,
respectively.
55
Other than those described above, we have no material transactions which
involved or are planned to involve a direct or indirect interest of a director,
executive officer, greater than 5% stockholder or any family member of such
parties.
We believe that all of the transactions set forth above were made on terms
no less favorable to us than could have been obtained from unaffiliated third
parties. All future transactions between us and our officers, directors and
principal shareholders and their affiliates will be on terms no less favorable
than could be obtained from unaffiliated third parties and will be approved by
the independent members of our board of directors.
MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS
MARKET INFORMATION.
Our common stock has been listed and quoted on the OTC Bulletin Board
since December 1998. From January 1, 2003 through April 1, 2004 our common stock
traded under the symbol "BKET", from April 2, 2004 through June 26, 2006 under
the symbol "SYII" and since June 27, 2006 under the symbol "SYVT". All prices
reflected herein have been adjusted to reflect the 1-for-10 reverse split of our
common stock that was effected on April 2, 2004.
The following chart sets forth the high and low sale prices for each
quarter during the fiscal years ended December 31, 2004 and 2005, respectively,
and the first, second and third quarters of 2006. Such prices represent
quotations between dealers, without dealer markup, markdown or commissions, and
may not represent actual transactions.
HIGH LOW
---- ---
2004 BY QUARTER
January 1 - March 31 $4.20 $0.70
April 1 - June 30 $4.75 $1.10
July 1 - September 30 $4.26 $1.40
October 1 - December 31 $4.10 $2.05
2005 BY QUARTER
January 1 - March 31 $3.25 $1.20
April 1 - June 30 $1.30 $0.53
July 1 - September 30 $1.15 $0.30
October 1 - December 31 $0.98 $0.35
2006 BY QUARTER
January 1 - March 31 $0.80 $0.55
April 1 - June 30 $1.55 $0.65
July 1 - September 30 $1.49 $0.75
On December 20, 2006, the closing sale price for shares of our common
stock in the over-the-counter market, as reported by NASD's OTCBB was $0.60.
56
No prediction can be made as to the effect, if any, that future sales of
shares of our common stock or the availability of our common stock for future
sale will have on the market price of our common stock prevailing from
time-to-time. Sales of substantial amounts of our common stock in the public
market could adversely affect the prevailing market price of our common stock.
RECORD HOLDERS
As of the date hereof there were 365 record holders of our common stock.
As of the date hereof there were 24,092,092 shares of common stock outstanding.
DIVIDENDS
We have not paid dividends on our common stock in the past and do not
anticipate doing so in the foreseeable future. We currently intend to retain
future earnings, if any, to fund the development and growth of our business. The
holders of our Series A Preferred Stock are entitled to receive dividends at a
rate of 5% per annum, payable in cash or shares of our common stock, on a
cumulative basis.
EQUITY COMPENSATION PLAN INFORMATION
-------------------------------------------------------------------------------------------------------------------
Number of securities to be Weighted average Number of securities
issued upon exercise of exercise price of remaining available for
outstanding options, warrants outstanding options, future issuance under equity
and rights warrants and rights compensation plans
(excluding securities
reflected in column (a))
(a) (b) (c)
-------------------------------------------------------------------------------------------------------------------
Equity compensation plans 2,790,000 $1.65 1,910,000
approved by security
holders
-------------------------------------------------------------------------------------------------------------------
Equity compensation plans 4,000,000 $0.01 -0-
not approved by security
holders
-------------------------------------------------------------------------------------------------------------------
Total 6,790,000 $0.684 1,910,000
-------------------------------------------------------------------------------------------------------------------
57
EXECUTIVE COMPENSATION
The following table sets forth, for the fiscal years indicated, all
compensation awarded to, paid to or earned by the following type of executive
officers for the fiscal years ended December 31, 2003, 2004 and 2005: (i)
individuals who served as, or acted in the capacity of, our principal executive
officer for the fiscal year ended December 31, 2005; and (ii) our other most
highly compensated executive officers, who together with the principal executive
officer are our most highly compensated officers whose salary and bonus exceeded
$100,000 with respect to the fiscal years ended December 31, 2005, 2004 and 2003
and who were employed by us at the end of fiscal year 2005.
SUMMARY COMPENSATION TABLE*
LONG TERM COMPENSATION
----------------------
ANNUAL COMPENSATION AWARDS PAYOUTS
--------------------------------- ------------------------- -----------------------
NAME AND PRINCIPAL POSITION YEAR SALARY BONUS OTHER ANNUAL RESTRICTED SECURITIES LTIP ALL OTHER
COMPENSATION STOCK UNDERLYING PAYOUTS COMPENSATION
AWARD(S) OPTIONS/SARS
($) ($) ($) ($) (#) ($) ($)
Darwin Hu, Chief Executive 2005 200,000 -- -- -- 1,500,000(1) -- --
Officer and Chairman.
2004 200,000 -- -- -- -- -- --
2003 200,000 -- -- -- -- -- --
William Hawkins 2005 160,000 -- -- -- 1,000,000(2) -- --
Chief Operating Officer,
Acting Chief Financial
Officer and Secretary.
2004 160,000 -- -- -- -- -- --
2003 160,000 -- -- -- -- -- --
David Clark 2005 150,000 -- -- -- 800,000(3) -- --
Senior Vice President of 2004 68,750
Business Development.
-- -- -- -- -- --
----------
* Salary reflects total compensation paid to these executives (both before
and after the merger described in Item 1).
(1) As of the date hereof, 1,000,000 of such options have vested.
(2) As of the date hereof, 666,667 of such options have vested.
(3) As of the date hereof, 533,333 of such options have vested.
58
OPTION GRANTS IN FISCAL 2005
The following table sets forth certain information regarding stock options
held as of December 31, 2005 by the named executive officers.
Number of
Securities % of Total Granted
Underlying to Employees in Exercise Expiration
Options Fiscal Year Price ($/Sh) Date
Name and Principal Position Granted
Darwin Hu 1,500,000 35.4% $.01 April 26,
President and Chief Executive Officer 2012
William Hawkins 1,000,000 16.4% $.01 April 26,
Chief Operating Officer, Acting Chief 2012
Financial Officer and Secretary
David Clark 800,000 18.9% $.01 April 26,
Senior Vice President of Business 2012
Development
AGGREGATE OPTIONS EXERCISEABLE IN LAST FISCAL YEAR
AND FISCAL YEAR END OPTION VALUES
Number of Securities Value of Unexercised
Underlying Unexercised In-the-Money Options
Options at December 31, 2005 at December 31, 2005 (1)
---------------------------- ------------------------
Name and Principal Position Exercisable Unexercisable Exercisable Unexercisable
--------------------------- ----------- ------------- ----------- -------------
Darwin Hu 500,000 1,560,000 $ 310,000 $ 967,200
President, Chief Executive Officer
and Chairman of the Board
William Hawkins 333,333 1,026,666 $ 206,666 $ 636,533
Chief operating Officer, Acting Chief
Financial Officer and Secretary.
David Clark 266,666 933,333 $ 165,333 $ 578,666
Vice President of Business Development
----------
(1) As of December 31, 2005, the market value of a share of common stock
was $0.62.
No shares were exercised by named executive officers in fiscal year ended
December 31, 2005.
As of December 31, 2005, options to purchase a total of 2,210,000 shares
of common stock were granted under our 2002 Amended and Restated Stock option
Plan, at exercise prices of $0.65 to $2.00 per share. One-fourth of the options
granted vest on the first anniversary, one-fourth of the options granted vest on
the second anniversary, one-fourth of the options granted vest on the third
anniversary and one-fourth of the options vest on the fourth anniversary. The
options expire on the ten year anniversary of their grant date. None of these
options have been issued pursuant to the 2002 Amended and Restated Stock Option
Plan described below.
59
2002 AMENDED AND RESTATED STOCK OPTION PLAN
DESCRIPTION OF THE 2002 PLAN
THE PURPOSE OF THE 2002 PLAN
The purpose of the 2002 Plan is to provide additional incentive to our
directors, officers, employees and consultants to us who are primarily
responsible for our management and growth. Each option shall be designated at
the time of grant as either an incentive stock option (an "ISO") or as a
non-qualified stock option (a "NQSO").
Each option shall be designated at the time of grant as either an
incentive stock option (an "ISO") or a non-qualified stock option (a "NQSO").
The Board of Directors believes that the ability to grant stock options to
employees which qualify for ISO treatment provides an additional material
incentive to certain key employees. The Internal Revenue Code requires that ISOs
be granted pursuant to an option plan that receives shareholder approval within
one year of its adoption. We adopted the 2002 Plan in order to comply with this
statutory requirement and preserve its ability to grant ISOs.
The benefits to be derived from the 2002 Plan, if any, are not
quantifiable or determinable.
ADMINISTRATION OF THE PLAN
The 2002 Plan shall be administered by the Board of Directors, or by any
committee that we may in the future form and to which the Board of Directors may
delegate the authority to perform such functions (in either case, the
"Administrator"). The Board of Directors shall appoint and remove members of the
committee in its discretion in accordance with applicable laws. In the event
that we establish such a committee and are required to comply with Rule 16b-3
under the Exchange Act and Section 162(m) of the Internal Revenue Code (the
"Code"), the committee shall, in the Board of Director's discretion, be
comprised solely of "non-employee directors" within the meaning of said Rule
16b-3 and "outside directors" within the meaning of Section 162(m) of the Code.
Notwithstanding the foregoing, the Administrator may delegate non-discretionary
administrative duties to any of our employees as it deems proper and the Board
of Directors, in its absolute discretion, may at any time and from time to time
exercise any and all rights and duties of the Administrator under the 2002 Plan.
Subject to the other provisions of the 2002 Plan, the Administrator shall
have the authority, in its discretion: (i) to grant options; (ii) to determine
the fair market value of the Common Stock subject to options; (iii) to determine
the exercise price of options granted; (iv) to determine the persons to whom,
and the time or times at which, options shall be granted, and the number of
shares subject to each option; (v) to interpret the 2002 Plan; (vi) to
prescribe, amend, and rescind rules and regulations relating to the 2002 Plan;
(vii) to determine the terms and provisions of each option granted (which need
not be identical), including but not limited to, the time or times at which
options shall be exercisable; (viii) with the consent of the optionee, to modify
or amend any option; (ix) to defer (with the consent of the optionee) the
exercise date of any option; (x) to authorize any person to execute on our
behalf any instrument evidencing the grant of an option; and (xi) to make all
other determinations deemed necessary or advisable for the administration of the
2002 Plan. The Administrator may delegate non-discretionary administrative
duties to any of our employees as it deems proper.
60
SHARES OF STOCK SUBJECT TO THE 2002 PLAN
The total number of shares of stock which may be issued under options
granted pursuant to the 2002 Plan shall not exceed 3,200,000 shares of Common
Stock, $.001 par value per share. On June 23, 2006 at our annual meeting of
stockholders, our stockholders approved the adoption of the 2002 Amended and
Restated Stock Option Plan (the "Plan"). Under the Plan, the Company has
reserved 3,200,000 shares of its common stock to issue to eligible current and
prospective employees, consultants and directors of the Company. In July 2004
employees were granted options under the Plan to purchase 2,200,000 shares of
the Company's common stock at $2.00 per share, 220,000 of which were cancelled
in May 2005. The options have a term of ten years and beginning July 15, 2005,
vest in equal annual installments of 25% per year over four years. In December
2005 employees were granted options under the Plan to purchase 230,000 shares of
the Company's common stock at $0.65 per share. The number of options granted to
individual directors, officers (who are not also directors) and others are as
follows:
GRANT DATE
JULY 21, 2004
-------------
DIRECTORS
Darwin Hu 560,000
David Clark 400,000
Peter Mor (former 80,000
director)
Lawrence Liang 80,000
OFFICERS
William Hawkins 360,000
OTHERS 640,000
CANCELLED MAY 2005 (220,000)
---------
Subtotal 1,900,000
GRANT DATE
DECEMBER 8, 2005
-------------
OTHERS 230,000
-------
GRANT DATE
MAY 18, 2006
-------------
OTHERS 660,000
Total 2,790,000
The number of shares of Common Stock subject to options granted pursuant
to the 2002 Plan may be adjusted under certain conditions. If our stock changed
by reason of a stock split, reverse stock split, stock dividend,
recapitalization, combination or reclassification, appropriate adjustments shall
be made by the Board of Directors in (i) the number and class of shares of stock
subject to the 2002 Plan, and (ii) the exercise price of each outstanding
option; provided, however, that we shall not be required to issue fractional
shares as a result of any such adjustments. Each such adjustment shall be
subject to approval by the Board of Directors in its sole discretion.
61
In the event of the proposed dissolution or liquidation of us, the
Administrator shall notify each optionee at least thirty days prior to such
proposed action. To the extent not previously exercised, all options will
terminate immediately prior to the consummation of such proposed action;
provided, however, that the Administrator, in the exercise of its sole
discretion, may permit exercise of any options prior to their termination, even
if such options were not otherwise exercisable. In the event that we merge or
consolidate with or into another corporation or entity in which we do not
survive, or in the event of a sale of all or substantially all of our assets in
which our shareholders receive securities of the acquiring entity or an
affiliate thereof, all options shall be assumed or equivalent options shall be
substituted by the successor corporation (or other entity) or a parent or
subsidiary of such successor corporation (or other entity); provided, however,
that if such successor does not agree to assume the options or to substitute
equivalent options therefor, the Administrator, in the exercise of its sole
discretion, may permit the exercise of any of the options prior to consummation
of such event, even if such options were not otherwise exercisable.
PARTICIPATION
Every person who at the date of grant of an option is an employee of ours
or of any Affiliate (as defined below) of ours is eligible to receive NQSOs or
ISOs under the 2002 Plan. Every person who at the date of grant is a consultant
to, or non-employee director of, us or any Affiliate (as defined below) of us is
eligible to receive NQSOs under the 2002 Plan. The term "Affiliate" as used in
the 2002 Plan means a parent or subsidiary corporation as defined in the
applicable provisions (currently Sections 424(e) and (f), respectively) of the
Code. The term "employee" includes an officer or director who is an employee of
ours. The term "consultant" includes persons employed by, or otherwise
affiliated with, a consultant.
OPTION PRICE
The exercise price of a NQSO shall be not less than 85% of the fair market
value of the stock subject to the option on the date of grant. To the extent
required by applicable laws, rules and regulations, the exercise price of a NQSO
granted to any person who owns, directly or by attribution under the Code
(currently Section 424(d)), stock possessing more than 10% of the total combined
voting power of all of our classes of stock or of any Affiliate (a "10%
Shareholder") shall in no event be less than 110% of the fair market value of
the stock covered by the option at the time the option is granted. The exercise
price of an ISO shall be determined in accordance with the applicable provisions
of the Code and shall in no event be less than the fair market value of the
stock covered by the option at the time the option is granted. The exercise
price of an ISO granted to any 10% Percent Shareholder shall in no event be less
than 110% of the fair market value of the stock covered by the Option at the
time the Option is granted.
TERM OF THE OPTIONS
The Administrator, in its sole discretion, shall fix the term of each
option, provided that the maximum term of an option shall be ten years. ISOs
granted to a 10% Shareholder shall expire not more than five years after the
date of grant. The 2002 Plan provides for the earlier expiration of options in
the event of certain terminations of employment of the holder.
RESTRICTIONS ON GRANT AND EXERCISE
Except with the express written approval of the Administrator which
approval the Administrator is authorized to give only with respect to NQSOs, no
option granted under the 2002 Plan shall be assignable or otherwise transferable
by the optionee except by will or by operation of law. During the life of the
optionee, an option shall be exercisable only by the optionee.
62
TERMINATION OF THE 2002 PLAN
The 2002 Plan shall become effective upon adoption by the Board or
Directors; provided, however, that no option shall be exercisable unless and
until written consent of the our shareholders, or approval of our shareholders
voting at a validly called shareholders meeting, is obtained within twelve
months after adoption by the Board of Directors. If such shareholder approval is
not obtained within such time, options granted pursuant to the 2002 Plan shall
be of the same force and effect as if such approval was obtained except that all
ISOs granted pursuant to the 2002 Plan shall be treated as NQSOs. Options may be
granted and exercised under the 2002 Plan only after there has been compliance
with all applicable federal and state securities laws. The 2002 Plan shall
terminate within ten years from the date of its adoption by the Board of
Directors.
TERMINATION OF EMPLOYMENT
If for any reason other than death or permanent and total disability, an
optionee ceases to be employed by us or any of our Affiliates (such event being
called a "Termination"), options held at the date of Termination (to the extent
then exercisable) may be exercised in whole or in part at any time within three
months of the date of such Termination, or such other period of not less than
thirty days after the date of such Termination as is specified in the Option
Agreement or by amendment thereof (but in no event after the expiration date of
the option (the "Expiration Date")); provided, however, that if such exercise of
the option would result in liability for the optionee under Section 16(b) of the
Exchange Act, then such three-month period automatically shall be extended until
the tenth day following the last date upon which optionee has any liability
under Section 16(b) (but in no event after the Expiration Date). If an optionee
dies or becomes permanently and totally disabled (within the meaning of Section
22(e)(3) of the Code) while employed by us or an Affiliate or within the period
that the option remains exercisable after Termination, options then held (to the
extent then exercisable) may be exercised, in whole or in part, by the optionee,
by the optionee's personal representative or by the person to whom the option is
transferred by devise or the laws of descent and distribution, at any time
within twelve months after the death or twelve months after the permanent and
total disability of the optionee or any longer period specified in the Option
Agreement or by amendment thereof (but in no event after the Expiration Date).
"Employment" includes service as a director or as a consultant. For purposes of
the 2002 Plan, an optionee's employment shall not be deemed to terminate by
reason of sick leave, military leave or other leave of absence approved by the
Administrator, if the period of any such leave does not exceed 90 days or, if
longer, if the optionee's right to reemployment by us or any Affiliate is
guaranteed either contractually or by statute.
AMENDMENTS TO THE PLAN
The Board of Directors may at any time amend, alter, suspend or
discontinue the 2002 Plan. Without the consent of an optionee, no amendment,
alteration, suspension or discontinuance may adversely affect outstanding
options except to conform the 2002 Plan and ISOs granted under the 2002 Plan to
the requirements of federal or other tax laws relating to ISOs. No amendment,
alteration, suspension or discontinuance shall require Shareholder approval
unless (i) shareholder approval is required to preserve incentive stock option
treatment for federal income tax purposes or (ii) the Board of Directors
otherwise concludes that shareholder approval is advisable.
TAX TREATMENT OF THE OPTIONS
Under the Code, neither the grant nor the exercise of an ISO is a taxable
event to the optionee (except to the extent an optionee may be subject to
alternative minimum tax); rather, the optionee is subject to tax only upon the
sale of the Common Stock acquired upon exercise of the ISO. Upon such a sale,
the entire difference between the amount realized upon the sale and the exercise
price of the option will be taxable to the optionee. Subject to certain holding
period requirements, such difference will be taxed as a capital gain rather than
as ordinary income. Optionees who receive NQSOs will be subject to taxation upon
exercise of such options on the spread between the fair market value of the
Common Stock on the date of exercise and the exercise price of such options.
This spread is treated as ordinary income to the optionee, and we are permitted
to deduct as an employee expense a corresponding amount. NQSOs do not give rise
to a tax preference item subject to the alternative minimum tax.
63
2006 STOCK OPTION PLAN
DESCRIPTION OF THE PLAN
THE PURPOSE OF THE PLAN
The purpose of the Plan is to provide additional incentive to the
directors, officers, employees and consultants of the Company who are primarily
responsible for the management and growth of the Company. Each option shall be
designated at the time of grant as either an incentive stock option (an "ISO")
or as a non-qualified stock option (a "NQSO").
The Board of Directors believes that the ability to grant stock options to
employees which qualify for ISO treatment provides an additional material
incentive to certain key employees. The Internal Revenue Code requires that ISOs
be granted pursuant to an option plan that receives stockholder approval within
one year of its adoption. The Company adopted the Plan in order to comply with
this statutory requirement and preserve its ability to grant ISOs.
The benefits to be derived from the Plan, if any, are not quantifiable or
determinable.
ADMINISTRATION OF THE PLAN
The Plan shall be administered by the Board of Directors of the Company,
or by any committee that the Company may in the future form and to which the
Board of Directors may delegate the authority to perform such functions (in
either case, the "Administrator"). The Board of Directors shall appoint and
remove members of the committee in its discretion in accordance with applicable
laws. In the event that the Company establishes such a committee and is required
to comply with Rule 16b-3 under the Exchange Act and Section 162(m) of the
Internal Revenue Code (the "Code"), the committee shall, in the Board of
Director's discretion, be comprised solely of "non-employee directors" within
the meaning of said Rule 16b-3 and "outside directors" within the meaning of
Section 162(m) of the Code. Notwithstanding the foregoing, the Administrator may
delegate non-discretionary administrative duties to such employees of the
Company as it deems proper and the Board of Directors, in its absolute
discretion, may at any time and from time to time exercise any and all rights
and duties of the Administrator under the Plan.
Subject to the other provisions of the Plan, the Administrator shall have
the authority, in its discretion: (i) to grant options; (ii) to determine the
fair market value of the Common Stock subject to options; (iii) to determine the
exercise price of options granted; (iv) to determine the persons to whom, and
the time or times at which, options shall be granted, and the number of shares
subject to each option; (v) to interpret the Plan; (vi) to prescribe, amend, and
rescind rules and regulations relating to the Plan; (vii) to determine the terms
and provisions of each option granted (which need not be identical), including
but not limited to, the time or times at which options shall be exercisable;
(viii) with the consent of the optionee, to modify or amend any option; (ix) to
defer (with the consent of the optionee) the exercise date of any option; (x) to
authorize any person to execute on behalf of the Company any instrument
evidencing the grant of an option; and (xi) to make all other determinations
deemed necessary or advisable for the administration of the Plan. The
Administrator may delegate non-discretionary administrative duties to such
employees of the Company as it deems proper.
64
SHARES OF STOCK SUBJECT TO THE PLAN
Subject to the conditions outlined below, the total number of shares of
stock which may be issued under options granted pursuant to the Plan shall not
exceed 1,500,000 shares of Common Stock, $.001 par value per share.
The number of shares of Common Stock subject to options granted pursuant
to the Plan may be adjusted under certain conditions. If the stock of the
Company is changed by reason of a stock split, reverse stock split, stock
dividend, recapitalization, combination or reclassification, appropriate
adjustments shall be made by the Board of Directors in (i) the number and class
of shares of stock subject to the Plan, and (ii) the exercise price of each
outstanding option; provided, however, that the Company shall not be required to
issue fractional shares as a result of any such adjustments. Each such
adjustment shall be subject to approval by the Board of Directors in its sole
discretion.
In the event of the proposed dissolution or liquidation of the Company,
the Administrator shall notify each optionee at least thirty days prior to such
proposed action. To the extent not previously exercised, all options will
terminate immediately prior to the consummation of such proposed action;
provided, however, that the Administrator, in the exercise of its sole
discretion, may permit exercise of any options prior to their termination, even
if such options were not otherwise exercisable. In the event of a merger or
consolidation of the Company with or into another corporation or entity in which
the Company does not survive, or in the event of a sale of all or substantially
all of the assets of the Company in which the Stockholders of the Company
receive securities of the acquiring entity or an affiliate thereof, all options
shall be assumed or equivalent options shall be substituted by the successor
corporation (or other entity) or a parent or subsidiary of such successor
corporation (or other entity); provided, however, that if such successor does
not agree to assume the options or to substitute equivalent options therefor,
the Administrator, in the exercise of its sole discretion, may permit the
exercise of any of the options prior to consummation of such event, even if such
options were not otherwise exercisable.
PARTICIPATION
Every person who at the date of grant of an option is an employee of the
Company or of any Affiliate (as defined below) of the Company is eligible to
receive NQSOs or ISOs under the Plan. Every person who at the date of grant is a
consultant to, or non-employee director of, the Company or any Affiliate (as
defined below) of the Company is eligible to receive NQSOs under the Plan. The
term "Affiliate" as used in the Plan means a parent or subsidiary corporation as
defined in the applicable provisions (currently Sections 424(e) and (f),
respectively) of the Code. The term "employee" includes an officer or director
who is an employee of the Company. The term "consultant" includes persons
employed by, or otherwise affiliated with, a consultant.
65
OPTION PRICE
The exercise price of a NQSO shall be not less than 85% of the fair market
value of the stock subject to the option on the date of grant. To the extent
required by applicable laws, rules and regulations, the exercise price of a NQSO
granted to any person who owns, directly or by attribution under the Code
(currently Section 424(d)), stock possessing more than 10% of the total combined
voting power of all classes of stock of the Company or of any Affiliate (a "10%
Stockholder") shall in no event be less than 110% of the fair market value of
the stock covered by the option at the time the option is granted. The exercise
price of an ISO shall be determined in accordance with the applicable provisions
of the Code and shall in no event be less than the fair market value of the
stock covered by the option at the time the option is granted. The exercise
price of an ISO granted to any 10% Stockholder shall in no event be less than
110% of the fair market value of the stock covered by the Option at the time the
Option is granted.
TERM OF THE OPTIONS
The Administrator, in its sole discretion, shall fix the term of each
option, provided that the maximum term of an option shall be ten years. ISOs
granted to a 10% Stockholder shall expire not more than five years after the
date of grant. The Plan provides for the earlier expiration of options in the
event of certain terminations of employment of the holder.
RESTRICTIONS ON GRANT AND EXERCISE
Except with the express written approval of the Administrator which
approval the Administrator is authorized to give only with respect to NQSOs, no
option granted under the Plan shall be assignable or otherwise transferable by
the optionee except by will or by operation of law. During the life of the
optionee, an option shall be exercisable only by the optionee.
TERMINATION OF THE PLAN
The Plan shall become effective upon adoption by the Board or Directors;
provided, however, that no option shall be exercisable unless and until written
consent of the Stockholders of the Company, or approval of Stockholders of the
Company voting at a validly called Stockholders' meeting, is obtained within
twelve months after adoption by the Board of Directors. If such Stockholder
approval is not obtained within such time, options granted pursuant to the Plan
shall be of the same force and effect as if such approval was obtained except
that all ISOs granted pursuant to the Plan shall be treated as NQSOs. Options
may be granted and exercised under the Plan only after there has been compliance
with all applicable federal and state securities laws. The Plan shall terminate
within ten years from the date of its adoption by the Board of Directors.
TERMINATION OF EMPLOYMENT
If for any reason other than death or permanent and total disability, an
optionee ceases to be employed by the Company or any of its Affiliates (such
event being called a "Termination"), options held at the date of Termination (to
the extent then exercisable) may be exercised in whole or in part at any time
within three months of the date of such Termination, or such other period of not
less than thirty days after the date of such Termination as is specified in the
Option Agreement or by amendment thereof (but in no event after the expiration
date of the option (the "Expiration Date")); provided, however, that if such
exercise of the option would result in liability for the optionee under Section
16(b) of the Exchange Act, then such three-month period automatically shall be
extended until the tenth day following the last date upon which optionee has any
liability under Section 16(b) (but in no event after the Expiration Date). If an
optionee dies or becomes permanently and totally disabled (within the meaning of
Section 22(e)(3) of the Code) while employed by the Company or an Affiliate or
within the period that the option remains exercisable after Termination, options
then held (to the extent then exercisable) may be exercised, in whole or in
part, by the optionee, by the optionee's personal representative or by the
person to whom the option is transferred by devise or the laws of descent and
distribution, at any time within twelve months after the death or twelve months
after the permanent and total disability of the optionee or any longer period
specified in the Option Agreement or by amendment thereof (but in no event after
the Expiration Date). "Employment" includes service as a director or as a
consultant. For purposes of the Plan, an optionee's employment shall not be
deemed to terminate by reason of sick leave, military leave or other leave of
absence approved by the Administrator, if the period of any such leave does not
exceed 90 days or, if longer, if the optionee's right to reemployment by the
Company or any Affiliate is guaranteed either contractually or by statute.
66
AMENDMENTS TO THE PLAN
The Board of Directors may at any time amend, alter, suspend or
discontinue the Plan. Without the consent of an optionee, no amendment,
alteration, suspension or discontinuance may adversely affect outstanding
options except to conform the Plan and ISOs granted under the Plan to the
requirements of federal or other tax laws relating to ISOs. No amendment,
alteration, suspension or discontinuance shall require Stockholder approval
unless (i) stockholder approval is required to preserve incentive stock option
treatment for federal income tax purposes or (ii) the Board of Directors
otherwise concludes that stockholder approval is advisable.
TAX TREATMENT OF THE OPTIONS
Under the Code, neither the grant nor the exercise of an ISO is a taxable
event to the optionee (except to the extent an optionee may be subject to
alternative minimum tax); rather, the optionee is subject to tax only upon the
sale of the Common Stock acquired upon exercise of the ISO. Upon such a sale,
the entire difference between the amount realized upon the sale and the exercise
price of the option will be taxable to the optionee. Subject to certain holding
period requirements, such difference will be taxed as a capital gain rather than
as ordinary income. Optionees who receive NQSOs will be subject to taxation upon
exercise of such options on the spread between the fair market value of the
Common Stock on the date of exercise and the exercise price of such options.
This spread is treated as ordinary income to the optionee, and the Company is
permitted to deduct as an employee expense a corresponding amount. NQSOs do not
give rise to a tax preference item subject to the alternative minimum tax.
EMPLOYMENT AGREEMENTS
In April 2005, we entered into an employment agreement with Mr. Darwin Hu
pursuant to which he will serve as our President and Chief Executive Officer.
The agreement provides for an initial term of three years, an annual salary to
Mr. Hu of $200,000 and an annual bonus to be determined by our board of
directors. In connection with the agreement, Mr. Hu was issued non-qualified
options to purchase up to 1,500,000 shares of our common stock at an exercise
price of $0.01 per share. One-third of the options vested immediately upon the
execution of the employment agreement, one-third vested on April 3, 2006 and
one-third shall vest on April 2, 2007. The agreement also provides for the
executive's ability to participate in our health insurance program. In the event
that Mr. Hu's employment is terminated other than with good cause, he will
receive a payment of the lesser of his then remaining salary due pursuant to the
employment agreement or six months of base salary at his then current annual
salary.
67
In April 2005, we entered into an employment agreement with Mr. William
Hawkins pursuant to which he will serve as our Chief Operating Officer. The
agreement provides an initial term of three years, an annual salary to Mr.
Hawkins of $160,000 and an annual bonus to be determined by our board of
directors. In connection with the agreement, Mr. Hawkins was issued
non-qualified options to purchase up to 1,000,000 shares of our common stock at
an exercise price of $0.01 per share. One-third of the options vested
immediately upon the execution of the employment agreement, one-third vested on
April 3, 2006 and one-third shall vest on April 2, 2007. The agreement also
provides for the executive's ability to participate in our health insurance
program. In the event that Mr. Hawkins' employment is terminated other than with
good cause, he will receive a payment of the lesser of his then remaining salary
due pursuant to the employment agreement or six months of base salary at his
then current annual salary.
In April 2005, we entered into an employment agreement with Mr. David
Clark pursuant to which he will serve as our Senior Vice President of Business
Development. The agreement provides for an initial term of three years, an
annual salary to Mr. Clark of $150,000 and an annual bonus to be determined by
our board of directors. In connection with the agreement, Mr. Clark was issued
non-qualified options to purchase up to 800,000 shares of our common stock at an
exercise price of $0.01 per share. One-third of the options vested immediately
upon the execution of the employment agreement, one-third vested on April 3,
2006 and one-third shall vest on April 2, 2007. The agreement also provides for
the executive's ability to participate in our health insurance program. In the
event that Mr. Clark's employment is terminated other than with good cause, he
will receive a payment of the lesser of his then remaining salary due pursuant
to the employment agreement or six months of base salary at his then current
annual salary.
FINANCIAL STATEMENTS
See Financial Statements beginning on Page F-1.
LEGAL MATTERS
The law firm of Richardson & Patel LLP, of New York, New York, is passing
on the validity of our common stock. A partner of the firm beneficially owns
16,667 shares of our common stock, which shares were issued to such partner in
exchange for legal services rendered when such partner was employed by a prior
law firm.
EXPERTS
The financial statements as of December 31, 2005 and for the years ended
December 31, 2005 and 2004 included in this prospectus have been included in
reliance on the report of Clancy and Co., P.L.L.C., independent registered
public accounting firm, given on the authority of said firm as experts in
auditing and accounting.
AVAILABLE INFORMATION
We file annual, quarterly and special reports, proxy statements and other
information with the Securities and Exchange Commission. You may read and copy
any document we file at the Commission's public reference rooms at 100 F Street,
N.E., Washington, D.C. 20549. You may obtain information on the operation of the
Public Reference Room by calling the SEC at 1-800-SEC-0330. We also make
available free of charge our annual, quarterly and current reports, proxy
statements and other information upon request. To request such materials, please
contact William Hawkins at 1772 Technology Drive, San Jose, California 95110.
Additionally, please note that we file our SEC reports electronically. The SEC
maintains an Internet site that contains reports, proxy and information
statements, and other information regarding issuers that file electronically
with the SEC at http://www.sec.gov. Our Internet address is
http://www.syscaninc.com. Our website and the information contained therein or
connected thereto are not incorporated into this prospectus.
68
We have filed with the Commission post-effective amendment #2 to a
registration statement (which contains this prospectus) on Form SB-2 under the
Securities Act relating to the common stock being offered pursuant to this
prospectus. This prospectus does not contain all of the information set forth in
the registration statement and the exhibits and schedules to the registration
statement. Please refer to the registration statement and its exhibits and
schedules for further information with respect to us and the common stock.
Statements contained in this prospectus as to the contents of any contract or
other document are not necessarily complete and, in each instance, we refer you
to the copy of that contract or document filed as an exhibit to the registration
statement. You may read and obtain a copy of the registration statement and its
exhibits and schedules from the SEC.
[remainder of page intentionally left blank]
69
SYSVIEW TECHNOLOGY, INC.
Consolidated Balance Sheet as of September 30, 2006 F-2
Consolidated Statements of Operations for the three and nine months
ended September 30, 2006 and 2005 F-3
Consolidated Statements of Cash Flows for the three and nine months
ended September 30, 2006 and 2005 F-4
Condensed Notes to Consolidated Financial Statements F-5
Report of Independent Registered Public Accounting Firm - Clancy and
Co., P.L.L.C. F-13
Consolidated Balance Sheet as of December 31, 2005 F-14
Consolidated Statements of Operations for the years ended December 31,
2005 and 2004 F-15
Consolidated Statement of Stockholders' Equity for the years ended
December 31, 2005 and 2004 F-16
Consolidated Statements of Cash Flows for the years ended December 31,
2005 and 2004 F-17
Notes to Consolidated Financial Statements F-19
F-1
SYSVIEW TECHNOLOGY, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS)
SEPTEMBER 30, DECEMBER 31,
2006 2005
-------------- --------------
ASSETS (Unaudited) (Audited)
Current assets:
Cash and cash equivalents $ 1,419 $ 1,426
Trade receivables 2,086 1,285
Inventories 998 751
Prepaid expenses and other current assets 401 319
Due from affiliated parties 2,076 2,403
-------------- --------------
Total current assets 6,980 6,184
Fixed assets, net 343 167
Goodwill 555 555
Long-term investment 998 998
-------------- --------------
Total assets $ 8,876 $ 7,904
============== ==============
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Bank line and letter of credit $ 1,013 $ 1,013
Trade payables and other accrued expenses 628 445
Accrued dividends on Series A 5% cumulative convertible preferred stock 130 71
-------------- --------------
Total current liabilities 1,771 1,529
Other liabilities
Liability under derivative contracts 1,005 503
-------------- --------------
Total liabilities 2,776 2,032
Commitments and contingencies (note 9)
Preferred stock, $.001 par value, 2,000 authorized:
Series A 5% cumulative convertible preferred stock, 16 shares issued 830 468
and outstanding at September 30, 2006 and December 31, 2005;
liquidation value of $1,565 and $1,615 at September 30, 2006
and December 31, 2005, respectively
Series B convertible preferred stock, 11.5 shares issued and 56 --
outstanding at September 30, 2006, liquidation value of $1,150
Stockholders' equity:
Common stock $.001par value, 50,000 authorized, 24,642 shares and 24,592
shares issued and 24,142 shares and 24,092 outstanding at September 30, 24 24
2006 and December 31, 2005, respectively (500 shares held in escrow)
-------------- --------------
Additional paid-in capital 29,317 28,137
-------------- --------------
Accumulated deficit (24,127) (22,757)
-------------- --------------
Total Stockholders' equity 5,124 5,404
-------------- --------------
Total liabilities and stockholders' equity $ 8,876 $ 7,904
============== ==============
See notes to financial statements
F-2
SYSVIEW TECHNOLOGY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
THREE MONTHS ENDED NINE MONTHS ENDED
SEPTEMBER 30, SEPTEMBER 30,
-------------------- --------------------
2006 2005 2006 2005
-------- -------- -------- --------
Net sales $ 4,098 $ 2,207 $ 9,075 $ 5,402
Cost of sales 2,700 1,417 5,976 3,404
-------- -------- -------- --------
Gross profit 1,398 790 3,099 1,998
Operating expenses:
Selling and marketing 307 332 900 742
General and administrative 676 698 1,963 2,329
Research and development 584 242 1,449 640
-------- -------- -------- --------
Total operating expenses 1,567 1,272 4,312 3,711
-------- -------- -------- --------
Operating loss (169) (482) (1,213) (1,713)
-------- -------- -------- --------
Other income (expense):
Fair value of warrants issued (173) -- (173) (290)
Preferred stock issuance costs (80) -- (80) (237)
Change in fair value of derivative instruments 955 (686) 645 975
Other (15) 6 (45) 16
-------- -------- -------- --------
Total other income (expense) 687 (680) 347 464
-------- -------- -------- --------
Net income (loss) before income taxes 518 (1,162) (866) (1,249)
Provision for income taxes -- -- -- 1
-------- -------- -------- --------
Net income (loss) 518 (1,162) (866) (1,250)
Dividend on Series A and accretion of Series A and Series B
preferred stock redemption value (209) (184) (504) (394)
-------- -------- -------- --------
Net income (loss) available to common stockholders $ 309 $ (1,346) $ (1,370) $ (1,644)
======== ======== ======== ========
Net income (loss) per common share - basic and diluted $ 0.01 $ (0.06) $ (0.06) $ (0.07)
======== ======== ======== ========
Weighted average common shares outstanding - basic and diluted 24,093 23,111 24,092 23,118
======== ======== ======== ========
See notes to financial statements
F-3
SYSVIEW TECHNOLOGY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(IN THOUSANDS)
NINE MONTHS ENDED
SEPTEMBER 30,
--------------------
2006 2005
-------- --------
OPERATING ACTIVITIES
Net loss available to common stockholders $ (1,370) $ (1,644)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation expense 33 21
Stock-based compensation cost - options 977 1,341
Preferred stock issuance expenses paid by issuance of warrants 173 290
Change in fair value of derivative instruments (645) (975)
Accretion of Series A and Series B preferred stock redemption 445 394
value
Common stock issued for services rendered -- 75
Changes in operating assets and liabilities:
Trade receivables (801) (173)
Inventories (247) (440)
Prepaid expenses and other current assets (82) 69
Accrued dividends on Series A preferred stock 59 51
Trade payables and other current liabilities 183 (45)
-------- --------
Cash used by operating activities (1,275) (1,036)
-------- --------
INVESTING ACTIVITIES:
Capital expenditures (209) (167)
-------- --------
Cash used by investing activities (209) (167)
-------- --------
FINANCING ACTIVITIES:
Proceeds from issuance of preferred stock 1,150 1,865
Net repayments under line of credit and letters of credit -- (146)
Advances/repayments - related parties 327 91
-------- --------
Cash provided by financing activities 1,477 1,810
-------- --------
Net increase (decrease) in cash and cash equivalents (7) 607
Cash and cash equivalents at beginning of period 1,426 687
-------- --------
Cash and cash equivalents at end of period $ 1,419 $ 1,294
======== ========
See notes to financial statements
F-4
SYSCAN IMAGING, INC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (UNAUDITED)
NOTE 1 - BACKGROUND AND BASIS OF PRESENTATION
BACKGROUND
Sysview Technology, Inc., (referred to herein as "Sysview" or the "Company")
develops, designs and delivers various imaging technology solutions to the
corporate/enterprise, small office-home office ("SOHO"), professional practice
and consumer markets. Sysview is headquartered in San Jose, California, and is
principally engaged in the design/development OEM marketing of mobile/compact
scanners and marketing of Contact Image Sensor ("CIS") modules for use in
scanners and fax machines. Additionally, the Company is currently in the process
of expanding its business to the image display market Sysview's manufacturing is
completed at a China-based facility, which provides a low-cost manufacturing
base for these industrial and consumer products. See Note 3. Sysview's products
are ideally suited for the mobile computer user who needs to scan and/or fax
documents while away from the office.
BASIS OF PRESENTATION
The accompanying unaudited condensed consolidated financial statements of
Sysview have been prepared in accordance with accounting principles generally
accepted in the United States for interim financial information and the
instructions to Form 10-QSB and Article 10 of Regulation S-X. Accordingly, they
do not include all information and disclosures necessary for a presentation of
the Company's financial position, results of operations, and cash flows in
conformity with accounting principles generally accepted in the United States.
In the opinion of management, all adjustments (which include only normal
recurring adjustments) necessary to present fairly the financial position,
results of operations and cash flows for all periods presented have been made.
Preparing financial statements requires management to make estimates and
assumptions that affect the reported amounts of assets, liabilities, revenue and
expenses. Actual results may differ from these estimates. The results of
operations for the period ended September 30, 2006 are not necessarily
indicative of the operating results that may be expected for the entire year
ending December 31, 2006. The interim financial statements should be read in
conjunction with the financial statements in the Company's Amended Annual Report
on Form 10-KSB/A for the year ended December 31, 2005, filed with the Securities
and Exchange Commission ("SEC") on August 15, 2006.
The consolidated financial statements include the accounts of Sysview and its
subsidiaries. All significant intercompany transactions and balances have been
eliminated.
Certain accounts have been reclassified to conform to the current period
presentation.
NOTE 2 - RECENT ACCOUNTING PRONOUNCEMENTS
In December 2004, the Financial Accounting Standards Board ("FASB") issued
Statement of Financial Accounting Standards ("SFAS") 123-R, SHARE-BASED PAYMENT
("SFAS 123(R)"). SFAS 123(R) replaces SFAS 123, ACCOUNTING FOR STOCK-BASED
COMPENSATION, and supersedes the Accounting Principles Board ("APB") APB Opinion
25, ACCOUNTING FOR STOCK ISSUED TO EMPLOYEES ("APB 25"). SFAS 123(R) requires,
among other things, that all share-based payments to employees, including grants
of stock options, be measured based on their grant-date fair value and
recognized as expense. Effective January 1, 2006, Sysview adopted the fair value
recognition provisions of SFAS 123(R) using the modified prospective application
method. Under this transition method, compensation expense recognized for the
three and nine months ended September 30, 2006, includes the applicable amounts
of: (a) compensation expense of all stock-based payments granted prior to, but
not yet vested as of January 1, 2006 (based on the grant-date fair value
estimated in accordance with the original provisions of SFAS 123 and APB 25),
and (b) compensation expense for all stock-based payments granted subsequent to
January 1, 2006 (based on the grant-date fair value estimated in accordance with
the new provisions of SFAS 123(R)). Results for periods prior to January 1,
2006, have not been restated. See Note 6.
F-5
SYSCAN IMAGING, INC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (UNAUDITED)
On June 7, 2005, the FASB issued Statement 154, ACCOUNTING CHANGES AND ERROR
CORRECTIONS, A REPLACEMENT OF APB OPINION 20 AND FASB STATEMENT 3, ("SFAS 154").
SFAS 154 changes the requirements for the accounting for and reporting of a
change in accounting principle. Previously, most voluntary changes in accounting
principles were required recognition via a cumulative effect adjustment within
net income (loss) of the period of the change. SFAS 154 requires retrospective
application to prior periods' financial statements, unless it is impracticable
to determine either the period-specific effects or the cumulative effect of the
change. SFAS 154 is effective for accounting changes made in fiscal years
beginning after December 15, 2005. Sysview adopted SFAS 154 on January 1, 2006.
The adoption had no impact to the Company's consolidated financial position,
results of operations or cash flows.
In February 2006, the FASB issued SFAS 155, ACCOUNTING FOR CERTAIN HYBRID
FINANCIAL INSTRUMENTS - AN AMENDMENT OF FASB STATEMENTS 133 AND 140, ("SFAS
155"). SFAS will be effective for the Company beginning January 1, 2007. The
statement permits interests in hybrid financial instruments that contain an
embedded derivative that would otherwise require bifurcation, to be accounted
for as a single financial instrument at fair value, with changes in fair value
recognized in earnings. This election is permitted on an
instrument-by-instrument basis for all hybrid financial instruments held,
obtained, or issued as of the adoption date. The Company is currently evaluating
the potential impact this standard may have its consolidated financial position,
cash flows and results of operations, but does not believe the impact of the
adoption will be material.
In June 2006, the FASB issued Interpretation 48, ACCOUNTING FOR UNCERTAINTY IN
INCOME TAXES -- AN INTERPRETATION OF FASB STATEMENT NO. 109 ("FIN 48"), which
clarifies the accounting for uncertainty in tax positions. This Interpretation
requires that the Company recognize in its financial statements the impact of a
tax position if that position is more likely than not of being sustained on
audit, based on the technical merits of the position. The provisions of FIN 48
are effective for the Company on January 1, 2007, with the cumulative effect of
the change in accounting principle, if any, recorded as an adjustment to opening
retained earnings. The Company does not expect there to be any significant
impact of adopting FIN 48 on its consolidated financial position, cash flows and
results of operations.
In September 2006, the FASB issued SFAS 157, FAIR VALUE MEASUREMENTS ("SFAS
157"), which provides guidance about how to measure assets and liabilities that
use fair value. SFAS 157 will apply whenever another US GAAP standard requires
(or permits) assets or liabilities to be measured at fair value but does not
expand the use of fair value to any new circumstances. This standard also will
require additional disclosures in both annual and quarterly reports. SFAS 157
will be effective for financial statements issued for fiscal years beginning
after November 15, 2007, and will be adopted by us beginning in the first
quarter of 2008. The Company is currently evaluating the potential impact this
standard may have its consolidated financial position, cash flows and results of
operations, but does not believe the impact of the adoption will be material.
In September 2006, the SEC staff issued Staff Accounting Bulletin ("SAB") 108,
CONSIDERING THE EFFECTS OF PRIOR YEAR MISSTATEMENTS WHEN QUANTIFYING
MISSTATEMENTS IN CURRENT YEAR FINANCIAL STATEMENTS ("SAB 108"). SAB 108 was
issued to eliminate the diversity of practice in how public companies quantify
misstatements of financial statements, including misstatements that were not
material to prior years' financial statements. The Company will apply the
provisions of SAB 108 to its annual financial statements for the year ending
December 31, 2006. The Company has evaluated the potential impact of SAB 108 and
does not believe the impact of the application of this guidance will be material
to its consolidated financial position, cash flows and results of operations.
Other recent accounting pronouncements issued by the FASB (including its
Emerging Issues Task Force ("EITF")), the American Institute of Certified Public
Accountants ("AICPA"), and the SEC did not or are not believed by management to
have a material impact on the Company's present or future financial statements.
F-6
SYSCAN IMAGING, INC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (UNAUDITED)
NOTE 3 - RELATED PARTY TRANSACTIONS
The Company purchases the majority of its finished scanner imaging products from
a wholly-owned subsidiary of its majority stockholder, Syscan Technology
Holdings Limited ("STH"). See Note 5. The Company's Chairman and CEO, Darwin Hu,
was formerly the CEO of STH.
Related party purchases from entities that are wholly-owned subsidiaries of STH
were $3,254,000 for the nine months ended September 30, 2006, and $1,542,000 and
$3,521,000 for the three and nine months ended September 30, 2005. The purchases
were carried out in the normal course of business.
The following table is a summary of unsecured, interest-free and payable upon
demand, amounts due from affiliated entities (IN THOUSANDS):
SEPTEMBER 30, DECEMBER 31,
2006 2005
------ ------
STH wholly-owed subsidiaries $1,630 $1,957
STH 346 346
Syscan Imaging Limited 100 100
------ ------
$2,076 $2,403
====== ======
NOTE 4 - CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS
Financial instruments that subject the Company to credit risk are cash balances
maintained in excess of federal depository insurance limits and trade
receivables.
CASH AND CASH EQUIVALENTS
The Company maintains cash balances at several banks. Accounts at each
institution are insured by the Federal Deposit Insurance Corporation ("FDIC") up
to $100,000. As of September 30, 2006, the Company had consolidated balances of
approximately $1,013,000, which were not guaranteed by FDIC. The Company has not
experienced any losses in such accounts and believes the exposure is minimal.
MAJOR CUSTOMERS AND TRADE RECEIVABLES
A relatively small number of customers account for a significant percentage of
the Company's sales. The percentage of sales derived from significant customers
is as follows:
THREE MONTHS ENDED NINE MONTHS ENDED
SEPTEMBER 30, SEPTEMBER 30,
-------------------- -------------------
2006 2005 2006 2005
-------- -------- -------- --------
Customer A 68% 29% 59% 32%
Customer B 6 23 13 18
Customer C 10 16 10 14
Customer D -- 9 -- 12
Trade receivables from these customers totaled $1,853,000 at September 30, 2006.
As of September 30, 2006 all the Company's trade receivables were unsecured.
F-7
SYSCAN IMAGING, INC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (UNAUDITED)
NOTE 5 - CONCENTRATION OF SUPPLIER RISK
The Company purchases substantially all its finished scanner imaging products
from one vendor that is also a subsidiary of the Company's majority stockholder.
See Note 3. If this vendor became unable to provide materials in a timely manner
and the Company was unable to find alternative vendors, the Company's business,
operating results and financial condition would be materially adversely
affected.
NOTE 6 - EMPLOYEE EQUITY INCENTIVE PLANS
STOCK-BASED COMPENSATION
Sysview has several stock-based employee compensation plans, which are more
fully described in the 2005 Annual Report on Form 10-KSB/A-1. Prior to January
1, 2006, Sysview accounted for awards granted under those plans following the
recognition and measurement principles of APB 25 and related interpretations.
Accordingly, compensation expense, equal to the difference between the total
exercise price and the total fair market value, for awards granted at an
exercise price less than fair market value of the underlying common stock on the
grant date, was amortized over the vesting period and included in the Condensed
Consolidated Statement of Operations. Effective January 1, 2006, Syscan adopted
the fair value recognition provisions of SFAS 123(R). See Note 2.
The following table sets forth the total stock-based compensation expense
included in the Condensed Consolidated Statements of Operations (IN THOUSANDS):
THREE MONTHS ENDED NINE MONTHS ENDED
SEPTEMBER 30, SEPTEMBER 30,
--------------------- --------------------
2006 2005 2006 2005
--------- -------- -------- --------
Selling and marketing $ 13 $ 13 $ 38 $ 73
General and administrative 227 211 788 1,195
Research and development 96 13 151 73
At September 30, 2006, the Company had approximately $1,197,000 of total
unrecognized compensation cost related to unvested stock options. This cost is
expected to be recognized over a weighted-average period of approximately 18
months.
STOCK OPTIONS
The following table summarizes stock option activity and related information for
the nine months ended September 30, 2006:
WEIGHTED-
AVERAGE
EXERCISE
OPTIONS PRICE
--------- -----
Outstanding at December 31, 2005 3,760,000 $0.01
Granted 1,190,000 0.69
Exercised -- --
Cancelled 60,000 1.17
--------- -----
Outstanding at September 30, 2006 4,890,000 $0.18
========= =====
The following table summarizes all options outstanding and exercisable by price
range as of September 30, 2006:
F-8
SYSCAN IMAGING, INC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (UNAUDITED)
OPTIONS OUTSTANDING OPTIONS EXERCISABLE
--------------------------------------------------------- -------------------------------------
WEIGHTED-AVERAGE
REMAINING
CONTRACTUAL LIFE WEIGHTED-AVERAGE WEIGHTED-AVERAGE
RANGE OF EXERCISE PRICES NUMBER OUTSTANDING (YEARS) EXERCISE PRICE NUMBER EXERCISABLE EXERCISE PRICE
------------------------- ------------------ ---------------- ---------------- ------------------ ----------------
$0.01 4,000,000 5.57 $0.01 2,666,666 $0.01
$0.65 - $1.01 890,000 9.64 $0.92 -- --
NOTE 7 - BASIC AND DILUTED NET INCOME (LOSS) PER SHARE
Basic net income (loss) per share is computed by dividing net income (loss) by
the weighted average number of shares of common stock outstanding during the
period. Diluted net income (loss) per share is computed by dividing net income
(loss) by the weighted average number of shares of common stock and common stock
equivalents outstanding during the period.
Common stock equivalents were not considered in calculating diluted net loss per
common share for the nine months ended September 30, 2006 or for the three and
nine months ended September 30, 2005 as their effect would be anti-dilutive.
Common stock equivalents were taken into consideration in calculating diluted
net income per common share for the three months ended September 30, 2006, but
the impact did not change net income per share. As a result, for all periods
presented, the Company's basic and diluted net income (loss) per share is the
same.
The computation of the Company's basic and diluted earnings per share for the
three months ended September 30, 2006 is as follows (IN THOUSANDS, EXCEPT PER
SHARE AMOUNTS):
Net income $ 309
Weighted average common shares outstanding 24,093
Dilutive effect of employee equity incentive plans 223
-------
Weighted average common shares outstanding,
assuming dilution 24,316
=======
Basic earnings per common share $ 0.01
=======
Diluted earnings per common share $ 0.01
=======
The diluted earnings per share calculation for the three months ended September
30, 2006 excludes the potential dilutive effect of 2,454,000 of the Company's
options and warrants as the exercise prices of these stock options and warrants
were greater than or equal to the average market value of the common shares and
2,508,000 of the Company's convertible preferred stock as their impact was
anti-dilutive.
F-9
SYSCAN IMAGING, INC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (UNAUDITED)
NOTE 8 - EQUITY
COMMON STOCK ACTIVITY
During the nine months ended September 30, 2006 the Company issued 50,000 shares
of common stock for the conversion of 500 shares of Series A 5% cumulative
convertible preferred stock ("Series A Stock") as discussed below.
PREFERRED STOCK ACTIVITY
SERIES A 5% CUMULATIVE CONVERTIBLE PREFERRED STOCK
During the nine months ended September 30, 2006, $50,000 of Series A Stock (500
shares) were converted into 50,000 shares of common stock.
SERIES B CONVERTIBLE PREFERRED STOCK
On August 8, 2006, the Company completed a private placement with a group of
accredited investors for the sale of 11,500 shares of the Company's Series B
Convertible Preferred Stock ("Series B Stock") along with warrants, expiring
three years from the date of issuance, to purchase additional shares of the
Company's stock. Pursuant to a registration rights agreement (as discussed
below), the Company filed a Form SB-2 on October 11, 2006, with the Securities
and Exchange Commission ("SEC"), to register the shares of common stock issuable
upon conversion of the Series B Stock and upon exercise of the warrants. As of
the date of this filing, this registration has not yet been declared effective
by the SEC.
Total common stock issuable upon conversions of underlying the Series B Stock
and warrants follows:
Series B Stock (1) 1,150,000
Warrants issued to purchasers in private placement (2) 575,000
Warrants issued to placement agent in the private placement (2) 100,000
---------
1,825,000
=========
(1) Convertible at $1.00 per share, subject to anti-dilution provisions.
(2) Convertible at $1.50 per share, subject to anti-dilution provisions.
The Series B Stock was priced at $100 per share and the Company received
proceeds of $1,150,000 less offering costs and expenses. Starboard Capital
Markets, LLC, a NASD member firm, acted as placement agent in the sale for which
it received $80,000 in commissions and 100,000 warrants to purchase shares of
the Company's common stock at an exercise price equal to $1.50 per share. The
fair value of these warrants totaled $26,000 and such amount was charged to
other income (expense) and credited to additional paid-in capital during the
three months ended September 30, 2006.
The material terms of the Series B Stock are as follows:
SERIES B STOCK CONVERSION RIGHTS. All or any portion of the stated value of the
Series B Stock outstanding may be converted into common stock at anytime by the
Investors. The initial fixed conversion price of the Series B Stock is $1.00 per
share ("Conversion Price"). The Conversion Price is subject to anti-dilution
protection adjustments, on a full ratchet basis, until the date that is twelve
months from the effective date of the Registration Statement required to be
filed pursuant to the Registration Rights Agreement, upon the Company's issuance
of additional shares of common stock, or securities convertible into common
stock, at a price that is less than the then Conversion Price.
REDEMPTION. On August 7, 2009 ("Redemption Date"), all of the outstanding Series
B Stock shall be redeemed for a per share redemption price equal to the stated
value on the Redemption Date ("Redemption Price"). The Redemption Price is
payable by the Company in cash or in shares of common stock at the Company's
discretion and shall be paid within five trading days after the Redemption Date.
In the event the Company elects to pay all or some of the Redemption Price in
shares of common stock, the shares of common stock to be delivered to the
Investors shall be valued at 85% of the fifteen-day volume weighted average
price of the common stock on the Redemption Date.
F-10
SYSCAN IMAGING, INC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (UNAUDITED)
RIGHT TO COMPEL CONVERSION. If, on any date after August 7, 2007, (A) the
closing market price for a share of Common Stock for ten consecutive trading
days equals at least $4.00 (subject to adjustment for certain events), and (B)
the average reported daily trading volume during such ten-day period equals or
exceeds 100,000 shares, then the Company shall have the right, at its option, to
convert, all, but not less than all, of the outstanding shares of the Series B
Stock at the Conversion Price; provided that the Registration Statement shall be
effective at all times during such 10-day period and during the 30-day notice
period to the Investors.
WARRANT TERMS. The Warrants grant Investors the right to purchase up to an
aggregate of 575,000 shares of common stock of the Company at an exercise price
of $1.50 per share. The Warrants expire on August 7, 2009 and must be exercised
by the payment of cash, except if there is no effective registration statement
covering the resale of the shares of common stock underlying the Warrants, at
which time an investor may exercise their Warrants on a cashless basis.
RESTRICTIONS ON CONVERSION OF SERIES B STOCK AND EXERCISE OF WARRANTS. No holder
of the Series B Stock is entitled to receive shares upon conversion of the
Series B Stock held by such holder if such receipt would cause such holder to be
deemed to beneficially own in excess of 4.999% of the outstanding shares of the
Company's common stock on the date of issuance of such shares (this provision
may be waived upon 61 days prior written notice to the Company). In addition, no
individual holder is entitled to receive shares upon conversion of the Series B
Stock if the transaction causes such holder to beneficially own in excess of
9.999% of the outstanding shares of the Company's common stock on the date of
issuance of such shares (this provision may be waived upon 61 days prior written
notice to the Company).
None of the individual holders of the Series B warrants are entitled to exercise
any warrant held by them, if the exercise causes the holder to beneficially own
in excess of 4.999% of the outstanding shares of the Company's Common Stock on
the date of issuance of such shares.
REGISTRATION RIGHTS. Pursuant to the terms of a Registration Rights Agreement
between the Investors and the Company, the Company was obligated to file a
registration statement on Form SB-2 (which was filed on October 11, 2006)
registering the resale of shares of the Company's common stock issuable upon
conversion of the Series B Stock and exercise of the related warrants. The
Company was required to file the registration statement within 60 days of August
8, 2006 and have the registration statement declared effective within 120 days
of August 8, 2006. If the registration statement was not timely filed, or
declared effective within the timeframe described, or if the registration is
suspended other than as permitted, in the Registration Rights Agreement, the
Company will be obligated to pay each Investor a fee equal to one percent of
such investor's purchase price of the Series B Stock for each 30 day period
thereafter (pro rated for partial periods), that such registration conditions
are not satisfied, up to a maximum of 12 months.
RIGHT OF FIRST REFUSAL. Subject to certain conditions, the Company has granted
the investors a right of first refusal, for a period of one year from the
effective date of the registration statement required to be filed in connection
with this transaction, to participate in any subsequent financing that the
Company conducts.
F-11
SYSCAN IMAGING, INC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (UNAUDITED)
VOTING RIGHTS. Holders of the Series B Stock shall have no voting rights.
However, so long as any shares of Series B Stock are outstanding, the Company
shall not, without the affirmative vote of the holders of a majority of the
shares of the Series B Stock then outstanding, (a) alter or change adversely the
powers, preferences or rights given to the Series B Stock or alter or amend the
Series B Certificate of Designation, (b) authorize or create any class of stock
ranking as to dividends or distribution of assets upon a liquidation senior to
or otherwise PARI PASSU with the Series B Stock, (c) amend its certificate or
articles of incorporation or other charter documents so as to affect adversely
any rights of the holders of the Series B Stock, (d) increase the authorized
number of shares of the Series B Stock, or (e) enter into any agreement with
respect to the foregoing.
LIQUIDATION PREFERENCE. Upon any liquidation, dissolution or winding up of the
Company, whether voluntary or involuntary, and subject to the rights of the
holders of Series A Stock, the holders of the Series B Stock shall be entitled
to receive out of the assets of the Company, whether such assets are capital or
surplus, for each share of Series B Stock an amount equal to the stated value
per share before any distribution or payment shall be made to the holders of any
securities of the Company with rights junior to the Series B Stock, and if the
assets of the Company shall be insufficient to pay in full such amounts, then
the entire assets to be distributed to the holders of the Series B Stock shall
be distributed among such holders ratably in accordance with the respective
amounts that would be payable on such shares if all amounts payable thereon were
paid in full.
SERIES A STOCK DIVIDENDS
The Company's Series A Stock accrues cumulative dividends at a rate of five
percent per annum, payable semiannually on July 1 and January 1. Dividends are
payable in cash, by accretion of the stated value or in shares of common stock.
Subject to certain terms and conditions, the decision whether to accrete
dividends to the stated value of the Series A Stock or to pay for dividends in
cash or in shares of common stock, is at the Company's discretion. To date, the
Company has not paid any dividends. During the three and nine months ended
September 30, 2006, Series A Stock dividends were approximately $22,000 and
$59,000, respectively, and recorded as a non-operating expense on the Company's
statement of operations.
PREFERRED STOCK ACCOUNTING TREATMENT
Pursuant to SFAS 133, "ACCOUNTING FOR DERIVATIVE INSTRUMENTS AND HEDGING
ACTIVITIES" ("SFAS 133") and EITF Abstract No. 00-19, "ACCOUNTING FOR DERIVATIVE
FINANCIAL INSTRUMENTS" ("EITF 00-19"), the Company's Series A Stock and related
warrants and the Series B Stock and related warrants, are deemed derivative
instruments as a result of the embedded conversion feature. Accordingly, the
fair value of these derivative instruments has been recorded in the Company's
consolidated balance sheet as a liability with the corresponding amount as a
discount to the Series A Stock and Series B Stock, respectively. The discounts
are being accreted, on a straight-line basis, from the respective issuance date
through the respective redemption date adjusted for conversions. Accretion of
the preferred stock redemption value, for both Series A and Series B, for the
three and nine months ended September 30, 2006 was approximately $187,000 and
$445,000 and is disclosed as a non-operating expense on the Company's
consolidated statement of operations. The total decrease in the fair value of
the liability for derivative contracts, for both Series A and Series B, totaled
approximately $955,000 and $645,000 for the three and nine months ended
September 30, 2006 with the offsetting adjustment disclosed with other income
(expense) in the consolidated statements of operations.
The Company computes fair value of these derivatives using the Black-Scholes
valuation model. The Black-Scholes model was developed for use in estimating the
fair value of traded options that have no vesting restrictions and are fully
transferable. In addition, option valuation models require the input of highly
subjective assumptions, including the expected stock price volatility. The
Company's derivative instruments have characteristics significantly different
from traded options, and the input assumptions used in the model can materially
affect the fair value estimate.
F-12
SYSCAN IMAGING, INC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (UNAUDITED)
The assumptions used in the Black-Scholes valuation model to estimate fair value
of each derivative instrument and the resulting weighted average estimated value
of the Series A Stock derivative liability and the Series B Stock derivative
liability as of September 30, 2006 and 2005 are as follows:
SEPTEMBER 30,
--------------------
2006 2005
-------- --------
Weighted average estimated values per share $ 0.34 $ 0.56
Expected life in years 3.0 3.0
Expected volatility 42% 85%
Expected dividend yield 0% 0%
Risk free interest rate 5.34% 4%
NOTE 9 - COMMITMENTS AND CONTINGENCIES
OPERATING LEASES
The Company is committed under various non-cancelable operating leases which
extend through November 2011. Future minimum rental commitments are as follows
(IN THOUSANDS):
FUTURE
YEAR ENDING MINIMUM LEASE
SEPTEMBER 30, PAYMENTS
-------------- -------------
2007 $ 251
2008 269
2009 46
2010 1
2011 1
-------------
Total $568
=============
BANK LINE OF CREDIT
The Company has a line of credit to borrow up to $2,500,000, bearing interest at
the rate of prime (8.25% at September 30, 2006) plus 0.5% and secured by all of
the assets of the Company. Interest payments are due monthly and all unpaid
interest and principal is due in full on October 30, 2006. See Note 11. Upon
certain events of default, the default variable interest rate increases to prime
plus 5.5%. The Company had $1,487,000 available for use at September 30, 2006.
EMPLOYMENT AGREEMENTS
The Company maintains employment agreements with its executive officers which
extend through 2008. The agreements provide for a base salary, annual bonus to
be determined by the Board of Directors, termination payments, stock options,
non-competition provisions, and other terms and conditions of employment. In
addition, the Company maintains employment agreements with other key employees
with similar terms and conditions. As of September 30, 2006 termination payments
totaling $489,000 remain in effect.
LITIGATION, CLAIMS AND ASSESSMENTS
On May 20, 2003, Syscan, Inc., the Company's wholly-owned subsidiary, filed a
lawsuit named SYSCAN, INC. V. PORTABLE PERIPHERAL CO., LTD. ("PPL"), IMAGING
RECOGNITION INTEGRATED SYSTEMS, INC., CARDREADER INC. AND TARGUS INC. (Case No.
C03-02367 VRW) in United States District Court, Northern District of California.
Syscan, Inc. alleges claims against the above-mentioned parties for patent
infringement of patent nos. 6,054,707, 6,275,309 and 6,459,506, and unfair
competition. Syscan, Inc. expects to continue the case unless a reasonable
settlement amount from the defendants or a licensing agreement to the
satisfaction of Syscan, Inc. is entered.
Syscan, Inc. is seeking: (1) a temporary restraining order, preliminary
injunction and permanent injunction against defendants, restraining defendants
from patent infringement and unfair competition; (2) treble damages due to
defendants' willful infringement; (3) punitive damages; (4) accounting of unjust
enrichment by defendants, resulting from defendants' unfair competition; and (5)
attorney's fees and costs.
F-13
SYSCAN IMAGING, INC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (UNAUDITED)
The defendants are jointly represented by PPL's counsel. PPL has initiated
counterclaims against Syscan, Inc. for patent invalidity. Syscan, Inc. has not
yet been able to quantify its damage claim against PPL. Syscan, Inc. intends to
vigorously pursue this claim and denies PPL's counterclaim of patent invalidity.
There was a hearing in the Northern District of California on October 14, 2005,
in which arguments were presented to the court on the patent validity. The court
rendered a claim construction order on March 27, 2006 and a supplemental claim
construction order on July 5, 2006. Syscan has filed and served its final
infringement contentions on August 4, 2006 and a case management conference is
scheduled on August 29, 2006 for determining the discovery and trial calendar.
Syscan, Inc. expects to continue this case unless a reasonable settlement amount
from defendants or a licensing agreement to the satisfaction of Syscan, Inc. is
entered. See Note 11 for an update.
The Company experiences routine litigation in the normal course of its business
and does not believe that any pending litigation will have a material adverse
effect on the Company's financial condition, results of operations or cash
flows.
SERIES A PREFERRED STOCK REGISTRATION RIGHTS AGREEMENT
In connection with the issuance of Series A Preferred Stock, the Company
executed a registration rights agreement ("Agreement") with the purchasers
thereof under which the Company agreed to register the common shares underlying
the Series A Stock and related warrants. The Agreement provides for liquidated
damages in the event the registration statement is not maintained continuously
effective for a period of two years following the March 15, 2005 closing date.
The liquidated damages total an amount equal to one percent (pro-rated for
partial months) of the purchase price of the Series A Stock for each thirty day
period effectiveness of a registration statement is not maintained and two
percent for each thirty day period the registration statement ceases to remain
effective. This registration, which was originally declared effective by the SEC
on July 7, 2005, became ineffective April 30, 2006. The Company updated the
original registration statement by filing amendments on June 6, 2006 and August
22, 2006, and the SEC declared the registration effective September 15, 2006. As
a result, the Company accrued $113,000 and $145,000, included in general and
administrative expense, for damages during the three and nine months ended
September 30, 2006, respectively.
NOTE 10 - SEGMENT AND GEOGRAPHIC INFORMATION
SEGMENT INFORMATION
Sysview operates in one segment, the design, development and delivery of
various imaging technology solutions, most notably scanners, as defined by SFAS
131, DISCLOSURES ABOUT SEGMENTS OF AN ENTERPRISE AND RELATED INFORMATION ("SFAS
131").
GEOGRAPHIC INFORMATION
During the three and nine months ended September 30, 2006 and 2005,
Sysview recorded net sales throughout the U.S., Asia and Europe as determined by
the final destination of the product. The following table summarizes total net
sales attributable to significant countries (IN THOUSANDS):
F-14
THREE MONTHS ENDED NINE MONTHS ENDED
SEPTEMBER 30, SEPTEMBER 30,
------------------- -------------------
2006 2005 2006 2005
------ ------ ------ ------
U.S. $3,910 $1,911 $8,497 $4,672
Asia 111 245 317 525
Europe and other 77 51 261 205
------ ------ ------ ------
$4,098 $2,207 $9,075 $5,402
====== ====== ====== ======
Substantially all Sysview's identifiable assets are located in the U.S.
NOTE 11 - SUBSEQUENT EVENT
BANK LINE OF CREDIT
The Company's line of credit (see Note 9) matured on October 30, 2006. Although
the Company is currently negotiating a new line of credit with the same bank,
the new terms have not been finalized. The bank agreed to extend the Company's
current line of credit for two months with the existing terms while the new
agreement is finalized.
Referring to the lawsuit as more fully described in Note 9 above, the Company
formally withdrew the lawsuit and the entire action was dismissed per a court
order dated November 21, 2006.
[END OF INTERIM FINANCIAL STATEMENTS]
F-15
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of
Sysview Technology, Inc.
We have audited the accompanying consolidated balance sheet of Sysview
Technology, Inc. (formerly known as Syscan Imaging, Inc.) (a Delaware
Corporation) and Subsidiaries (the "Company") as of December 31, 2005, and the
related consolidated statements of operations, changes in stockholders' equity,
and cash flows for the years ended December 31, 2005 and 2004. These
consolidated financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on these consolidated
financial statements based on our audit.
We conducted our audit in accordance with the standards of the Public
Company Accounting Oversight Board (United States). Those standards require that
we plan and perform the audit to obtain reasonable assurance about whether the
consolidated financial statements are free of material misstatement. An audit
includes examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by management, as well
as evaluating the overall financial statement presentation. We believe that our
audit provides a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present
fairly, in all material respects, the consolidated financial position of the
Company as of December 31, 2005, and the consolidated results of its operations
and its cash flows for the years ended December 31, 2005 and 2004, in conformity
with generally accepted accounting principles in the United States of America.
The consolidated financial statements for 2005 have been restated as more fully
described in Note 1.
/s/ Clancy and Co., P.L.L.C.
----------------------------
Clancy and Co., P.L.L.C.
Scottsdale, Arizona
April 12, 2006, except for the updates to Note 1 which is dated July 24, 2006
F-1
SYSVIEW TECHNOLOGY, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEET
DECEMBER 31, 2005
ASSETS (RESTATED)
--------------------------------------------------------------------------------
Current assets
Cash and cash equivalents $ 1,426,138
Trade receivables, net 1,284,766
Inventories 751,228
Prepayments, deposits and other current assets 319,270
Due from related parties 2,402,520
------------
Total current assets 6,183,922
Fixed assets, net 167,219
Other assets
Goodwill 555,485
Long-term investment 997,692
------------
Total other assets 1,553,177
------------
TOTAL ASSETS $ 7,904,318
============
LIABILITIES AND STOCKHOLDERS' EQUITY
--------------------------------------------------------------------------------
Current liabilities
Bank line of credit $ 833,036
Letter of credit 180,000
Trade payables 259,365
Other payables and accruals 185,699
Accrued dividends on 5% convertible preferred stock 71,155
------------
Total current liabilities 1,529,255
Other liabilities
Liability under derivative contracts 502,995
------------
Total liabilities 2,032,250
Commitments and contingencies
5% Convertible preferred stock, $0.001 par value,
2,000,000 shares authorized, 16,150 shares
issued and outstanding, liquidation
value of $16,150,000 467,699
Stockholders' equity
Common stock: $0.001 par value;
50,000,000 shares authorized;
24,592,092 shares issued
and 24,092,092 shares outstanding
[escrow = 500,000 shares] 24,092
Additional paid- in capital 28,137,633
Accumulated deficit (22,757,356)
------------
Total stockholders' equity 5,404,369
------------
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 7,904,318
============
THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS.
F-2
SYSVIEW TECHNOLOGY, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
YEARS ENDED DECEMBER 31
2005 2004
(RESTATED)
------------ ------------
NET SALES $ 7,848,007 $ 6,057,821
COSTS OF SALES 4,988,618 4,125,962
------------ ------------
GROSS PROFIT 2,859,389 1,931,859
OPERATING EXPENSES
Selling and marketing expenses 1,037,221 745,557
General and administrative expenses 2,917,564 839,909
Research and development expenses 951,333 528,417
------------ ------------
Total operating expenses 4,906,118 2,113,883
------------ ------------
OPERATING LOSS (2,046,729) (182,024)
Other income (expense)
Change in fair value of derivative instruments 1,112,005 --
Fair value of warrants issued (290,000) --
Preferred stock issuance costs (236,500) --
Interest income 23,642 5,966
Other income - exchange gain 4,673 8,613
Interest expense (57,097) (11,621)
------------ ------------
Total other income (expense) 556,723 2,958
------------ ------------
NET LOSS BEFORE PROVISION FOR INCOME TAXES (1,490,006) (179,066)
Provision for income taxes 3,232 800
------------ ------------
NET LOSS (1,493,238) (179,866)
Dividend on 5% convertible preferred stock and accretion of
preferred stock redemption value (545,435) --
------------ ------------
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS $ (2,038,673) $ (179,866)
============ ============
BASIC AND DILUTED LOSS PER SHARE $ (0.09) $ (0.01)
============ ============
WEIGHTED AVERAGE SHARES OUTSTANDING 23,279,389 22,599,454
============ ============
THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS.
F-3
SYSVIEW TECHNOLOGY, INC. AND SUBISIDARIES
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
YEARS ENDED DECEMBER 31, 2005 AND 2004
COMMON COMMON ADDITIONAL
STOCK STOCK PAID IN ACCUMULATED
(SHARES) (AMOUNT) CAPITAL DEFICIT TOTAL
(RESTATED) (RESTATED) (RESTATED)
---------------------------------------------------------------------------
BALANCE - DECEMBER 31, 2003 21,082,935 21,083 $ 25,480,290 $(20,538,817) $ 4,962,556
---------------------------------------------------------------------------
Recapitalization to effect reverse
acquisition 2,027,580 2,027 (2,027) -- --
Net loss -- -- (179,866) (179,866)
---------------------------------------------------------------------------
BALANCE - DECEMBER 31, 2004 23,110,515 23,110 25,478,263 (20,718,683) 4,782,690
---------------------------------------------------------------------------
Common stock issued for Series A
preferred stock conversions 256,581 257 256,324 -- 256,581
Issuance of common stock for services
rendered 224,996 225 156,772 -- 156,997
Stock-based compensation cost - options -- -- 1,576,774 -- 1,576,774
Fair value of warrants issued for
payment of preferred stock issuance
expenses -- -- 290,000 -- 290,000
Common stock issued for acquisition
of subsidiary, 1,000,000 shares
less 500,000 held in escrow per
agreement 500,000 500 379,500 -- 380,000
Net loss -- -- -- (2,038,673) (2,038,673)
---------------------------------------------------------------------------
BALANCE - DECEMBER 31, 2005 24,092,092 $ 24,092 $ 28,137,633 $(22,757,356) $ 5,404,369
===========================================================================
THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS.
F-4
SYSVIEW TECHNOLOGY, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
YEARS ENDED DECEMBER 31
2005 2004
(RESTATED)
----------- -----------
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss $(2,038,673) $ (179,866)
----------- -----------
Adjustments to reconcile net loss to net cash flows used in operating
activities
Depreciation 31,303 3,279
Loss on disposal of fixed assets -- 9,861
Common stock issued for services 156,997 --
Stock-based compensation cost - options 1,576,774 --
Fair value adjustment to liabilities under derivative contracts (1,112,005) --
Accretion of 5% convertible preferred stock redemption value 467,699 --
Preferred stock issuance expenses paid by issuance of warrants 290,000 --
Conversion of Series A preferred stock dividends for common stock 6,581 --
Write back of provision for doubtful accounts -- 41,178
Changes in assets and liabilities
(Increase) decrease trade receivables (156,893) 930,231
(Increase) decrease in inventories (254,548) (297,130)
(Increase) decrease in other current assets (101,130) (207,325)
Increase (decrease) in trade payables 197,060 36,661
Increase (decrease) in other payables and accruals 135,587 (362,898)
----------- -----------
Net cash flows used in operating activities (801,248) (26,009)
----------- -----------
CASH FLOWS FROM INVESTING ACTIVITIES
Cash acquired in reverse acquisition -- 28,288
Cash paid for subsidiary (97,896) --
Capital expenditures (169,588) (26,309)
----------- -----------
Net cash flows provided by (used in) investing activities (267,484) 1,979
----------- -----------
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from the issuance of preferred stock 1,865,000 --
Advances under bank line of credit 150,000 700,000
Repayments under bank lines of credit (250,000) --
Advances under bank letters of credit 180,000 233,036
Advances / repayments - related party amounts (137,533) (1,241,425)
----------- -----------
Net cash flows provided by (used in) financing activities 1,807,467 (308,389)
----------- -----------
Increase (decrease) in cash and cash equivalents 738,735 (332,419)
Cash and cash equivalents, beginning of year 687,403 1,019,822
----------- -----------
Cash and cash equivalents, end of year $ 1,426,138 $ 687,403
=========== ===========
Cash paid for:
Interest $ 57,097 $ 11,621
=========== ===========
Income taxes $ 3,232 $ 800
=========== ===========
THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS.
F-5
SYSVIEW TECHNOLOGY, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
YEARS ENDED DECEMBER 31
2005 2004
(RESTATED)
---------- --------
SUPPLEMENTAL NON-CASH INVESTING AND FINANCING ACTIVITIES:
Common stock issued for services $ 156,997 --
Stock-based compensation cost - options $1,576,774 --
Proceeds from issuance of 5% Convertible Preferred Stock to Liability under
Derivative Contracts $1,865,000 --
Conversion of Series A Preferred Stock for Common Stock $ 256,581 --
Preferred stock issuance expenses paid by issuance of warrants $ 290,000 --
THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS.
F-6
SYSVIEW TECHNOLOGY, INC. AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2005
NOTE 1 - BACKGROUND, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES
BACKGROUND
Sysview Technology, Inc., (referred to herein as "Syscan" or the "Company")
(formerly known as Syscan Imaging, Inc.), develops, designs and delivers various
imaging technology solutions to the corporate/enterprise, small office-home
office (SOHO), professional practice and consumer markets. Sysview is
headquartered in San Jose, California, and is principally engaged in the design,
development and marketing of Contact Image Sensor ("CIS") modules for use in
scanners and fax machines. Syscan's manufacturing is completed at an affiliated
China-based facility, which provides a low-cost manufacturing base for these
industrial and consumer products. Syscan's products are ideally suited for the
mobile computer user who needs to scan and/or fax documents while away from
their office. Effective June 27, 2006, we changed our name from Syscan Imaging,
Inc. to Sysview Technology, Inc.
On April 2, 2004, Sysview Technology, Inc. (formerly known as "Syscan Imaging,
Inc." and prior thereto aso "BankEngine Technologies, Inc." and referred to
herein as the "Company") completed its acquisition of 100% of the issued and
outstanding capital stock of Syscan, Inc. ("Syscan") pursuant to a Share
Exchange Agreement ("Agreement") dated March 29, 2004, in exchange for
20,859,459 shares of the Company's common stock. Pursuant to the Agreement, the
sole stockholder of Syscan, Inc., Syscan Imaging Limited, received 18,773,514
post-reverse split shares of the Company's common stock in exchange for all of
the issued and outstanding capital stock of Syscan, Inc. In connection with the
issuance of the Company's common stock to Syscan Imaging Limited, Syscan Imaging
Limited beneficially became the owner of 81.2% of the issued and outstanding
securities of the Company. Its ultimate holding company is Syscan Technology
Holdings Limited, a company which is incorporated in Bermuda and its shares are
listed on The Growth Enterprise Market of The Stock Exchange of Hong Kong
Limited.
BASIS OF PRESENTATION
As a result of the reverse acquisition, the financial statements of the Company
become those of Sysview and thus, the consolidated financial statements of the
Company represent the activities of its 100% owned subsidiary, Syscan, Inc. and
the Company's other wholly-owned subsidiaries. Although the Company is the legal
acquirer, Sysview will be treated as having acquired the Company for accounting
purposes and all of the operations reported represent the historical financial
statements of Sysview and the Company's other wholly-owned subsidiaries.
RESTATEMENT TO CONSOLIDATED FINANCIAL STATEMENTS
The Company amended the consolidated financial statements for the year ended
December 31, 2005 and extended or modified certain notes to the consolidated
financial statements to provide additional information as detailed below.
The restatements were made to recognize stock-based compensation costs over the
period in which the requisite service is performed instead of recognizing the
entire intrinsic value on the grant date. The effect of the restatement was a
decrease in net loss from $3,273,899 to $2,038,673, or $1,235,226 and a decrease
in loss per share from $0.14 to $0.09. The restatement had no effect on total
stockholders equity. Refer to the Company's "Stock-based compensation cost"
accounting policy note under Summary of Significant Accounting Policies.
F-7
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
PRINCIPLES OF CONSOLIDATION - The consolidated financial statements include the
accounts of the Company and its subsidiaries. The results of subsidiaries
acquired or disposed of during the periods presented are consolidated from or to
their effective dates of acquisition or disposal. All significant inter-company
balances and transactions have been eliminated in consolidation.
USE OF ESTIMATES - The preparation of financial statements in conformity with
U.S. generally accepted accounting principles requires management to make
estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenues and expenses
during the reporting period. Management makes its best estimate of the ultimate
outcome for these items based on historical trends and other information
available when the financial statements are prepared. Changes in estimates are
recognized in accordance with the accounting rules for the estimate, which is
typically in the period when new information becomes available to management.
Actual results could differ from those estimates.
FAIR VALUE OF FINANCIAL INSTRUMENTS - For certain of the Company's financial
instruments, including cash and cash equivalents, trade receivables and
payables, prepaid expenses and other current assets, amounts due to / from
related parties, and other payables and accruals, the carrying amounts
approximate fair values due to their short maturities.
RELATED PARTY TRANSACTIONS - A related party is generally defined as (i) any
person that holds 10% or more of the Company's securities and their immediate
families, (ii) the Company's management, (iii) someone that directly or
indirectly controls, is controlled by or is under common control with the
Company, or (iv) anyone who can significantly influence the financial and
operating decisions of the Company. A transaction is considered to be a related
party transaction when there is a transfer of resources or obligations between
related parties.
CASH AND CASH EQUIVALENTS - The Company considers all highly liquid instruments
purchased with an original maturity of three months or less to be cash
equivalents.
CONCENTRATION OF CREDIT RISK - Credit risk represents the accounting loss that
would be recognized at the reporting date if counterparties failed completely to
perform as contracted. Concentrations of credit risk (whether on or off balance
sheet) that arise from financial instruments exist for groups of customers or
counterparties when they have similar economic characteristics that would cause
their ability to meet contractual obligations to be similarly affected by
changes in economic or other conditions are described below.
Financial instruments that subject the Company to credit risk are cash balances
maintained in excess of federal depository insurance limits and accounts
receivable with no collateral or security. The Company maintains cash balances
at several banks. Accounts at each institution are insured by the Federal
Deposit Insurance Corporation ("FDIC") up to $100,000. As of December 31, 2005,
the Company had consolidated balances of approximately $1,030,000, which were
not guaranteed by FDIC. The Company has not experienced any losses in such
accounts and believes the exposure is minimal. As of December 31, 2005, all the
Company's receivables were unsecured.
Other potential areas that potentially expose the Company to a concentration of
credit risk are as follows:
GEOGRAPHIC SALES AND SIGNIFICANT CUSTOMERS - The Company operates in a single
industry segment that being scanner and fax modules. The Company markets its
products in the United States, Europe and the Asia Pacific region through its
sales personnel and independent sales representatives.
The Company's geographic sales as a percent of total revenue are as follows:
2005 2004
---- ----
United States 87% 96%
Asia Pacific 9% 2%
Europe and others 4% 2%
Sales to major customers, as a percentage of total revenues, are as follows:
2005 2004
---- ----
Customer A 33% 38%
Customer B 18% 16%
Customer C 16% 15%
Customer D 12% 9%
F-8
TRADE RECEIVABLES - The Company's customers are concentrated in the
industrial/consumer electronics channels and with major original equipment
manufacturers. As of December 31, 2005, the concentration was approximately
92.5% (3customers). The loss of any of these customers could have a material
adverse effect on the company results of operations, financial position and cash
flows.
SIGNIFICANT VENDORS - For the years ended December 31, 2005 and 2004, the
Company's purchases of finished scanner imaging products have primarily been
concentrated with one vendor that is a subsidiary of the Company's majority
stockholder. If this vendor was unable to provide materials in a timely manner
and the Company was unable to find alternative vendors, the Company's business,
operating results and financial condition would be materially adversely
affected.
PRODUCT SALES - The Company had 3 (2004: 4) different product categories in 2005
that each accounted for more than 10% of sales. If any of these products were to
become obsolete or unmarketable and the Company was unable to successfully
develop and market alternative products, the Company's business, operating
results and financial condition could be adversely affected
INVENTORIES - Inventories consist of finished goods, which are stated at the
lower of cost or net realizable value, with cost computed on a first-in,
first-out basis. Provision is made for obsolete, slow-moving or defective items
where appropriate. The amount of any provision of inventories is recognized as
an expense in the period the provision occurs. The amount of any reversal of any
provision is recognized as other income in the period the reversal occurs. There
was no provision recorded at December 31, 2005.
FIXED ASSETS - Fixed assets, stated at cost, are depreciated over the estimated
useful lives of the assets using the straight-line method over periods ranging
from three to ten years. Significant improvements and betterments are
capitalized. Routine repairs and maintenance are expensed when incurred. Gains
and losses on disposal of fixed assets are recognized in the statement of
operations based on the net disposal proceeds less the carrying amount of the
assets. Depreciation expense charged to operations in 2005 was $31,303 (2003:
$3,279).
LONG-LIVED ASSETS - Long-lived assets, such as fixed assets, are reviewed for
impairment when circumstances indicate the carrying value of an asset may not be
recoverable. For assets that are to be held and used, an impairment loss is
recognized when the estimated undiscounted cash flows associated with the asset
or group of assets is less than their carrying value. If impairment exists, an
adjustment is made to write the asset down to its fair value, and a loss is
recorded as the difference between the carrying value and fair value. Fair
values are determined based on quoted market values, discounted cash flows or
internal and external appraisals, as applicable. Assets to be disposed of are
carried at the lower of carrying value or estimated net realizable value.
LONG-TERM INVESTMENTS - Long-term investments are carried at cost less provision
for any impairment in value. Income from long-term investments is accounted for
to the extent of dividends received or receivable. Upon disposal of investments,
any profit and loss thereon is accounted for in the statement of operations.
REVENUE RECOGNITION - Revenues consist of product sales including optical image
capturing devices, modules of optical image capturing devices, and chips and
other optoelectronic products. Revenue is recognized when the product is shipped
and the risks and rewards of ownership have transferred to the customer. The
Company recognizes shipping and handling fees as revenue, and the related
expenses as a component of cost of sales. All internal handling charges are
charged to selling, general and administrative expenses.
ALLOWANCE FOR DOUBTFUL ACCOUNTS AND RETURN ALLOWANCES - The Company presents
trade receivables, net of allowances for doubtful accounts and returns, to
ensure trade receivable are not overstated due to uncollectibility. The
allowances are calculated based on detailed review of certain individual
customer accounts and an estimation of the overall economic conditions affecting
the Company's customer base. The Company reviews a customer's credit history
before extending credit. If the financial condition of its customers were to
deteriorate, resulting in an impairment of their ability to make payments,
additional allowances may be required. There was no allowance for doubtful
accounts at December 31, 2005, as management believes all of its trade
receivables are collectible.
RESEARCH AND DEVELOPMENT EXPENSES - Research and development costs are expensed
as incurred and amounted to $951,333 in 2005 (2004: $528,417).
ADVERTISING COSTS - Advertising costs are expensed as incurred and were
immaterial for both periods presented.
F-9
INCOME TAXES - The Company accounts for income taxes under the liability method
of accounting for income taxes in accordance with the provisions of Statement of
Financial Accounting Standards ("SFAS") No. 109, "Accounting for Income Taxes."
Current income tax expense or benefit is the amount of income taxes expected to
be payable or refundable for the current year. A deferred income tax asset or
liability is computed for the expected future impact of differences between the
financial reporting and tax basis of assets and liabilities and for the expected
future tax benefit to be derived from tax credits and loss carryforwards.
Deferred tax assets are reduced by a valuation allowance when, in the opinion of
management, it is more likely than not that some portion or all of the deferred
tax assets will not be realized.
INTANGIBLE ASSETS - Intangible assets represents goodwill arising from the
excess of the purchase consideration over the fair value of the net assets at
the date of acquisition of subsidiaries. Goodwill arising in a business
combination initiated after June 30, 2001 is not amortized, but assessed
annually for indicators of impairment.
COMPREHENSIVE INCOME - The Company includes items of other comprehensive income
by their nature in a financial statement and displays the accumulated balance of
other comprehensive income separately in the equity section of the balance
sheet.
FOREIGN CURRENCY TRANSLATION - The reporting currency used in the preparation of
these consolidated financial statements is U.S. dollars. Local currencies are
the functional currencies for the Company's subsidiaries. For the purpose of
consolidation, assets and liabilities of subsidiaries with functional currencies
other than U.S. dollars are translated into U.S. dollars at the applicable rates
of exchange in effect at the balance sheet date and income and expense items are
translated into U.S. dollars at the average applicable rates during the year.
Translation gains and losses resulting from fluctuations in exchange rates are
recorded as a separate component of other comprehensive income within
stockholders' equity as cumulative translation adjustments. Gains and losses
resulting from foreign currency transactions are included in results of
operations.
EARNINGS PER SHARE - Basic earnings or loss per share ("EPS") is calculated
using net earnings or loss (numerator) divided by the weighted-average number of
shares outstanding (denominator) during the reporting period. Diluted EPS is
based on the weighted average number of common shares outstanding and dilutive
common stock equivalents. All EPS amounts in the financial statements are basic
EPS, as defined by SFAS No. 128, "Earnings Per Share." Diluted EPS does not
differ materially from basic EPS for all periods presented. Convertible
securities that could potentially dilute basic earnings per share in the future
such as options and warrants are not included in the computation of diluted EPS
because to do so would be antidilutive. All per share and per share information
are adjusted retroactively to reflect stock splits and changes in par value.
STOCK-BASED COMPENSATION COST - The Company accounts for stock-based
compensation using the intrinsic value method prescribed in Accounting
Principles Board ("APB") Opinion No. 25, "Accounting for Stock Issued to
Employees." Compensation cost for stock options, if any, is measured as the
total excess of the quoted market price of the Company's stock at the date of
grant over the amount an employee must pay to acquire the stock, and is
amortized over the vesting period of the grant. SFAS No.123, "Accounting for
Stock-Based Compensation," established accounting and disclosure requirements
using a fair-value-based method of accounting for stock-based employee
compensation plans. The Company has elected to remain on its current method of
accounting as described above, and has adopted the disclosure requirements of
SFAS No. 123. In December 2002, the FASB issued SFAS No. 148, "Accounting for
Stock-Based Compensation - Transition and Disclosure, amending FASB No. 123, and
"Accounting for Stock-Based Compensation". This statement amends Statement No.
123 to provide alternative methods of transition for an entity that voluntarily
changes to the fair value based method of accounting for stock-based employee
compensation. See Note 5 for a description of the stock-based compensation plan.
The weighted average fair value on the date of grant was $0.7695 for those
options granted in 2005. The fair value of each option grant is estimated on the
date of grant using the Black-Scholes Option pricing model with the following
weighted-average assumptions: dividend yield of 0%, expected volatility of 144%,
risk-free interest rate of 5%, and expected life of two years. For 2004, the
estimated fair value of the options on the date of grant using the Black-Scholes
option pricing model was based on a risk free interest rate of 1.91%, an
expected volatility of 100%, an expected life of 2 years and no dividend yield.
Had compensation expense for the Company's stock-based compensation plans been
determined under SFAS No. 123, based on the fair market value at the grant
dates, the Company's pro forma net earnings and pro forma net earnings per share
would have been reflected as follows for the years ended December 31:
F-10
2005 2004
----------- -----------
(restated)
Net earnings (loss) available to common stockholders $(2,038,673) $ (179,866)
Add: Stock-based compensation cost included in reported net
earnings (loss) 1,576,744 --
Less: Stock-based employee compensation cost determined
under fair value based method for all awards, net of related
tax effects (1,596,425) (3,824)
----------- -----------
Pro forma net earnings (loss) $(2,058,354) $ (183,690)
=========== ===========
Basic and diluted net earning ( loss) per share, as reported $ (0.09) $ (0.01)
=========== ===========
Pro-forma basic and diluted net earnings (loss) per share $ (0.09) $ (0.01)
=========== ===========
RECENT ACCOUNTING PRONOUNCEMENTS - The Financial Accounting Standards Board
issued the following new accounting pronouncements:
In December 2004, the FASB issued SFAS No. 123 (Revised 2004) "Share-Based
Payment" ("SFAS No. 123R"). SFAS No. 123R addresses all forms of share-based
payment ("SBP") awards, including shares issued under employee stock purchase
plans, stock options, restricted stock and stock appreciation rights. SFAS No.
123R will require the Company to expense SBP awards with compensation cost for
SBP transactions measured at fair value. On March 29, 2005, the SEC issued Staff
Accounting Bulletin (SAB) 107 which expresses the views of the SEC regarding the
interaction between SFAS No. 123R and certain SEC rules and regulations and
provides the SEC's views regarding the valuation of share-based payment
arrangements for public companies. In April 2005, the SEC issued a release which
amends the compliance dates for SFAS No. 123R. We expect the adoption of SFAS
No. 123R and SAB 107 to have a material impact on the Company's financial
statements.
In May 2005, the FASB issued SFAS No. 154, "Accounting Changes and Error
Corrections". SFAS No. 154 replaces APB Opinion No. 20 "Accounting Changes" and
SFAS No. 3, "Reporting Accounting Changes in Interim Financial Statements". SFAS
No. 154 requires retrospective application to prior periods' financial
statements of changes in accounting principle, unless it is impracticable to
determine either the period-specific effects or the cumulative effect of the
change. We do not expect the adoption of SFAS No. 154 to have any impact on the
Company's financial statements.
RECLASSIFICATIONS AND ADJUSTMENTS - Certain prior period amounts have been
reclassified to conform to the current period presentation.
NOTE 2 - RELATED PARTY TRANSACTIONS
The Company purchases significantly all of its finished scanner imaging products
from the parent company of its majority stockholder, Syscan Technology Holdings
Limited ("STH"). The Company's Chairman and CEO, Darwin Hu, was formerly the CEO
of STH, and beneficially owns approximately 5.33% of the issued and outstanding
capital stock of STH.
The following is a summary of significant related party purchases from entities
that are wholly-owned subsidiaries of STH. The transactions were carried out in
the normal course of the Company's business.
2005 2004
-------- -------
SYSCAN Intervision Limited, a wholly-owned
subsidiary of STH (purchases) $4.915M $3.825M
======= =======
SYSCAN Optoelectronics Technology
(Shenzhen) Company Limited,
a wholly-owned subsidiary of
STH (purchases) -- $0.520M
======= =======
F-11
Amounts due from related parties are unsecured, interest-free and repayable on
demand and consisted of the following:
Due from STH $ 345,998
Due from Majority Stockholder 100,000
Due from various subsidiaries
wholly-owned by STH 1,956,522
----------
$2,402,520
==========
NOTE 3 - FIXED ASSETS, NET
Fixed assets consist of the following:
Computer and office equipment $ 62,286
Furniture and fixtures 2,565
Tooling and product design 137,018
--------
201,869
Less: accumulated depreciation 34,650
--------
$167,219
========
NOTE 4 - LONG-TERM INVESTMENT
Long-term investment consists of an equity interest in CMOS Sensor, Inc.
("CMOS"), a California corporation, which is principally engaged in the research
and development of infra-red sensors and CMOS sensors. On June 26, 2002, the
Company acquired 100% equity interest of Syscan Laser Technology Ltd. ("Syscan
Laser") from Syscan Holdings Limited, a fellow subsidiary of the Company, for
total consideration of $1. At the date of acquisition, Syscan Laser held 9.7%
equity interest (representing 750,000 shares purchased at $0.80 per share) in
CMOS. On October 29, 2003, the Company acquired 100% equity interest of
Leadbuilt Technology Limited ("Leadbuilt") from Syscan InterVision Limited, a
fellow subsidiary of the Company, for total consideration of $1. At the date of
acquisition, Leadbuilt held 6.4% (representing 500,000 shares purchased at $0.80
per share) equity interest in CMOS. As a result of both transactions, the
Company increased its equity interest in CMOS from 9.7% to 16.1%. The Company's
management and directors are of the opinion that the underlying value of the
long-term investment is not less than the carrying value at December 31, 2005.
NOTE 5 - STOCKHOLDERS' EQUITY
COMMON STOCK
THE COMPANY HAD THE FOLLOWING EQUITY ACTIVITY DURING 2005:
o issuance of 224,996 shares of restricted common stock for investor
relations services valued at the fair market value of the services
rendered;
o issuance of 256,581 shares of common stock for the conversion of
2,500 shares of Series A preferred stock; and
o issuance of 1,000,000 shares of common stock for the acquisition of
Nanodisplay, Inc., 500,000 of which are held in escrow by the
Company pending certain milestones to be met per the acquisition
agreement. These shares have been accounted for as issued, but not
outstanding. (Note 8)
In connection with investor relations services rendered for common stock issued,
the Company overpaid a consultant $30,000. The Company also has ended its
relationship with the consultant due to non-performance. The consultant has
agreed to repay the $30,000 overpayment by December 1, 2006 and return 75,000
shares. As of the date of issuance of these financial statements, both remain
outstanding. The shares are reflected as issued since they are outstanding and
no receivable has been set up for the repayment since it is uncertain whether or
not repayment will occur. Neither has a material effect on the overall financial
statement presentation.
F-12
THE COMPANY HAD THE FOLLOWING EQUITY ACTIVITY DURING 2004:
On April 2, 2004, the Company completed its acquisition of 100% of the issued
and outstanding capital stock of Sysview pursuant to an Agreement dated March
29, 2004, in exchange for 20,859,459 shares of the Company's common stock. As
part of the reorganization of the Company on April 2, 2004, the common shares of
the Company were subject to a reverse split of 1 share for each 10 shares
outstanding.
Immediately prior to the Agreement, the Company had 2,027,580 shares of common
stock issued and outstanding. The acquisition was accounted for as
recapitalization of Sysview because the shareholders of Sysview controlled the
Company after the acquisition. Sysview was treated as the acquiring entity for
accounting purposes and the Company was the surviving entity for legal purposes.
The combined company is considered to be a continuation of the operations of
Syscan. The issued and outstanding common stock of Sysview prior to the
completion of the acquisition was restated to reflect the 21,082,935 common
stock issued by the Company.
PREFERRED STOCK
PREFERRED STOCK AUTHORIZED, RIGHTS AND PREFERENCES
The Company has authorized 2,000,000 shares of preferred stock, $0.001 par value
and the Company's Board of Directors has authorized 60,000 shares to be
designated as Series A Preferred Stock. The Company filed a certificate of
designation for the 5% Convertible Preferred Stock with the Delaware Secretary
of State on March 15, 2005. This filing constituted an amendment to the
Company's certificate of incorporation, designating the terms, rights and
preferences of a new series of preferred stock of the Company as follows:
PREFERRED STOCK CONVERSION RIGHTS. All or any portion of the stated value of
Preferred Stock outstanding may be converted into common stock at anytime by the
purchasers. The initial fixed conversion price of the preferred stock is $1.00
per share ("Conversion Price"). The Conversion Price is subject to anti-dilution
protection adjustments, on a full ratchet basis, at anytime that the preferred
stock is outstanding and prior to the effective date of the registration
statement required to be filed pursuant to the Registration Rights Agreement,
upon our issuance of additional shares of common stock, or securities
convertible into common stock, at a price that is less than the then Conversion
Price.
DIVIDENDS. The Preferred Stock accrues dividends at a rate of 5% per annum,
payable semiannually on July 1 and January 1 in cash, by accretion of the stated
value or in shares of common stock. Subject to certain terms and conditions, the
decision whether to accrete dividends to the stated value of the Preferred Stock
or to pay for dividends in cash or in shares of common stock, shall be at our
discretion.
REDEMPTION. On March 15, 2008 (the "Redemption Date"), all of the outstanding
Preferred Stock shall be redeemed for a per share redemption price equal to the
stated value on the Redemption Date (the "Redemption Price"). The Redemption
Price is payable by us in cash or in shares of common stock at our discretion
and shall be paid within five trading days after the Redemption Date. In the
event we elect to pay all or some of the Redemption Price in shares of common
stock, the shares of common stock to be delivered to the purchasers shall be
valued at 85% of the fifteen-day volume weighted average price of the common
stock on the Redemption Date.
RIGHT TO COMPEL CONVERSION. If, on any date after March 15, 2006, (A) the
closing market price per share of our common stock for ten (10) consecutive
trading days equals at least $4.00 (subject to adjustment for certain events),
and (B) the average reported daily trading volume during such ten-day period
equals or exceeds 100,000 shares, then we shall have the right, at our option,
to convert, all, but not less than all, of the outstanding shares of Preferred
Stock at the Conversion Price; provided that there shall be an effective
registration statement covering the resale of the shares of common stock
underlying the preferred stock at all times during such 10-day period and during
the 30-day notice period to the holders thereof.
RESTRICTIONS ON CONVERSION OF PREFERRED STOCK. No holder of our Preferred Stock
is entitled to receive shares upon payment of dividends on the Preferred Stock,
or upon conversion of the Preferred Stock held by such holder if such receipt
would cause such holder to be deemed to beneficially own in excess of 4.999% of
the outstanding shares of our common stock on the date of issuance of such
shares (such provision may be waived by such holder upon 61 days prior written
notice to us). In addition, no individual holder is entitled to receive shares
upon payment of dividends on the Preferred Stock, or upon conversion of the
Preferred Stock held by such holder if such receipt would cause such holder to
be deemed to beneficially own in excess of 9.999% of the outstanding shares of
our common stock on the date of issuance of such shares (such provision may be
waived by such holder upon 61 days prior written notice to us).
F-13
REGISTRATION RIGHTS. Pursuant to the terms of a Registration Rights Agreement
between us and the holders of the preferred stock, we were obligated to file a
registration statement on Form SB-2 registering the resale of shares of our
common stock issuable upon conversion of the preferred stock and exercise of the
warrants. We were required to file the registration statement on or before April
24, 2005 and have the registration statement declared effective on or before
July 13, 2005, which we completed prior to that date. If the registration
statement was not declared effective within the timeframe described, or if the
registration was suspended other than as permitted in the Registration Rights
Agreement, we are obligated to pay each holder a fee equal to 1.0% of such
holders purchase price of the Preferred Stock during the first 90 days, and 2.0%
for each 30 day period thereafter (pro rated for partial periods), that such
registration conditions are not satisfied.
RIGHT OF FIRST REFUSAL. Subject to certain conditions, we have granted the
holders a right of first refusal, for a period until one (1) year from the
effective date of the registration statement required to be filed in connection
with the purchase of the Preferred Stock, to participate in any subsequent
financing that we conduct.
VOTING RIGHTS. Holders of the Preferred Stock shall have no voting rights.
However, so long as any shares of Preferred Stock are outstanding, we shall not,
without the affirmative vote of the holders of a majority of the shares of the
Preferred Stock then outstanding, (a) alter or change adversely the powers,
preferences or rights given to the Preferred Stock or alter or amend the Series
A Certificate of Designation, (b) authorize or create any class of stock ranking
as to dividends or distribution of assets upon a liquidation senior to or
otherwise pari passu with the Preferred Stock, (c) amend our certificate or
articles of incorporation or other charter documents so as to affect adversely
any rights of the holders of the Preferred Stock, (d) increase the authorized
number of shares of Preferred Stock, or (e) enter into any agreement with
respect to the foregoing.
LIQUIDATION PREFERENCE. Upon our liquidation, dissolution or winding up, whether
voluntary or involuntary (a "Liquidation"), the holders of the Preferred Stock
shall be entitled to receive out of our assets, whether such assets are capital
or surplus, for each share of Preferred Stock an amount equal to the stated
value per share before any distribution or payment shall be made to the holders
of any of our securities with rights junior to the Preferred Stock, and if our
assets shall be insufficient to pay in full such amounts, then the entire assets
to be distributed to the holders of the Preferred Stock shall be distributed
among such holders ratably in accordance with the respective amounts that would
be payable on such shares if all amounts payable thereon were paid in full.
ANTI-DILUTION. Holders of the Preferred Stock are entitled to full ratchet
anti-dilution protection for issuances of common stock or common stock
equivalents, prior to the effective date of the registration statement covering
the resale of the shares of common stock underlying the Preferred Stock, at less
than the Conversion Price. Holders of Preferred Stock also have standard
anti-dilution protection for splits, dividends, subdivisions, distributions,
reclassifications and combinations of our common stock.
PREFERRED STOCK ISSUED
On March 15, 2005, the Company completed a private placement with a group of
accredited investors for the sale of 18,650 shares of the Company's 5% Series A
Convertible Preferred Stock along with warrants, expiring five years from the
date of issuance, to purchase additional shares of the Company's stock. Pursuant
to a registration rights agreement (Note 7), the Company has registered the
shares of common stock issuable upon conversion of the Preferred Stock and upon
exercise of the warrants with the Securities and Exchange Commission on Form
SB-2. The Company will not receive any proceeds from any sales made by the
selling stockholders but will pay the expenses of the offering. However, the
Company will receive the proceeds from the exercise of the warrants issued to
the selling stockholders if and when they are exercised. This registration was
declared effective by the SEC on July 7, 2005, and remains effective as of the
date of this filing.
Total common stock issuable upon conversions of the underlying the preferred
stock and warrants follows:
Series A Convertible Preferred stock (1) 1,865,000
Maximum accrued dividends on the shares
of Series A Convertible Preferred stock (1) 279,750
Warrants issued to purchasers in private
placement (2) 932,500
Warrants issued to placement agent in the
private placement (1) 186,500
---------
3,263,750
=========
(1) convertible at $1.00 per share, subject to adjustment pursuant to
the anti-dilution provisions
(2) convertible at $2.00 per share, subject to adjustment pursuant to
the anti-dilution provisions
F-14
The 5% Series A Convertible Preferred Stock has no voting rights and ranks ahead
of the common stock of the Company upon liquidation of the Company and with
respect to the payment of dividends. The holders are entitled to receive
cumulative dividends at the rate per share of 5% per annum, payable
semi-annually on July 1 and January 1 from the date of original issuance through
the date of redemption or conversion thereof payable in cash, by accretion of
the stated value, or in shares of common stock, the form of which is at the
discretion of the Company.
The 5% Series A Convertible Preferred Stock was priced at $100 per share and the
Company received proceeds of $1,865,000 less offering costs and expenses.
Starboard Capital Markets, LLC, a NASD member firm, acted as placement agent in
the sale of the preferred stock for which it received $186,500 in commissions
and 186,500 warrants to purchase shares of the Company's common stock at an
exercise price equal to $1.00 per share. The fair value of these warrants
totaled $290,000 and such amount was charged to other income/(expense) and
credited to additional paid-in capital during 2005. The Company also incurred
cash expenses totaling $50,000.
The warrants must be exercised by the payment of cash, except if there is no
effective registration statement covering the resale of the shares of common
stock underlying the warrants, a holder may exercise their warrants on a
cashless basis. Holders of the warrants are entitled to full ratchet
anti-dilution protection for issuances of common stock or common stock
equivalents, prior to the effective date of the registration statement covering
the resale of the shares of common stock underlying the preferred stock, at less
than the exercise price of such warrants. Holders of warrants also have standard
anti-dilution protection for splits, dividends, subdivisions, distributions,
reclassifications and combinations of our common stock. None of the individual
holders of the warrants are entitled to exercise any such warrant held by them,
if such exercise would cause such holder to be deemed to beneficially own in
excess of 4.999% of the outstanding shares of the Company's common stock on the
date of issuance of such shares.
PREFERRED STOCK ACCOUNTING TREATMENT
Pursuant to SFAS 133 and EITF Abstract No. 00-19, the embedded conversion
feature associated with the 5% Convertible Preferred Stock and the warrants
issued to the 5% Convertible Preferred Stock purchasers have been determined to
be derivative instruments. Accordingly, the fair value of these derivative
instruments has been recorded as a liability on the consolidated balance sheet
with the corresponding amount recorded as a discount to the 5% Convertible
Preferred Stock. Such discount is being accreted from the date of issuance, less
conversions, to the redemption date of the 5% Convertible Preferred Stock and
totaled $467,699 for the period from the date of issuance (March 15, 2005) to
December 31, 2005. The change in the fair value of the liability for derivative
contracts totaled $(1,112,005) in 2005 and has been credited to other
income/(expense) in the consolidated statements of operations.
The Company computes fair value of these derivatives using the Black-Scholes
valuation model. The Black-Scholes model was developed for use in estimating the
fair value of traded options that have no vesting restrictions and are fully
transferable. In addition, option valuation models require the input of highly
subjective assumptions, including the expected stock price volatility. The
Company's derivative instruments have characteristics significantly different
from traded options, and the input assumptions used in the model can materially
affect the fair value estimate. The assumptions used in this model to estimate
fair value of each derivative instrument and the resulting value of the
derivative liability as of December 31, 2005 are as follows:
Embedded conversion feature
associated with the 5%
Warrants Warrants Convertible Preferred Stock
----------------------------------------------------
Exercise/Conversion Price $ 1.00 2.00 $ 1.00
Fair Value of the Company's Common Stock $ 0.62 0.62 $ 0.62
Expected life in years 4.25 4.25 2.25
Expected volatility 99.77 99.77% 99.77
Expected dividend yield 0.0 0.00% 0.0
Risk free rate 4.0 4.0% 4.0
Calculated fair value per share $ 0.46 0.37 0.31
F-15
The 5% Convertible Preferred Stock is Mandatorily Redeemable Preferred Stock as
defined by SFAS 150 "ACCOUNTING FOR CERTAIN FINANCIAL INSTRUMENTS WITH
CHARACTERISTICS OF BOTH LIABILITIES AND EQUITY", and would also qualify as
"Preferred Stocks Subject to Mandatory Redemption Requirements or Whose
Redemption is Outside the Control of the Issuer" as defined by Accounting Series
Release ("ASR") No. 268 - "REDEEMABLE PREFERRED STOCKS". The conversion feature
associated with the 5% Convertible Preferred Stock is not a non-substantive or
minimal feature and therefore the provisions of ASR No. 268 have been applied in
classifying the 5% Convertible Preferred Stock separate from stockholders'
equity. The Company must redeem any outstanding 5% Convertible Preferred Stock
on March 15, 2008.
PREFERRED STOCK CONVERSIONS
During the third quarter of 2005, $250,000 of Series A Convertible Preferred
Stock (2,500 shares) plus dividend shares of 6,581 were converted into 256,581
shares of common stock. As of December 31, 2005, total Series A 5% Convertible
Preferred Stock outstanding was $1,615,000 or 16,150 shares.
STOCK OPTIONS
BOARD OF DIRECTOR APPROVED STOCK OPTIONS SUBJECT TO SHAREHOLDER APPROVAL AND
OTHER OUTSTANDING OPTIONS
On April 2, 2004, the Company's Board of Directors authorized the increase in
the number of stock options available under the 2002 Stock Option Plan (the
"Plan") from 200,000 to 2,200,000. On July 21, 2004, the Company's Board of
Directors further authorized the increase in the number of stock options
available under the 2002 Stock Option Plan from 2,200,000 to 3,200,000. The
subject increases are subject to stockholder ratification at the next annual or
special meeting of stockholders, which has not been obtained as of the date this
filing.
On April 13, 2004, the Company's Board of Directors authorized an aggregate of
1,700,000 options under the Plan to certain individuals at $1.50 per share, and
expiring through April 2014. These options were canceled by the Board of
Directors on May 7, 2004. On July 21, 2004, the Company's Board of Directors
further authorized an aggregate of 2,200,000 options under the 2002 Stock Option
Plan to be issued to certain individuals at $2.00 per share and expiring through
July 2014. During 2005, 220,000 options were canceled and the Company granted
230,000 options to certain individuals at $0.65, representing the fair market
value on the date of grant and expiring ten years from the date of grant,
bringing total options outstanding to 2,210,000. The grant of the above options
is subject to stockholder ratification of the Company's increase in the number
of stock options available for grant under the Plan. The Company plans to obtain
stockholder approval at its annual or special meeting of stockholders, which has
not yet been scheduled as of the date of this filing.
As part of an employment agreement signed in December 2003, the employee
received 500,000 options to acquire shares of the company at $0.09 per share for
a term of 2 years. Following the restructuring of the Company on April 2, 2004,
and in connection with the 1-for-10 reverse split, the options were re-issued as
50,000 options to acquire shares at $0.90 per share. The Company also issued
100,000 options to its former legal counsel in consideration of services
rendered. The options are exercisable at $0.25 per share for a term expiring
December 2005. These options have been re-issued as 10,000 options to acquire
shares at $2.50 per share following the reverse split in April 2004.
On April 26, 2005, the Company entered into employment agreements with its
executive officers, the terms of which were previously approved by the
independent members of the Company's board of directors. The employment
agreements extend through 2008 and provide for a base salary, annual bonus to be
determined by the Board of Directors, termination payments, stock options,
non-competition provisions, and other terms and conditions of employment. In
addition, the Company maintains employment agreements with other key employees
with similar terms and conditions.
Total options granted under the agreements with the Company's executive officers
were 3,300,000, exercisable at $0.01 per share. One-third of the options vest on
the date of execution of the employment agreement, one-third vest on April 3,
2006 and one-third vest on April 2, 2007.
Additionally, the Company issued an aggregate of 400,000 options exercisable at
$0.01 per share to two of its key employees in connection with the execution of
employment agreements with such individuals. One-third of such options vest on
April 26, 2005, one-third vest on April 3, 2006 and one-third vest on April 2,
2007.
F-16
Information about options outstanding and exercisable at December 31, 2005 is
summarized below:
-------------------------------------------------------------------------------------------------------------------
WEIGHTED- WEIGHTED-
AVERAGE AVERAGE WEIGHTED- WEIGHTED-
RANGE OF EXERCISE NUMBER REMAINING AVERAGE NUMBER REMAINING AVERAGE
PRICES OUTSTANDING CONTRACTUAL LIFE EXERCISE EXERCISABLE CONTRACTUAL EXERCISE
(YEARS) PRICE LIFE (YEARS) PRICE
-------------------------------------------------------------------------------------------------------------------
$0.01 3,700,000 6.25 $0.01 1,233,333 6.25 $0.01
-------------------------------------------------------------------------------------------------------------------
$0.90-$2.50 60,000 -- $1.17 60,000 -- $1.17
NOTE 6- INCOME TAXES
Provision for income taxes for all periods presented represents the minimum
franchise tax due, $800 per annum, in the State of California for each
California entity of the consolidated entity and prior years franchise taxes
paid in 2005 for a total of $3,232 (2004: $800). No provision for Hong Kong
Profits Tax has been made for the periods presented as the Company and its
subsidiaries operating in Hong Kong have no assessable profits during the years
being reported.
The Company believes sufficient uncertainty exists regarding the realizability
of the net operating loss carryforwards and other timing differences for the
periods presented. Accordingly, a valuation allowance has been provided for the
entire amount related thereto. The valuation allowance increased (decreased) by
approximately $596,000 (2004: $142,000).
As of December 31, 2005, the Company has available net operating loss
carryforwards for federal and state income tax purposes of approximately
$6,716,000 and $600,000, which expire principally through 2025 and 2015,
respectively. State net operating loss carryforwards are based on federal net
operating losses, which are limited to certain percentages and carryover periods
based on the year incurred. Pursuant to the Tax Reform Act of 1986, annual
utilization of the Company's net operating loss carryforwards may be limited if
a cumulative change in ownership of more than 50% is deemed to occur within any
three-year period.
THE FOLLOWING TABLE RECONCILES THE STATUTORY RATES
TO THE COMPANY'S EFFECTIVE RATE:
2005 2004
------ ------
U.S. and California statutory rate (%) (43.0) (43.0)
Change in valuation allowance 43.0 43.0
------ ------
-- --
====== ======
THE NET DEFERRED INCOME TAX ASSET CONSISTED OF THE FOLLOWING:
2005 2004
----------- -----------
Deferred tax assets
Federal net operating loss carryforwards $ 6,716,000 $ 5,633,000
State net operating loss carryforwards 600,000 1,080,000
Capitalized R&D Expenses 932,000 932,000
Tax credit carryforwards 708,000 708,000
----------- -----------
8,956,000 8,353,000
Less valuation allowance 8,949,000 8,353,000
----------- -----------
7,000 2,000
Deferred tax liability
Excess tax over book depreciation (7,000) (2,000)
----------- -----------
Net deferred income tax asset -- --
=========== ===========
F-17
NOTE 7- COMMITMENTS AND CONTINGENCIES
OPERATING LEASES
The Company is committed under various non-cancelable operating leases which
expire through November 2007. Future minimum rental commitments are as follows:
2006-$139,000 and 2007-$135,000. Rent expense charged to operations was
approximately $131,000 for 2005 (2004: $99,000).
BANK LINE OF CREDIT AND LETTERS OF CREDIT
The Company has a line of credit to borrow up to $2,500,000, bearing interest at
the rate of prime (7.25% at December 31, 2005) plus 0.5% and secured by all of
the assets of the Company. Interest payments are due monthly and all unpaid
interest and principal is due in full on October 30, 2006. Upon certain events
of defaults as more fully described in the agreement, the default variable
interest rate increases to prime plus 5.5%. The Company had $1,486,964 available
for use at December 31, 2005. The total amount available can never be more than
the face amount of all advances under line of credit and letters of credit
outstanding.
The Company issues letters of credit in the normal course of business. The
amount outstanding as of December 31, 2005, represents one letter of credit for
goods shipped to a related entity, expiring on January 24, 2006. The letter of
credit is secured by all goods and inventory covered by the document.
EMPLOYMENT AGREEMENTS
The Company maintains employment agreements with its executive officers which
extend through 2008. The agreements provide for a base salary, annual bonus to
be determined by the Board of Directors, termination payments, stock options,
non-competition provisions, and other terms and conditions of employment. In
addition, the Company maintains employment agreements with other key employees
with similar terms and conditions.
LITIGATION, CLAIMS AND ASSESSMENTS
On May 20, 2003, Syscan, Inc., the Company's wholly-owned subsidiary, filed a
lawsuit named SYSCAN, INC. V. PORTABLE PERIPHERAL CO., LTD. ("PPL"), IMAGING
RECOGNITION INTEGRATED SYSTEMS, INC., CARDREADER INC. AND TARGUS INC. (Case No.
C03-02367 VRW) in United States District Court, Northern District of California.
Syscan, Inc. alleges claims against the above-mentioned parties for patent
infringement of patent nos. 6,054,707, 6,275,309 and 6,459,506, and unfair
competition. Syscan, Inc. expects to continue the case unless a reasonable
settlement amount from the defendants or a licensing agreement to the
satisfaction of Syscan, Inc. is entered.
Syscan, Inc. is seeking: (1) a temporary restraining order, preliminary
injunction and permanent injunction against defendants, restraining defendants
from patent infringement and unfair competition; (2) treble damages due to
defendants' willful infringement; (3) punitive damages; (4) accounting of unjust
enrichment by defendants, resulting from defendants' unfair competition; and (5)
attorney's fees and costs.
The defendants are jointly represented by PPL's counsel. PPL has initiated
counterclaims against Syscan, Inc. for patent invalidity. Syscan, Inc. has not
yet been able to quantify its damage claim against PPL. Syscan, Inc. intends to
vigorously pursue this claim and denies PPL's counterclaim of patent invalidity.
There was a hearing in the Northern District of California on October 14, 2005,
in which arguments were presented to the court on the patent validity. The court
rendered a claim construction order on March 27, 2006 and the Company has filed
a motion for reconsideration for certain claim terms construction that are
believed to be erroneous. The motion has been set for hearing and oral argument
on June 29, 2006. The Company expects to continue this case unless a reasonable
settlement amount from defendants or a licensing agreement to the satisfaction
of the Company is entered.
The Company experiences routine litigation in the normal course of its business
and does not believe that any pending litigation will have a material adverse
effect on the Company's financial condition, results of operations or cash
flows.
F-18
REGISTRATION RIGHTS AGREEMENT
In connection with the issuance of 5% Convertible Preferred Stock (Note 5, the
Company executed a Registration Rights Agreement (the "agreement") with the
purchasers thereof under which the Company agreed to register the common shares
underlying the 5% Convertible Preferred Stock and related warrants. The
agreement provides for liquidated damages in the event a registration statement
is not declared effective by the SEC within 120 days of the March 15, 2005
closing date or if the registration statement is not maintained continuously
effective for a period of two years following the closing date. The liquidated
damages total an amount equal to one percent (pro-rated for partial months) of
the purchase price of the 5% Convertible Preferred Stock for each thirty day
period effectiveness of a registration statement is not maintained and two
percent for each thirty day period the registration statement ceases to remain
effective.
NOTE 8 - BUSINESS ACQUISITION
During the fourth quarter of 2005, the Company acquired Nanodisplay, Inc.,
("Nano") through its wholly-owned subsidiary SysView Technology Inc., which
focuses on introducing breakthrough price-performance technology in the high
definition television (HDTV) display market. The Company filed the "Certificate
of Merger" effective November 17, 2005. Nanodisplay is a designer of liquid
crystal on silicon (LCoS) HDTV technology and the Company believes that the
acquired technology and personnel will contribute significantly to its efforts
in the display market. The aggregate purchase price was $477,896, including
$97,896 of cash and 1,000,000 shares of common stock (500,000 of which are being
held in escrow pursuant to certain terms and conditions as outlined in the
agreement and have not been valued at the acquisition date) valued at $380,000,
which was determined based on the average market price of the Company's common
shares over the 1-week period before and after the terms of the acquisition were
agreed to. Nanodisplay's financial information is incorporated into the
consolidation of the Company effective November 17, 2005, the effective date of
the merger.
The estimated fair values of the assets and liabilities acquired are summarized
as follows:
Fixed assets $ 4,948
Goodwill 541,992
----------
Total assets acquired 546,940
Accounts payable and accrued liabilities 69,042
----------
Fair value of net assets acquired $ 477,898
==========
Due to the start-up nature of Nanodisplay's operations and its recent formation
(September 27, 2004), it had no sales from inception to the effective date of
the merger and through December 31, 2005. Unaudited pro forma financial
information based on the assumption that the acquisition took place as of
beginning of the period (January 1, 2005), with comparative information for the
immediately preceding period as though the acquisition had been completed at the
beginning of that period follows:
2005 2004
-------------------------
Net sales $7,848,007 $6,057,821
Net loss $3,349,357 $ 280,414
Basic and diluted net loss per share $ 0.14 $ 0.01
[END OF AUDITED FINANCIAL STATEMENTS]
F-19
--------------------------------------------------------------------------------
YOU SHOULD RELY ONLY ON THE INFORMATION CONTAINED IN THIS DOCUMENT. WE
HAVE NOT AUTHORIZED ANYONE TO PROVIDE YOU WITH INFORMATION THAT IS DIFFERENT.
THIS DOCUMENT MAY ONLY BE USED WHERE IT IS LEGAL TO SELL THESE SECURITIES. THE
INFORMATION IN THIS DOCUMENT MAY ONLY BE ACCURATE ON THE DATE OF THIS DOCUMENT.
ADDITIONAL RISKS AND UNCERTAINTIES NOT PRESENTLY KNOWN OR THAT ARE
CURRENTLY DEEMED IMMATERIAL MAY ALSO IMPAIR OUR BUSINESS OPERATIONS. THE RISKS
AND UNCERTAINTIES DESCRIBED IN THIS DOCUMENT AND OTHER RISKS AND UNCERTAINTIES
WHICH WE MAY FACE IN THE FUTURE WILL HAVE A GREATER IMPACT ON THOSE WHO PURCHASE
OUR COMMON STOCK. THESE PURCHASERS WILL PURCHASE OUR COMMON STOCK AT THE MARKET
PRICE OR AT A PRIVATELY NEGOTIATED PRICE AND WILL RUN THE RISK OF LOSING THEIR
ENTIRE INVESTMENT.
SYSVIEW TECHNOLOGY, INC.
1,825,000
SHARES OF COMMON STOCK
---------------
PROSPECTUS
----------------
_________________, 2006
--------------------------------------------------------------------------------
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
ITEM 24. INDEMNIFICATION OF DIRECTORS AND OFFICERS.
Our certificate of incorporation provides that all our directors,
officers, employees and agents shall be entitled to be indemnified by us to the
fullest extent permitted under the Delaware General Corporation Law, provided
that they acted in good faith and that they reasoned their conduct or action was
in, or not opposed to, the best interest of our company.
Our Bylaws provide for indemnification of our officers, directors and
others who become a party to an action on our behalf by us to the fullest extent
not prohibited under the Delaware General Corporation Law. Further, we maintain
officer and director liability insurance.
ITEM 25. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.
The following table sets forth estimated expenses expected to be incurred
in connection with the issuance and distribution of the securities being
registered. All such expenses will be paid by us.
Securities and Exchange Commission Registration Fee.......... $ 66.40
Printing and Engraving Expenses.............................. $ 200
Accounting Fees and Expenses................................. $ 10,000
Legal Fees and Expenses...................................... $ 10,000
Blue Sky Qualification Fees and Expenses..................... $ -0-
Miscellaneous................................................ $ 733.60
TOTAL........................................................ $21,000.00
ITEM 26. RECENT SALES OF UNREGISTERED SECURITIES.
In the last three years, we sold the following unregistered securities:
On August 8, 2006, we sold $1,150,000 of our Series B Convertible
Preferred Stock. Starboard Capital Markets, LLC, an NASD member firm, acted as
placement agent in the sale of the Preferred Stock, for which it received
$80,000 in commissions and 100,000 warrants to purchase shares of our common
stock, par value $.001 per share at an exercise price equal $1.50 per share.
In connection with the financing, we also issued to the purchasers common
stock purchase warrants to purchase up to an aggregate of 575,000 shares of our
Common Stock at an exercise price of $1.50 per share. The Warrants are
exercisable for a period of three years from the date of issuance. We have
agreed, pursuant to a registration rights agreement, to register the shares of
Common Stock issuable upon conversion of the Preferred Stock and upon exercise
of the Warrants with the Securities and Exchange Commission.
On October 24, 2005, we issued an aggregate of 500,000 shares of our
common stock to the former shareholders of Nanodisplay, Inc., a California
corporation, in connection with an Agreement and Plan of Merger and
Reorganization by and among us, Nano Acquisition Corp. (our wholly-owned
subsidiary), Nanodisplay, Inc. and the shareholders of Nanodisplay, Inc.,
pursuant to which we acquired all of the issued and outstanding capital stock of
Nanodisplay, Inc.
II-1
On October 6, 2005, we issued 125,000 restricted shares to FG Management
Inc. for public/investor relations services.
During the period from July 1, 2005 through September 30, 2005, we issued
an aggregate of 99,996 restricted shares to Investor Relations Group for
public/investor relations services.
On March 15, 2005, we sold $1,865,000 of our Series A Convertible
Preferred Stock. Starboard Capital Markets, LLC, an NASD member firm, acted as
placement agent in the sale of the Preferred Stock, for which it received
$186,500 in commissions and 186,500 warrants to purchase shares of our common
stock, par value $.001 per share at an exercise price equal $1.00 per share.
In connection with the financing, we also issued to the purchasers common
stock purchase warrants to purchase up to an aggregate of 932,500 shares of our
Common Stock at an exercise price of $2.00 per share. The Warrants are
exercisable for a period of five years from the date of issuance. We have
agreed, pursuant to a registration rights agreement, to register the shares of
Common Stock issuable upon conversion of the Preferred Stock and upon exercise
of the Warrants with the Securities and Exchange Commission.
In July 2004, we granted options to purchase up to 2,200,000 shares of our
common stock to our officers, directors and employees pursuant to our 2002 Stock
Option Plan. The options are exercisable for a period of ten years from the date
of grant at an exercise price of $2.00 per share. The options vest equally over
a four year period beginning in July 2005.
On April 2, 2004, in connection with our acquisition of Syscan, Inc., we
issued an aggregate of 20,859,459 shares of its common stock to Syscan Imaging
Limited in exchange for 100% of the issued and outstanding common stock of
Syscan, Inc. Syscan Imaging Limited simultaneously transferred 2,085,945 shares
of our common stock it was entitled to receive in connection with its sale of
Syscan, Inc. to Emerald Asset Advisors pursuant to a consulting agreement
entered into between the parties, as compensation for Emerald's services in
connection with the acquisition of Syscan, Inc. by us.
On April 2, 2004, we issued a total of 223,476 shares of our $0.001 par
value per share common stock at a value of $1.00 per share to Michael Xirinachs,
a former director of the company, upon the completion of the April 2, 2004,
Share Exchange Agreement acquisition: (i) as settlement of loans payable
totaling $23,476; and (ii) settlement in full of an employment contract signed
in December 2003 for 200,000 post-reverse split common shares.
In February 2004, we sold 50,000 shares of our common stock at purchase
price of $1.00 per share to one accredited investor. We used the proceeds from
this sale for working capital and general corporate purposes.
In December 2003, we issued 10,000 shares of our common stock to Paul
Ankorn (former director) and 10,000 shares of our common stock to William
Campbell (former director) as compensation for serving on our board of
directors.
Other than as specifically set forth above, all of the above offerings and
sales were deemed to be exempt under Section 4(2) of the Securities Act. No
advertising or general solicitation was employed in offering the securities. In
each instance, the offerings and sales were made to a limited number of persons,
who were either (i) accredited investors, (ii) business associates of ours,
(iii) our employees, or (iv) our executive officers or directors. In addition,
the transfer of such securities was restricted by us in accordance with the
requirements of the Securities Act. With respect to the issuances to accredited
investors, in addition to representations by them, we have made independent
II-2
determinations that they were accredited or sophisticated investors, capable of
analyzing the merits and risks of their investment, and that they understood the
speculative nature of their investment. With respect to our business associates,
employees and executive officers or directors, in addition to representations by
them, they were provided with detailed information and had access to all
material information about us, and we have made independent determinations that
they were capable of analyzing the merits and risks of their investment, and
that they understood the speculative nature of their investment. Furthermore,
all of the above-referenced persons were provided with access to our filings
with the Securities and Exchange Commission.
ITEM 27. EXHIBITS AND REPORTS ON FORM 8-K.
The following exhibits are filed with this registration statement.
2.1 Share Exchange Agreement (previously filed as exhibit 99.1 on Form
8-K dated April 19, 2004).
3.1 Certificate of Incorporation dated February 15, 2002 (previously
filed as exhibit 3.1 on Form 10-KSB dated March 31, 2005).
3.2 Certificate of Amendment to the Company's Certificate of
Incorporation dated March 19, 2004 (previously filed as exhibit 3.2
on Form 10-KSB dated March 31, 2005).
3.3 Certificate of Designation of Preferences, Rights and Limitations of
Series A Preferred Stock as filed with the Secretary of State of the
State of Delaware on March 15, 2005 (previously filed as exhibit
10.4 on Form 8-K dated March 21, 2005)
3.4 Amended and Restated Bylaws (previously filed as exhibit 3.4 on Form
10-KSB dated March 31, 2005).
3.5 Certificate of Amendment to the Company's Certificate of
Incorporation dated June 23, 2006 (previously filed as exhibit 3.5
on Form 10-QSB dated August 21, 2006).
3.6 Certificate of Designation of Preferences, Rights and Limitations of
Series B Preferred Stock as filed with the Secretary of State of the
State of Delaware on June 10, 2006 (previously filed as exhibit 10.4
on Form 8-K dated August 14, 2006)
5.1* Opinion of Richardson & Patel, LLP
10.1 Form of Convertible Preferred Stock and Common Stock Warrant
Purchase Agreement entered into by and between the Company and the
purchasers (previously filed as exhibit 10.1 on Form 8-K dated March
21, 2005).
10.2 Form of Common Stock Purchase Warrant (previously filed as exhibit
10.2 on Form 8-K dated March 21, 2005).
10.3 Form of Registration Rights Agreement (previously filed as exhibit
10.3 on Form 8-K dated March 21, 2005).
II-3
10.4 2002 Amended and Restated Stock Option Plan (previously filed as
exhibit 10.4 on Form 10-KSB dated March 31, 2005).
10.5 Employment Agreement entered between the Company and Darwin Hu on
April 26, 2005 (previously filed as exhibit 10.5 on Form 8-K dated
May 2, 2005).
10.6 Employment Agreement entered between the Company and William Hawkins
on April 26, 2005 (previously filed as exhibit 10.6 on Form 8-K
dated May 2, 2005).
10.7 Employment Agreement entered between the Company and David Clark on
April 26, 2005 (previously filed as exhibit 10.7 on Form 8-K dated
May 2, 2005).
10.8 2006 Stock Option Plan (previously filed as exhibit 10.8 on Form
10-QSB dated August 21, 2006).
10.9 Form of Convertible Preferred Stock and Common Stock Warrant
Purchase Agreement entered into by and between the Company and the
purchasers (previously filed as exhibit 10.1 on Form 8-K dated
August 14, 2006).
10.10 Form of Common Stock Purchase Warrant (previously filed as exhibit
10.2 on Form 8-K dated August 14, 2006).
10.11 Form of Registration Rights Agreement (previously filed as exhibit
10.3 on Form 8-K dated August 14, 2006).
14 Code of Ethics adopted by the Company's board of directors on March
28, 2005 (previously filed as exhibit 14 on Form 10-KSB dated March
31, 2005).
21 Subsidiaries of the Company (previously filed as exhibit 21 on Form
10-KSB dated March 31, 2005).
23.1* Consent of Richardson & Patel, LLP (contained in Exhibit 5.1)
23.2* Consent of Clancy and Co., P.L.L.C.
----------
* Filed herewith
ITEM 28. UNDERTAKINGS.
The undersigned registrant hereby undertakes:
1. To file, during any period in which it offers or sells securities, a
post-effective amendment to this registration statement to:
i. Include any prospectus required by section 10(a)(3) of the
Securities Act;
II-4
ii. Reflect in the prospectus any facts or events which,
individually or together, represent a fundamental change in the information in
the registration statement; and notwithstanding the forgoing, any increase or
decrease in volume of securities offered (if the total dollar value of
securities offered would not exceed that which was registered) and any deviation
From the low or high end of the estimated maximum offering range may be
reflected in the form of prospects filed with the Commission pursuant to Rule
424(b) if, in the aggregate, the changes in the volume and price represent no
more than a 20% change in the maximum aggregate offering price set forth in the
"Calculation of Registration Fee" table in the effective registration statement.
iii. include any additional or changed material information on the
plan of distribution.
2. For determining liability under the Securities Act, treat each
post-effective amendment as a new registration statement of the securities
offered, and the offering of the securities at that time to be the initial bona
fide offering.
3. File a post-effective amendment to remove from registration any of the
securities that remain unsold at the end of the offering.
Each prospectus filed pursuant to Rule 424(b) as part of a registration
statement relating to an offering, other than registration statements relying on
Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be
deemed to be part of and included in the registration statement as of the date
it is first used after effectiveness. Provided, however, that no statement made
in a registration statement or prospectus that is part of the registration
statement or made in a document incorporated or deemed incorporated by reference
into the registration statement or prospectus that is part of the registration
statement will, as to a purchaser with a time of contract of sale prior to such
first use, supersede or modify any statement that was made in the registration
statement or prospectus that was part of the registration statement or made in
any such document immediately prior to such date of first use.
Insofar as indemnification for liabilities arising under the Securities
Act of 1933 (the "Act") may be permitted to directors, officers and controlling
persons of the small business issuer pursuant to the foregoing provisions, or
otherwise, the small business issuer has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy
as expressed in the Act and is, therefore, unenforceable. In the event that a
claim for indemnification against such liabilities (other than the payment by
the small business issuer of expenses incurred or paid by a director, officer or
controlling person of the small business issuer in the successful defense of any
action, suit or proceeding) is asserted by such director, officer or controlling
person in connection with the securities being registered, the small business
issuer will, unless in the opinion of its counsel the matter has been settled by
controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as
expressed in the Securities Act and will be governed by the final adjudication
of such issue.
II-5
SIGNATURES
In accordance with the requirements of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form SB-2 and authorized this registration
statement to be signed on its behalf by the undersigned, in the City of San
Jose, State of California on December 22, 2006.
SYSVIEW TECHNOLOGY, INC.
By: /s/ Darwin Hu
-------------
Name: Darwin Hu
Title: Chairman of the Board
and Chief Executive Officer
In accordance with the requirements of the Securities Act of 1933, this
Amendment #1 to Registration Statement on Form SB-2 has been signed by the
following persons in the capacities and on the dates stated.
Person Capacity Date
------ -------- ----
/s/ Darwin Hu Chairman and Chief Executive December 22, 2006
-------------------- Officer)
Darwin Hu
/s/ William Hawkins Chief Operating Officer, December 22, 2006
-------------------- Principal Accounting Officer,
William Hawkins Acting Chief Financial Officer
and Secretary
* Senior Vice President of December 22, 2006
-------------------- Business Development and
David Clark Director
* Director December 22, 2006
--------------------
Lawrence Liang
* Director December 22, 2006
--------------------
Lai Ming Lau
* By Darwin Hu As attorney-in-fact